JPH0427996B2 - - Google Patents
Info
- Publication number
- JPH0427996B2 JPH0427996B2 JP57054665A JP5466582A JPH0427996B2 JP H0427996 B2 JPH0427996 B2 JP H0427996B2 JP 57054665 A JP57054665 A JP 57054665A JP 5466582 A JP5466582 A JP 5466582A JP H0427996 B2 JPH0427996 B2 JP H0427996B2
- Authority
- JP
- Japan
- Prior art keywords
- lys
- added
- obzl
- reduced pressure
- under reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 56
- 150000003839 salts Chemical class 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 211
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 141
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 132
- 239000000243 solution Substances 0.000 description 118
- 238000006243 chemical reaction Methods 0.000 description 116
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 113
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 111
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 104
- 239000002244 precipitate Substances 0.000 description 100
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 94
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 78
- 239000000203 mixture Substances 0.000 description 68
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 64
- 229940024606 amino acid Drugs 0.000 description 59
- 235000001014 amino acid Nutrition 0.000 description 59
- 150000001413 amino acids Chemical class 0.000 description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 48
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 48
- -1 p-toluenesulfonyl group Chemical group 0.000 description 45
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 44
- 238000004809 thin layer chromatography Methods 0.000 description 44
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 38
- 239000005695 Ammonium acetate Substances 0.000 description 38
- 229940043376 ammonium acetate Drugs 0.000 description 38
- 235000019257 ammonium acetate Nutrition 0.000 description 38
- 238000000921 elemental analysis Methods 0.000 description 35
- 229910052739 hydrogen Inorganic materials 0.000 description 35
- 238000000034 method Methods 0.000 description 35
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 34
- 238000004458 analytical method Methods 0.000 description 34
- 238000001816 cooling Methods 0.000 description 34
- 235000017557 sodium bicarbonate Nutrition 0.000 description 32
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 32
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 29
- 238000002844 melting Methods 0.000 description 29
- 230000008018 melting Effects 0.000 description 29
- 239000000872 buffer Substances 0.000 description 28
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 24
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 24
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- 239000010410 layer Substances 0.000 description 23
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 23
- 238000003756 stirring Methods 0.000 description 23
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 20
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 19
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 18
- 239000005457 ice water Substances 0.000 description 18
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 description 17
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 description 17
- 125000001309 chloro group Chemical group Cl* 0.000 description 17
- 102000058004 human PTH Human genes 0.000 description 17
- 238000001914 filtration Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 15
- 238000001035 drying Methods 0.000 description 14
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 238000010828 elution Methods 0.000 description 12
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 12
- FHOAKXBXYSJBGX-YFKPBYRVSA-N (2s)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)C(O)=O FHOAKXBXYSJBGX-YFKPBYRVSA-N 0.000 description 11
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 11
- 239000008363 phosphate buffer Substances 0.000 description 11
- 239000004202 carbamide Substances 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 8
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- IXDYPXPIEIRSOX-UHFFFAOYSA-N anisole;hydrochloride Chemical compound Cl.COC1=CC=CC=C1 IXDYPXPIEIRSOX-UHFFFAOYSA-N 0.000 description 7
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 7
- 102000005936 beta-Galactosidase Human genes 0.000 description 7
- 108010005774 beta-Galactosidase Proteins 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 238000009833 condensation Methods 0.000 description 7
- 230000005494 condensation Effects 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- 229920005654 Sephadex Polymers 0.000 description 5
- 239000012507 Sephadex™ Substances 0.000 description 5
- 150000001540 azides Chemical group 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 210000004900 c-terminal fragment Anatomy 0.000 description 5
- 230000008105 immune reaction Effects 0.000 description 5
- 230000036046 immunoreaction Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- PBGVVLQMNSPMKN-LURJTMIESA-N 2-[[(2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]acetic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](C)C(=O)NCC(O)=O PBGVVLQMNSPMKN-LURJTMIESA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- 108090000445 Parathyroid hormone Proteins 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 108010041407 alanylaspartic acid Proteins 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 210000004898 n-terminal fragment Anatomy 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- OPINTGHFESTVAX-BQBZGAKWSA-N Gln-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N OPINTGHFESTVAX-BQBZGAKWSA-N 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 102000003982 Parathyroid hormone Human genes 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000000199 parathyroid hormone Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229960001153 serine Drugs 0.000 description 3
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 3
- 229960002898 threonine Drugs 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 101100074988 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nmp-1 gene Proteins 0.000 description 2
- 102100036893 Parathyroid hormone Human genes 0.000 description 2
- HMNSRTLZAJHSIK-YUMQZZPRSA-N Pro-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 HMNSRTLZAJHSIK-YUMQZZPRSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000002788 anti-peptide Effects 0.000 description 2
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- XFKWBMYVKWXMCO-UHFFFAOYSA-N chloroform;ethanol;ethyl acetate Chemical compound CCO.ClC(Cl)Cl.CCOC(C)=O XFKWBMYVKWXMCO-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- LTOHTVPCWUZTJY-UHFFFAOYSA-N ethoxyethane;ethyl acetate;hexane Chemical compound CCOCC.CCCCCC.CCOC(C)=O LTOHTVPCWUZTJY-UHFFFAOYSA-N 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- AZLPEJUVWWGLHA-UHFFFAOYSA-N ethyl acetate;hexane;methanol Chemical compound OC.CCCCCC.CCOC(C)=O AZLPEJUVWWGLHA-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 229960002885 histidine Drugs 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- WKKHCCZLKYKUDN-UHFFFAOYSA-N (2,6-dichlorophenyl)methanol Chemical compound OCC1=C(Cl)C=CC=C1Cl WKKHCCZLKYKUDN-UHFFFAOYSA-N 0.000 description 1
- HLCTYBOTPCIHTG-QMMMGPOBSA-N (2r)-3-(acetamidomethylsulfanyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(=O)NCSC[C@@H](C(O)=O)NC(=O)OC(C)(C)C HLCTYBOTPCIHTG-QMMMGPOBSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- PTHGDVCPCZKZKR-UHFFFAOYSA-N (4-chlorophenyl)methanol Chemical compound OCC1=CC=C(Cl)C=C1 PTHGDVCPCZKZKR-UHFFFAOYSA-N 0.000 description 1
- CVBUKMMMRLOKQR-UHFFFAOYSA-N 1-phenylbutane-1,3-dione Chemical compound CC(=O)CC(=O)C1=CC=CC=C1 CVBUKMMMRLOKQR-UHFFFAOYSA-N 0.000 description 1
- HSQFVBWFPBKHEB-UHFFFAOYSA-N 2,3,4-trichlorophenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1Cl HSQFVBWFPBKHEB-UHFFFAOYSA-N 0.000 description 1
- LHJGJYXLEPZJPM-UHFFFAOYSA-N 2,4,5-trichlorophenol Chemical compound OC1=CC(Cl)=C(Cl)C=C1Cl LHJGJYXLEPZJPM-UHFFFAOYSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- GBNHEBQXJVDXSW-UHFFFAOYSA-N 3,4,5-trichlorophenol Chemical compound OC1=CC(Cl)=C(Cl)C(Cl)=C1 GBNHEBQXJVDXSW-UHFFFAOYSA-N 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- JKTYGPATCNUWKN-UHFFFAOYSA-N 4-nitrobenzyl alcohol Chemical compound OCC1=CC=C([N+]([O-])=O)C=C1 JKTYGPATCNUWKN-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- AXBVSRMHOPMXBA-UHFFFAOYSA-N 4-nitrothiophenol Chemical compound [O-][N+](=O)C1=CC=C(S)C=C1 AXBVSRMHOPMXBA-UHFFFAOYSA-N 0.000 description 1
- KEULITJLZYZYPU-AWEZNQCLSA-N 4-o-benzyl 1-o-(2,5-dioxopyrrolidin-1-yl) (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanedioate Chemical compound C([C@H](NC(=O)OC(C)(C)C)C(=O)ON1C(CCC1=O)=O)C(=O)OCC1=CC=CC=C1 KEULITJLZYZYPU-AWEZNQCLSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- XAEWTDMGFGHWFK-IMJSIDKUSA-N Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O XAEWTDMGFGHWFK-IMJSIDKUSA-N 0.000 description 1
- QXRNAOYBCYVZCD-BQBZGAKWSA-N Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN QXRNAOYBCYVZCD-BQBZGAKWSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- 101001135732 Bos taurus Parathyroid hormone Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- DNWBUCHHMRQWCZ-GUBZILKMSA-N Lys-Ser-Gln Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O DNWBUCHHMRQWCZ-GUBZILKMSA-N 0.000 description 1
- 101100084404 Mus musculus Prodh gene Proteins 0.000 description 1
- 101100184046 Schizosaccharomyces pombe (strain 972 / ATCC 24843) mid1 gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- MBRZVWSXTLBVNY-UHFFFAOYSA-N acetic acid;chloroform;ethanol Chemical compound CCO.CC(O)=O.ClC(Cl)Cl MBRZVWSXTLBVNY-UHFFFAOYSA-N 0.000 description 1
- VXDSLUMUNWTSDB-UHFFFAOYSA-N acetic acid;chloroform;methanol Chemical compound OC.CC(O)=O.ClC(Cl)Cl VXDSLUMUNWTSDB-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- YIRBOOICRQFSOK-NSHDSACASA-N benzyl (2s)-2-amino-3-methylbutanoate Chemical compound CC(C)[C@H](N)C(=O)OCC1=CC=CC=C1 YIRBOOICRQFSOK-NSHDSACASA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 1
- HYGYSIDIKIGPJA-UHFFFAOYSA-N chloroform;ethyl acetate;methanol Chemical compound OC.ClC(Cl)Cl.CCOC(C)=O HYGYSIDIKIGPJA-UHFFFAOYSA-N 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- QILSFLSDHQAZET-UHFFFAOYSA-N diphenylmethanol Chemical compound C=1C=CC=CC=1C(O)C1=CC=CC=C1 QILSFLSDHQAZET-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 238000006698 hydrazinolysis reaction Methods 0.000 description 1
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 1
- DWKPPFQULDPWHX-VKHMYHEASA-N l-alanyl ester Chemical compound COC(=O)[C@H](C)N DWKPPFQULDPWHX-VKHMYHEASA-N 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 1
- QZJVWTNHFOMVHX-UHFFFAOYSA-N methanol;methyl acetate Chemical compound OC.COC(C)=O QZJVWTNHFOMVHX-UHFFFAOYSA-N 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 125000004492 methyl ester group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- MXHTZQSKTCCMFG-UHFFFAOYSA-N n,n-dibenzyl-1-phenylmethanamine Chemical compound C=1C=CC=CC=1CN(CC=1C=CC=CC=1)CC1=CC=CC=C1 MXHTZQSKTCCMFG-UHFFFAOYSA-N 0.000 description 1
- BFGNHBBJJWESFT-UHFFFAOYSA-N n,n-dimethylformamide;ethoxyethane Chemical compound CCOCC.CN(C)C=O BFGNHBBJJWESFT-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- VEDDBHYQWFOITD-UHFFFAOYSA-N para-bromobenzyl alcohol Chemical compound OCC1=CC=C(Br)C=C1 VEDDBHYQWFOITD-UHFFFAOYSA-N 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
本発明は、新規なペプチドに関する。さらに詳
しくは、本発明の式
H−Lys53−Lys−Glu55−Asp−Asn−Vsl−Leu
−Val60−Glu−Ser−His−Glu−Lys65−Ser−
Leu−Gly−Glu−Ala70−Asp−Lys−Ala−Asp
−Val75−Asn−Val−Leu−Thr−Lys80−Ala−
Lys−Ser−Gln84−OH [1]
で表わされるペプチドまたはその塩に関する。
本発明の新規な式[]で表わされるペプチド
(以下単にペプチドという)またはその塩は、式
[]で示されるアミノ酸順序に個々のアミノ酸
又は低級ペプチドを縮合して構成せしめ、縮合反
応の最終段階で側鎖の官能基の保護基を脱離する
ことにより得られる。縮合反応自体はペプチド合
成のための常法手段に従つて、保護基の着脱、縮
合反応を繰り返すことにより行なわれる。即ち、
本目的化合物の原料ならびにすべての中間体の製
造において使用される各種保護基はペプチド合成
で既知なもの、従つて加水分解、酸分解、還元、
アミノリシスまたはヒドラジノリシスのような既
知手段によつて容易に脱離することのできる保護
基が用いられる。このような保護基はペプチド合
成化学の分野の文献ならびに参考書に記載されて
いる。
例えばアミノ基に使用する保護基としては、ホ
ルミル基、トリフルオロアセチル基、フタロイル
基、p−トルエンスルホニル基、o−ニトロフエ
ニルスルフエニル基などのアシル基、ベンジルオ
キシカルボニル基、o(またはp)−ブロモベンジ
ルオキシカルボニル基、o(またはp)−クロロベ
ンジルオキシカルボニル基、p−ニトロベンジル
オキシカルボニル基、p−メトキシベンジルオキ
シカルボニル基などのベンジルオキシカルボニル
基、トリクロロエチルオキシカルボニル基、t−
ブチルオキシカルボニル基、t−アミルオキシカ
ルボニル基などの脂肪族オキシカルボニル基、2
−フエニル−イソプロポキシカルボニル基、2−
トリル−イソプロポキシカルボニル基、2−p−
ジフエニル−イソプロポキシカルボニル基などの
アラルキルオキシカルボニル基などがある。また
これらアミノ基をベンゾイルアセトン、アセチル
アセトンなどの1,3−ジケトンと反応させるこ
とによつて得られるエナミンの形成により保護す
ることができる。
カルボキシル基は、アミド形成、ヒドラチド形
成またはエステル化によつて保護される。即ちア
ミド基は3,4−ジメトキシベンジル基、ビス−
(p−メトキシフエニル)メチル基などによつて
置換される。ヒドラチド基はベンジルオキシカル
ボニル基、トリクロロエチルオキシカルボニル
基、トリフルオロアセチル基、t−ブチルオキシ
カルボニル基、トリチル基、2−p−ジフエニル
−イソプロポキシカルボニル基などによつて置換
される。エステル基はメタノール、エタノール、
t−ブタノール、シアノメチルアルコールなどの
アルカノール、ベンジルアルコール、p−ブロモ
ベンジルアルコール、p−クロロベンジルアルコ
ール、2,6−ジクロロベンジルアルコール、p
−メトキシベンジルアルコール、p−ニトロベン
ジルアルコール、ベンズヒドリルアルコール、ベ
ンゾイルメチルアルコール、p−ブロモベンゾイ
ルメチルアルコール、p−クロロベンゾイルメチ
ルアルコールなどのアラルカノール、2,4,6
−トリクロロフエノール、2,4,5−トリクロ
ロフエノール、3,4,5−トリクロロフエノー
ル、ペンタクロロフエノール、p−ニトロフエノ
ール、2,4−ジニトロフエノールなどのフエノ
ール、チオフエノール、p−ニトロチオフエノー
ルなどのチオフエノールなどによつて置換され
る。
前記セリンおよびスレオニンの水酸基は、例え
ばエステル化またはエーテル化によつて保護する
ことができる。このエステル化に適する基として
は、例えばアセチル基、ベンゾイル基、ベンジル
オキシカルボニル基、エチルオキシカルボニル基
などである。またエーテル化に適する基としては
例えばベンジル基、テトラヒドロピラニル基、t
−ブチル基である。これらの水酸基の保護には、
2,2,2−トリフルオロ−1−t−ブチルオキ
シカルボニルアミノエチル基、2,2,2−トリ
フルオロ−1−ベンジルオキシカルボニルアミノ
基も適する。しかしながら、これらの水酸基を必
ずしも保護する必要はない。
前記ヒスチジンのイミノ基を保護するのに使用
する基としては、例えばベンジル基、トリチル
基、ベンジルオキシカルボニル基、トシル基、
2,2,2−トリフルオロ−1−t−ブチルオキ
シカルボニルアミノエチル基、2,2,2−トリ
フルオロ−1−ベンジルオキシカルボニルアミノ
エチル基などであるが、このイミノ基を必ずしも
保護する必要はない。
本発明の式[]で表わされるペプチドの合成
においては、個々のアミノ酸もしくは低級ペプチ
ドの縮合は、例えば保護されたα−アミノ基およ
び活性化末端カルボキシル基をもつアミノ酸また
はペプチドと遊離α−アミノ基および保護された
末端カルボキシル基をもつアミノ酸またはペプチ
ドとを反応させるか、あるいは活性化α−アミノ
基および保護された末端カルボキシル基をもつア
ミノ酸またはペプチドと遊離の末端カルボキシル
基および保護されたα−アミノ基をもつアミノ酸
またはペプチドを反応させることにより実施する
ことができる。
この場合カルボキシル基は、アジド、酸無水
物、酸イミダゾリドまたは活性エステル、例えば
シアノメチルエステル、チオフエニルエステル、
p−ニトロチオフエニルエステル、p−メタンス
ルホニルフエニルエステル、チオジルエステル、
p−ニトロフエニルエステル、2,4−ジニトロ
フエニルエステル、2,4,5−トリクロロフエ
ニルエステル、2,4,6−トリクロロフエニル
エステル、ペンタクロロフエニルエステル、N−
ヒドロキシコハク酸イミドエステル、N−ヒドロ
キシフタル酸イミドエステル、8−ヒドロキシキ
ノリンエステルまたはN−ヒドロキシピペリジン
エステルなどに変換することによつて、あるいは
カルボジイミド、N,N′−カルボニル−ジイミ
ダゾールまたはイソオキゾリウム塩、例えばウツ
ドワード反応剤などを使用して反応させることに
よつて活性化することができる。
本発明において好ましい縮合方法は、カルボジ
イミド法、アジド法、活性エステル法および無水
物法である。縮合の各段階では、ラセミ化が起ら
ない方法またはラセミ化が最小になる方法を用い
るのが望ましく、好ましくはアジド法、活性エス
テル法、Wunsch法[Z.Naturforsch.,21b,426
(1966)]またはGeiger法[Chem.Ber.,103788
(1970)]とりわけ縮合剤としてN−エチル−
N′−3−ジメチルアミノプロピル−カルボジイ
ミド(WSCI)を用いる変法などを用いる。
縮合順序は式[]で示されるアミノ酸順序で
あれば、如何なる順序からも合成し得るが、C−
末端側から合成するのが有利である。
例えば保護されたペプチド(65−84)は、C未
端フラグメント69−84とN未端フラグメント65−
68をWSCIを用いるGeiger変法による方法で縮合
するのがよい。N末端フラグメント65−68は、フ
ラグメント66−68と65番目のアミノ酸を活性エス
テル法又はWSCIを用いるGeiger変法により縮合
するのがよい。
またC末端フラグメント69−84は、フラグメン
ト72−84に順次71番目のアミノ酸、70番目のアミ
ノ酸、69番目のアミノ酸を活性エステル法または
WSCIを用いるGeiger変法により縮合するのがよ
い。フラグメント72−84は、フラグメント77−84
に順次76番目のアミノ酸、75番目のアミノ酸、74
番目のアミノ酸およびフラグメント72−73を活性
エステル法またはWSCIを用いるGeiger変法によ
り縮合するのがよい。フラグメント77−84は、フ
ラグメント82−84とフラグメント77−81をWSCI
を用いるGeiger変法により縮合するのがよい。
保護されたペプチド(62−84)は、前述のC末
端フラグメント69−84とN末端フラグメント62−
68をWSCIを用いるGeiger変法により縮合するの
がよい。フラグメント62−68は、フラグメント65
−68に64番目のアミノ酸、フラグメント62−63を
活性エステルまたはWSCIを用いるGeiger変法及
びアジド法により縮合せしめるのがよい。
また保護されたペプチド(53−84)は、C末端
フラグメント55−84とN末端フラグメント53−54
をWSCIを用いるGeiger変法による方法で縮合す
るのがよい。C未端フラグメント55−84は、前述
の保護されたペプチド(62−84)に61番目のアミ
ノ酸を縮合させて得られたフラグメント61−84と
フラグメント59−60に58番目のアミノ酸、57番目
のアミノ酸を縮合して得られたフラグメント57−
60をWSCIを用いるGeiger変法による方法で縮合
し、56番目のアミノ酸、55番目のアミノ酸を順次
活性エステル法により縮合するのがよい。
上記のペプチドの合成に際して、その末端カル
ボキシル基は、これを必ずしも保護しなければな
らないわけではない。例えばアジド法、活性エス
テル法によつて縮合させる場合には、保護しなく
てもよい。
しかしながら、これらの基を前記で述べたよう
なエステル化によつて、例えばメチルエステル、
エチルエステル、ベンジルエステルなどで保護す
ることもできる。また、これらのエステル基は、
例えばメチルエステル基はこれを希薄な水酸化ナ
トリウム水溶液で分裂し、またヒドラジドに変
え、またベンジルエステル基は無水弗化水素また
は水素添加分解によつて分裂することができる。
これらのペプチドのα−アミノ基は、これらを通
常の保護基、例えばベンジルオキシカルボニル
基、t−ブトキシカルボニル基、t−アミノオキ
シカルボニル基で保護されるが、ベンジルオキシ
カルボニル基は水素添加分解によつて脱離され、
t−ブトキシカルボニル基、t−アミルオキシカ
ルボニル基はトリフルオロ酢酸で脱離される。
セリンおよびスレオニンの水酸基はベンジル基
で、リジンのε−アミノ基はo−クロロベンジル
オキシカルボニル基で、保護するのが適する。こ
れらの保護基は無水弗化水素で脱離される。
こうして保護されたペプチド(53−84)が得ら
れる。これらの保護基は、好ましくは、酸分解、
例えは無水弗化水素の処理によつて一段階で脱離
され、式[]の目的化合物が得られる。
上記の目的化合物[]は、公知のペプチドを
精製する手段により精製することができる。例え
ばセフアデツクスLH−20、セフアデツクスG−
50、Dowexl、カルボキシメチルセルロース等の
担体を用いるカラムクロマトグラフイーにより行
うことができる。
本発明のペプチド[]は、その方法の条件に
より塩基またはその塩の形で得られる。通常は酢
酸の如き有機酸との塩の形で保存され得る。
本発明のペプチド[]を抗原として得られる
抗体または本ペプチド[]を抗原とする免疫反
応により、エンザイムイムノアツセイ(EIA)、
ラジオイムノアツセイ(RIA)を利用して、ヒト
副甲状腺ホルモン(h−PTH)の濃度を測定し
得るものである。
まず本発明の式[]にて表わされるペプチド
の免疫反応における有用性を述べる。
(1) 抗体産生用ペプチドおよび抗体の作成
〔BSA−[Cys45]−ペプチド(45−84)結合物
の調製法〕
BSA(牛血清アルブミン)71.5mgを1mMEDTA
含有100mMリン酸緩衝液(PH8.0)25mlに溶解
し、これに5,5′−ジチオビス(2−ニトロ安息
香酸)436μgを加え、37℃で15分間反応させ、
遊離の−SH基を保護した。反応液に3−(2′−ベ
ンゾチアゾリル−ジチオ)プロピオン酸スクシン
イミドエステル7.59mg含有するジメチルホルムア
ミド溶液3mlを加え、5℃で1時間反応させた。
酢酸でPH5.0に調整後、反応液をセフアデツクス
G−25(45×70cm)のカラムに添加し、50mM酢
酸緩衝液(PH5.0)でゲルろ過を行つた。その素
通り画分を回収し、BSAのアミノ基に3−(2′−
ベンゾチアゾリル−ジチオ)・プロピオニル基を
導入した誘導体(BSAIモルに対し、5.67モル結
合)を得た。
次いで、この誘導体含有液のPHを7.0に調整後、
[Cys45]−ペプチド(45−84)10.85mgを加え、室
温下24時間撹拌反応した。反応液を蒸留水に対し
透析を行ない、透析内液を凍結乾燥し、BSA−
[Cys45]−ペプチド(45−84)結合物(結合モル
比1:5.17)を得た。
〔抗体の作成法]
ペプチド(46−84)、ペプチド(51−84)、ペプ
チド(53−84)の各抗原は500μgを、BSA−
[Cys45]−ペプチド(45−84)は1mg([Cys45]−
ペプチド(45−84)として約250μg)をそれぞ
れ、0.15MNaCl含有10mMリン酸緩衝液(PH7.4)
0.5mlに溶解し、これにフロイント・コンプリー
トアジユバンド(Freunds Complete Adjuvant)
0.5mlを加えて充分混和して乳剤を得た。モルモ
ツト一匹に得られた乳剤1mlを四肢沓の皮中、お
よび背中の皮下数カ所に注射した。10日おきに同
量の乳剤を5回皮下注射し、最終免疫より10日目
に心臓穿刺によりその全血を採取し、室温に1時
間放置し、凝固せしめた後、3000rpmで5分間遠
心してペプチド(4−84)、ペプチド(51−84)、
ペプチド(53−84)、およびBSA−[Cys45]−ペ
プチド−(45−84)に対する各抗血清を得た。
(2) 標識用ペプチド
〔β−ガラトシダーゼ−[Cys45]−ペプチド
(45−84)の調製法〕
[Cys45]−ペプチド(45−84)1mgを
lmMEDTA含有50mMリン酸緩衝液(PH7.0)1
mlに溶解し、これにN−〔2−(2′−ピリジル−ジ
チオ)エチル〕−3−(2′−ベンゾチアゾリル−ジ
チオ)プロピオンアミド165.3μgを含有するジメ
チルホルムアミド溶液165.3μを加えて、5℃で
2時間反応せしめた。反応液を酢酸でPH5.0に調
整した後、セフアデツクスG−15(15×40cm)の
カラムに添加し、50mM酢酸緩衝液(PH5.0)で
ゲルろ過を行つた。その素通り画分を回収し、
〔Cys(2′−ピリジル−S−S−(CH2)2−NH−CO
−(CH2)2−S)45〕ペプチド(45−84)誘導体を
得た。
次いでこの誘導体38.9μgを含有する100mMリ
ン酸緩衝液(PH80.)2mlに、β−ガラクトシダ
ーゼ2mgを加え、室温で3時間反応せしめた。反
応液をセフアデツクスG−150(1.5×90cm)のカ
ラムに添加し、0.15MNaCl含有10mMリン酸緩
衝液(PH7.4)でゲルろ過を行ないその素通り画
分を回収し、β−ガラクトシダーゼ[Cys45]−ペ
プチド(45−84)の結合物(純度94%)を得た。
〔125I−標識物の調製法〕
反応用試験管に、2mCiの放射活性を有する125I
−NaIを含有する500mMリン酸緩衝液(PH7.5)
50μ、[Tyr45]−ペプチド(45−84)、[Tyr50]
−ペプチド(50−84)、[Tyr52]−ペプチド(52
−84)、[Tyr64]−ペプチド(64−84)の各々を
2μgを含有する50mMリン酸緩衝液(PH7.5)10μ
、およびクロラミンT20μgを含有する50mM
リン酸緩衝液(PH7.5)20μを加えて、30秒間撹
拌反応せしめた。次いで、1%ヨウ化カリウム水
溶液10μ、および5%人血清アルブミン含有
0.1N酢酸0.5mlを加えた後、セフアデツクスG−
25(1.0×50cm)のカラムに反応液を添加し、
0.15MNaClを含有する10mMリン酸緩衝液(PH
7.4)でゲルろ過を行ない末反応の125I−NaIを除
去して、125I−[Tyr45]−ペプチド(45−84)、125I
−[Tyr50]−ペプチド(50−84)、125I−[Tyr52]−
ペプチド(52−84)、および125I−[Tyr64]−ペプ
チド(64−84)の各々標識化合物を得た。
得られた125I−[Tyr45]−ペプチド(45−84)
標識化合物の比活性は、540μCi/μg、反応収
率は76.5%であり、125I−[Tyr50]−ペプチド(50
−84)標識化合物の比活性は535μCi/μg、反
応収率75.5%であり、125I−[Tyr52]−ペプチド
(52−84)標識化合物の比活性は560μCi/μg、
反応収率74.8%であり、125I−[Tyr64]−ペプチド
(64−84)標識化合物の比活性は555μCi/μg、
反応収率は77.3%であつた。また同様にh−
PTH(1−34)やウシ−PTH(1−84)(抽出物)
を用いて標識した結果に比べて比活性で2〜3
倍、反応収率で3〜4倍良好であつた。
(3) 免疫反応
〔抗血清の免疫反応性〕
EIAによる抗体力価の測定
前述の各抗血清を免疫反応用媒体(0.25%
BSA、3mMEDTA、0.1%NaN3、0.15MNaClを
含有する10mMリン酸緩衝液(PH7.4)を用いて、
200、400、800、1600、3200、6400、12800、
25600倍に希釈した溶液100μ、β−ガラクトシ
ダーゼ[Cys45]−ペプチド(45−84)液
([Cys45]−ペプチド(45−84)として約20pg含
有)100μ、および免疫反応用媒体100μを小
試験管に加え、5℃にて24時間反応させ、次いで
モルモツト正常血清の100倍希釈液、100μ抗モ
ルモツトγ−グロブリン血清(ウサギ)の10倍希
釈液100μを加えてさらに5℃で24時間反応さ
せた。反応液に0.5MNaCl3mlを加えた後、
3000rpmで15分間遠心分離して、その沈澱物を回
収した。次いでこの沈澱物にβ−ガラクトシダー
ゼ活性測定液〔o−ニトロフエニール−β−D−
ガラクトピラノシド5mg/mlを有する0.1%BSA、
1mMMgCI2、0.1%NaN3、0.15MNaClを含有す
る10mMリン酸緩衝液(PH6.7)85部、および
200mMメルカプトエタノール含有メタノール液
15部よりなる溶液〕200μを加えて、37℃で60
分間反応させた。反応終了後、反応停止液
[100mMグリシン−NaOH緩衝液(PH11.0)〕を
2.3mlを加え、反応を停止させ、反応液の420nm
における吸光度を測定し、抗血清の各希釈濃度に
おけるβ−ガラクトシダーゼ[Cys45]−ペプチド
(45−84)との免疫反応による結合率を求めた。
3200倍希釈液における結果を第1表に示すが、他
の希釈倍数の濃度においても同様の傾向を示すも
のであつた。
The present invention relates to novel peptides. More specifically, the formula H-Lys 53 -Lys-Glu 55 -Asp-Asn-Vsl-Leu
−Val 60 −Glu−Ser−His−Glu−Lys 65 −Ser−
Leu−Gly−Glu−Ala 70 −Asp−Lys−Ala−Asp
−Val 75 −Asn−Val−Leu−Thr−Lys 80 −Ala−
It relates to a peptide represented by Lys-Ser-Gln 84 -OH [1] or a salt thereof. The novel peptide of the present invention represented by the formula [] (hereinafter simply referred to as peptide) or its salt is constructed by condensing individual amino acids or lower peptides in the amino acid order represented by the formula [], and the final step of the condensation reaction is It can be obtained by removing the protective group of the functional group on the side chain. The condensation reaction itself is carried out by repeating the attachment and detachment of a protecting group and the condensation reaction in accordance with conventional methods for peptide synthesis. That is,
The various protecting groups used in the production of the raw materials for the target compound and all intermediates are those known in peptide synthesis, such as hydrolysis, acidolysis, reduction,
Protecting groups are used that are easily removable by known means such as aminolysis or hydrazinolysis. Such protecting groups are described in the literature and reference books in the field of peptide synthetic chemistry. For example, protective groups used for amino groups include acyl groups such as formyl group, trifluoroacetyl group, phthaloyl group, p-toluenesulfonyl group, o-nitrophenylsulfenyl group, benzyloxycarbonyl group, o (or p )-bromobenzyloxycarbonyl group, o (or p)-chlorobenzyloxycarbonyl group, p-nitrobenzyloxycarbonyl group, benzyloxycarbonyl group such as p-methoxybenzyloxycarbonyl group, trichloroethyloxycarbonyl group, t-
Aliphatic oxycarbonyl groups such as butyloxycarbonyl group and t-amyloxycarbonyl group, 2
-phenyl-isopropoxycarbonyl group, 2-
Tolyl-isopropoxycarbonyl group, 2-p-
Examples include aralkyloxycarbonyl groups such as diphenyl-isopropoxycarbonyl groups. These amino groups can also be protected by forming enamines obtained by reacting with 1,3-diketones such as benzoylacetone and acetylacetone. Carboxyl groups are protected by amide formation, hydratide formation or esterification. That is, the amide group is a 3,4-dimethoxybenzyl group, a bis-
Substituted with (p-methoxyphenyl)methyl group, etc. The hydratide group is substituted with a benzyloxycarbonyl group, a trichloroethyloxycarbonyl group, a trifluoroacetyl group, a t-butyloxycarbonyl group, a trityl group, a 2-p-diphenyl-isopropoxycarbonyl group, and the like. Ester groups include methanol, ethanol,
Alkanols such as t-butanol and cyanomethyl alcohol, benzyl alcohol, p-bromobenzyl alcohol, p-chlorobenzyl alcohol, 2,6-dichlorobenzyl alcohol, p
- aralkanols such as methoxybenzyl alcohol, p-nitrobenzyl alcohol, benzhydryl alcohol, benzoylmethyl alcohol, p-bromobenzoylmethyl alcohol, p-chlorobenzoylmethyl alcohol, 2,4,6
- Phenols such as trichlorophenol, 2,4,5-trichlorophenol, 3,4,5-trichlorophenol, pentachlorophenol, p-nitrophenol, 2,4-dinitrophenol, thiophenol, p-nitrothiophenol, etc. is substituted by thiophenol, etc. The hydroxyl groups of the serine and threonine can be protected, for example, by esterification or etherification. Groups suitable for this esterification include, for example, acetyl group, benzoyl group, benzyloxycarbonyl group, and ethyloxycarbonyl group. Groups suitable for etherification include, for example, benzyl group, tetrahydropyranyl group, t
-butyl group. To protect these hydroxyl groups,
Also suitable are the 2,2,2-trifluoro-1-t-butyloxycarbonylaminoethyl group and the 2,2,2-trifluoro-1-benzyloxycarbonylamino group. However, it is not necessary to protect these hydroxyl groups. Examples of the group used to protect the imino group of histidine include benzyl group, trityl group, benzyloxycarbonyl group, tosyl group,
2,2,2-trifluoro-1-t-butyloxycarbonylaminoethyl group, 2,2,2-trifluoro-1-benzyloxycarbonylaminoethyl group, etc., but it is not necessary to protect this imino group. There isn't. In the synthesis of the peptides of the present invention represented by the formula [], the condensation of individual amino acids or lower peptides is carried out, for example, with amino acids or peptides having a protected α-amino group and an activated terminal carboxyl group, and a free α-amino group. and an amino acid or peptide with a protected terminal carboxyl group, or an amino acid or peptide with an activated α-amino group and a protected terminal carboxyl group with a free terminal carboxyl group and a protected α-amino group. This can be carried out by reacting amino acids or peptides with groups. In this case, the carboxyl group is an azide, an acid anhydride, an acid imidazolide or an active ester, such as cyanomethyl ester, thiophenyl ester,
p-nitrothiophenyl ester, p-methanesulfonylphenyl ester, thiodyl ester,
p-nitrophenyl ester, 2,4-dinitrophenyl ester, 2,4,5-trichlorophenyl ester, 2,4,6-trichlorophenyl ester, pentachlorophenyl ester, N-
or by converting into hydroxysuccinimide ester, N-hydroxyphthalic imide ester, 8-hydroxyquinoline ester or N-hydroxypiperidine ester, or carbodiimide, N,N'-carbonyl-diimidazole or isoxolium salt, For example, it can be activated by reacting with a woodward reactant or the like. Preferred condensation methods in the present invention are the carbodiimide method, azide method, active ester method and anhydride method. In each step of the condensation, it is desirable to use a method that does not cause racemization or a method that minimizes racemization, preferably the azide method, active ester method, or Wunsch method [Z.Naturforsch., 21b , 426
(1966)] or the Geiger method [Chem.Ber., 103 788
(1970)] in particular as a condensing agent.
A modified method using N'-3-dimethylaminopropyl-carbodiimide (WSCI) is used. The condensation order can be synthesized in any order as long as it is the amino acid order shown by the formula [ ], but C-
It is advantageous to synthesize from the terminal side. For example, the protected peptide (65-84) has a C-terminal fragment 69-84 and an N-terminal fragment 65-84.
68 is preferably condensed using a modified Geiger method using WSCI. N-terminal fragment 65-68 is preferably obtained by condensing fragment 66-68 with the 65th amino acid by the active ester method or the modified Geiger method using WSCI. In addition, the C-terminal fragment 69-84 is obtained by adding the 71st amino acid, the 70th amino acid, and the 69th amino acid to fragment 72-84 using the active ester method.
Condensation is preferably carried out by a modified Geiger method using WSCI. Fragment 72−84 is fragment 77−84
76th amino acid, 75th amino acid, 74th amino acid,
The amino acid No. 1 and fragments 72-73 are preferably condensed by the active ester method or a modified Geiger method using WSCI. Fragment 77-84 is WSCI fragment 82-84 and fragment 77-81
The condensation is preferably carried out by the modified Geiger method using . The protected peptide (62-84) consists of the previously described C-terminal fragment 69-84 and the N-terminal fragment 62-
68 is preferably condensed by a modified Geiger method using WSCI. Fragment 62−68 is fragment 65
-68 is preferably condensed with the 64th amino acid, fragment 62-63, by the modified Geiger method using an active ester or WSCI and the azide method. The protected peptide (53-84) also consists of a C-terminal fragment 55-84 and an N-terminal fragment 53-54.
It is preferable to condense them by a modified Geiger method using WSCI. C-terminal fragment 55-84 is fragment 61-84 obtained by condensing the 61st amino acid to the above-mentioned protected peptide (62-84), and fragment 59-60 with the 58th amino acid and the 57th amino acid. Fragment 57 obtained by condensing amino acids
It is preferable to condense 60 by a modified Geiger method using WSCI, and sequentially condense the 56th amino acid and the 55th amino acid by an active ester method. During the synthesis of the above peptides, the terminal carboxyl group does not necessarily have to be protected. For example, when condensation is carried out by an azide method or an active ester method, protection is not required. However, by esterification of these groups as described above, e.g. methyl ester,
It can also be protected with ethyl ester, benzyl ester, etc. In addition, these ester groups are
For example, a methyl ester group can be cleaved with dilute aqueous sodium hydroxide solution and converted to a hydrazide, and a benzyl ester group can be cleaved with anhydrous hydrogen fluoride or hydrogenolysis.
The α-amino groups of these peptides are protected by conventional protecting groups such as benzyloxycarbonyl, t-butoxycarbonyl, and t-aminooxycarbonyl groups, but the benzyloxycarbonyl group is susceptible to hydrogenolysis. and was separated,
The t-butoxycarbonyl group and t-amyloxycarbonyl group are removed with trifluoroacetic acid. The hydroxyl groups of serine and threonine are suitably protected with a benzyl group, and the ε-amino group of lysine is suitably protected with an o-chlorobenzyloxycarbonyl group. These protecting groups are removed with anhydrous hydrogen fluoride. The protected peptide (53-84) is thus obtained. These protecting groups are preferably protected against acid decomposition,
For example, it is eliminated in one step by treatment with anhydrous hydrogen fluoride to obtain the target compound of formula []. The above target compound [ ] can be purified by known means for purifying peptides. For example, Cephadex LH-20, Cephadex G-
It can be carried out by column chromatography using a carrier such as 50, Dowexl, or carboxymethylcellulose. The peptide [] of the present invention can be obtained in the form of a base or a salt thereof depending on the conditions of the method. Usually, it can be preserved in the form of a salt with an organic acid such as acetic acid. Enzyme immunoassay (EIA) can be performed by antibody obtained using the peptide of the present invention [] as an antigen or by an immune reaction using the present peptide [] as an antigen.
Radioimmunoassay (RIA) can be used to measure the concentration of human parathyroid hormone (h-PTH). First, the usefulness of the peptide represented by the formula [] of the present invention in immune reactions will be described. (1) Preparation of peptides and antibodies for antibody production [Preparation method of BSA-[Cys 45 ]-peptide (45-84) conjugate] 71.5 mg of BSA (bovine serum albumin) was added to 1mMEDTA.
Dissolved in 25 ml of 100 mM phosphate buffer (PH 8.0) containing 436 μg of 5,5′-dithiobis(2-nitrobenzoic acid) and reacted at 37°C for 15 minutes.
Free -SH groups were protected. 3 ml of a dimethylformamide solution containing 7.59 mg of 3-(2'-benzothiazolyl-dithio)propionic acid succinimide ester was added to the reaction solution, and the mixture was reacted at 5°C for 1 hour.
After adjusting the pH to 5.0 with acetic acid, the reaction solution was added to a column of Sephadex G-25 (45 x 70 cm), and gel filtration was performed with 50 mM acetate buffer (PH 5.0). The flow-through fraction was collected, and 3-(2'-
A derivative having a benzothiazolyl-dithio/propionyl group introduced therein (5.67 mol bond relative to BSAI mol) was obtained. Next, after adjusting the pH of this derivative-containing liquid to 7.0,
10.85 mg of [Cys 45 ]-peptide (45-84) was added, and the reaction was stirred at room temperature for 24 hours. The reaction solution was dialyzed against distilled water, the dialyzed solution was freeze-dried, and BSA-
A [Cys 45 ]-peptide (45-84) conjugate (binding molar ratio 1:5.17) was obtained. [Method for producing antibodies] 500 μg of each antigen of peptide (46-84), peptide (51-84), and peptide (53-84) was added to BSA-
[Cys 45 ]-peptide (45-84) is 1 mg ([Cys 45 ]-
Approximately 250 μg of peptide (45-84) was added to 10 mM phosphate buffer (PH7.4) containing 0.15M NaCl.
Dissolve in 0.5ml and add Freunds Complete Adjuvant to this.
0.5 ml was added and thoroughly mixed to obtain an emulsion. One ml of the obtained emulsion was injected into each guinea pig into the skin of the limbs and several subcutaneous locations on the back. The same amount of emulsion was subcutaneously injected 5 times every 10 days, and whole blood was collected by cardiac puncture on the 10th day after the final immunization, left at room temperature for 1 hour to solidify, and then centrifuged at 3000 rpm for 5 minutes. Peptide (4-84), Peptide (51-84),
Antisera against peptide (53-84) and BSA-[ Cys45 ]-peptide-(45-84) were obtained. (2) Peptide for labeling [Preparation method of β-galatosidase-[Cys 45 ]-peptide (45-84)] 1 mg of [Cys 45 ]-peptide (45-84)
lmMEDTA containing 50mM phosphate buffer (PH7.0) 1
ml of dimethylformamide solution containing 165.3 μg of N-[2-(2'-pyridyl-dithio)ethyl]-3-(2'-benzothiazolyl-dithio)propionamide. The reaction was allowed to proceed at ℃ for 2 hours. After adjusting the reaction solution to pH 5.0 with acetic acid, it was added to a column of Sephadex G-15 (15 x 40 cm), and gel filtration was performed with 50 mM acetate buffer (PH 5.0). Collect the fraction that passes through,
[Cys(2'-pyridyl-S-S-( CH2 ) 2- NH-CO
-( CH2 ) 2 -S) 45 ] peptide (45-84) derivative was obtained. Next, 2 mg of β-galactosidase was added to 2 ml of 100 mM phosphate buffer (PH80.) containing 38.9 μg of this derivative, and the mixture was allowed to react at room temperature for 3 hours. The reaction solution was added to a Sephadex G-150 (1.5 x 90 cm) column, gel filtrated with 10 mM phosphate buffer (PH7.4) containing 0.15 M NaCl, and the flow-through fraction was collected, and β-galactosidase [Cys 45 ]-peptide (45-84) conjugate (purity 94%) was obtained. [ 125 I-labeled product preparation method] In a reaction test tube, add 125 I with 2 mCi of radioactivity.
-500mM phosphate buffer containing NaI (PH7.5)
50μ, [Tyr 45 ]-peptide (45-84), [Tyr 50 ]
-Peptide (50-84), [Tyr 52 ]-Peptide (52
−84) and [Tyr 64 ]-peptide (64−84), respectively.
10μ of 50mM phosphate buffer (PH7.5) containing 2μg
, and 50mM containing 20μg of chloramine T
20μ of phosphate buffer (PH7.5) was added, and the reaction was stirred for 30 seconds. Next, 10μ of 1% potassium iodide aqueous solution and 5% human serum albumin were added.
After adding 0.5ml of 0.1N acetic acid,
Add the reaction solution to a 25 (1.0 x 50 cm) column,
10mM phosphate buffer (PH
Perform gel filtration in step 7.4) to remove the final reaction 125I -NaI to obtain 125I- [ Tyr45 ]-peptide (45-84), 125I
-[ Tyr50 ]-peptide (50-84), 125I- [ Tyr52 ]-
Labeled compounds of peptide (52-84) and 125 I-[Tyr 64 ]-peptide (64-84) were obtained. The obtained 125I- [ Tyr45 ]-peptide (45-84)
The specific activity of the labeled compound was 540 μCi/μg, the reaction yield was 76.5%, and 125 I-[Tyr 50 ]-peptide (50
-84) The specific activity of the labeled compound is 535 μCi/μg, reaction yield 75.5%, and the specific activity of the 125 I-[Tyr 52 ]-peptide (52-84) labeled compound is 560 μCi/μg,
The reaction yield was 74.8%, and the specific activity of the 125 I-[Tyr 64 ]-peptide (64-84) labeled compound was 555 μCi/μg.
The reaction yield was 77.3%. Similarly, h-
PTH (1-34) or bovine PTH (1-84) (extract)
The specific activity is 2-3 compared to the result of labeling using
The reaction yield was 3 to 4 times better. (3) Immune reaction [Immunoreactivity of antiserum] Measurement of antibody titer by EIA Each of the antisera mentioned above was added to the immune reaction medium (0.25%
Using 10mM phosphate buffer (PH7.4) containing BSA, 3mMEDTA, 0.1% NaN3 , 0.15M NaCl,
200, 400, 800, 1600, 3200, 6400, 12800,
Add 100μ of a 25,600-fold diluted solution, 100μ of β-galactosidase [Cys 45 ]-peptide (45-84) solution (containing about 20 pg as [Cys 45 ]-peptide (45-84)), and 100μ of the immunoreaction medium to a small plate. Add to the test tube and react at 5°C for 24 hours, then add 100 μl of normal guinea pig serum diluted and 100 μl of 100 μl anti-guinea pig γ-globulin serum (rabbit) diluted 10 times, and react at 5°C for another 24 hours. I let it happen. After adding 3ml of 0.5M NaCl to the reaction solution,
The precipitate was collected by centrifugation at 3000 rpm for 15 minutes. Next, this precipitate was added with a β-galactosidase activity measurement solution [o-nitrophenyl-β-D-
0.1% BSA with galactopyranoside 5 mg/ml,
85 parts of 10mM phosphate buffer (PH6.7) containing 1mMgCI2 , 0.1% NaN3 , 0.15M NaCl, and
Methanol solution containing 200mM mercaptoethanol
Solution consisting of 15 parts] Add 200μ and incubate at 37℃ for 60 minutes.
Allowed to react for minutes. After the reaction is complete, add the reaction stop solution [100mM glycine-NaOH buffer (PH11.0)].
Add 2.3ml to stop the reaction, and measure the reaction solution at 420nm.
The absorbance at each dilution of the antiserum was measured, and the binding rate due to the immunoreaction with β-galactosidase [Cys 45 ]-peptide (45-84) at each dilution concentration of the antiserum was determined.
The results for the 3200-fold dilution are shown in Table 1, but similar trends were observed for other dilutions.
【表】
その結果、いずれの抗原も、特異的な抗体を産
生しうる有用な免疫抗原であることが判明した。
また後述の各種h−PTH関連物質との免疫反
応性から判断した結果、h−PTHのC末端に特
異的な抗体を産生し得る抗原であることが明らか
である。
125I−標識物との免疫反応性
EIA系での測定の高力価を示した3種の抗血清
〔抗ペプチド(46−84);No.1−(A)、抗ペプチド
(53−84);No.3−(B)、および抗BSA−[Cys45]−
ペプチド(45−84);No.1−(C)〕を用い、各125I
−標識物との免疫反応性を調べた。
前記3種血清を免疫反応用媒体〔0.5%BSA含
有50mMベロナール緩衝液(PH8.0)〕で、200、
400、800、1600、3200、6400、12800、25600倍で
希釈した溶液100μ:各々125I−標識物(0.01μci
の放射活性を有する各標識体含有)100μ、お
よび免疫反応用媒体100μを小試験管に加え、
5℃にて45時間反応させ、次いでモルモツト正常
血清の100倍希釈液100μ、および抗モルモツト
γ−グロブリン血清ウサギの10倍希釈液100μ
加えて、さらに5℃で24時間反応を行なつた。反
応液を3000rpmで15分間遠心分離して、沈澱物を
回収し、その沈澱物の放射活性をγ−カウンター
を用いて測定し、各希釈濃度における抗血清との
各標識物との免疫反応による結合率を求めた。
6400倍希釈液における結果を第2表に示すが、他
の希釈倍数の濃度においても同様の傾向を示すも
のであつた。[Table] As a result, all antigens were found to be useful immunizing antigens capable of producing specific antibodies. Furthermore, judging from the immunoreactivity with various h-PTH-related substances described below, it is clear that this is an antigen capable of producing antibodies specific to the C-terminus of h-PTH. Immunoreactivity with 125 I-labeled substances Three antisera showed high titers when measured using the EIA system [anti-peptide (46-84); No. 1-(A), anti-peptide (53-84); ); No. 3-(B), and anti-BSA-[ Cys45 ]-
Peptide (45-84); No. 1-(C)], each 125 I
-Immunoreactivity with the labeled substance was investigated. The above three types of serum were mixed with immunoreaction medium [50mM veronal buffer containing 0.5% BSA (PH8.0)] at 200%
100μ of solutions diluted 400, 800, 1600, 3200, 6400, 12800, 25600 times: each 125 I-labeled substance (0.01μci
Add 100μ of each labeled substance with radioactivity) and 100μ of immunoreaction medium to a small test tube,
React for 45 hours at 5°C, then add 100μ of a 100-fold dilution of normal guinea pig serum and 100μ of a 10-fold dilution of rabbit anti-guinea pig γ-globulin serum.
In addition, the reaction was further carried out at 5°C for 24 hours. The reaction solution was centrifuged at 3000 rpm for 15 minutes to collect the precipitate, and the radioactivity of the precipitate was measured using a γ-counter, and the immunoreaction of each label with the antiserum at each diluted concentration was determined. The binding rate was determined.
The results for the 6400-fold dilution are shown in Table 2, but similar trends were observed for other dilutions.
【表】
その結果、いずれの標識抗原もh−PTHのC
末端特異抗体と良好な反応性を示すものであり、
RIAの標識抗原として有用なものであることが認
められた。
(4) 各種h−PTH関連物質との免疫反応性
〔h−PTH(1−84)の抽出・精製〕
h−PTH(1−84)は、副甲状線機能充進症の
患者より、その副甲状を摘出し、Keutmann等の
方法(A.C.S.,17,26,1978)に従い、抽出・精
製をした。
〔天然h−PTH(53−84)の調製法〕
上記した精製h−PTH(1−84)をトリプシン
消化し、Keutmann等の方法(A.C.S.,17,26,
1978)に従い調製した。
〔合成[Asp76]−h−PTH(53−84)〕
合成[Asp76]−h−PTH(53−84)は、特願昭
53−187686号明細書に従い合成した。
〔免疫交叉性の測定〕
各種h−PTH関連物質(天然h−PTH(1−
84)、天然h−PTH(53−84)、合成[Asp76]−h
−PTH(53−84)、本発明のペプチド(53−84)
をそれぞれ0.2〜2000fmole含有)溶液100μ、β
−ガラクトシダーゼ−[Cys45]ペプチド(45−
84)([Cys45]ペプチド(45−84)として約10pg
含有)液100μ、および抗血清希釈液(Aは、
15000倍希釈、Bは5000倍希釈、Cは9000倍希釈
したものを用いた)100μを反応用試験管に加
え、5℃にて24時間反応させ、次いでモルモツト
正常血清の100倍希釈液100μ、抗モルモツトγ
−グロブリン血清(ウサギ)の10倍希釈液100μ
を加えて、さらに5℃で24時間反応させた。反
応液に0.5MNaCl3mmlを加えた後、3000rpmで15
分間遠心分離して、その沈澱物を回収した。次い
でその沈澱物にβ−ガラクトシダーゼ活性測定液
(前記)200μを加え37℃で120分間反応させた。
反応終了後、反応停止液(前記)を2.3ml加え、
反応液を停止させ、反応液の420nmにおける吸光
度を測定した。
その結果第1図(抗血清−A)、第2図(抗血
清−B)、第3図(抗血清C)に示す通りであり、
各図中、〇−〇は本発明のペプチド(53−84)の
場合を示し、●−●は天然h−PTH(53−84)の
場合を示し、△−△は合成[Asp76]−h−PTH
(53−84)の場合を示し、□−□は、天然h−
PTH(1−84)の場合を示す。
以上の免疫反応などの結果から、本発明の式
[]で表わされる各種のペプチドは、84個のア
ミノ酸からなるペプチドホルモンであるh−
PTHのC末端側の血中濃度測定におけるPTH関
連疾患を診断するのに有用な試薬となるものであ
つた。
従つてまたこれらの各種ペプチドは、公知の
EIAやRIAにおける種々の定量手段、例えば競争
法やサンドイツチ法やこれらとの固相法や=抗体
法との組合せを用いる手段にて適宜使用すればよ
い。さらにEIAにおいては、前記の標識化合物質
であるβ−ガラクトシダーゼの他の公知の種々の
酵素、例えばペルオキシターゼやアルカリホスフ
アターゼなどを標識として適宜選択使用して酵素
標識したペプチドを得ればよい。
次いで、本発明の実施例を挙げて具体的に述べ
るが本発明はこれによつて何んら限定されるもの
ではない。
尚、本明細書中に記載の略記号は次の意味を有
する。
Gln;L−グルタミン
Ser;L−セリン
Lys;L−リジン
Ala;L−アラニン
Thr;L−スレオニン
Leu;L−ロイシン
Val;L−バリン
Asp;L−アスパラギン酸
Glu;L−グルタミン酸
Gly;グリシン
His;L−ヒスチジン
Asn;L−アスパラギン
Arg;L−アルギニン
Pro:L−プロリン
Tyr;L−チロシン
Cys;L−システイン
BOC;t−ブチルオキシカルボニル
AOC;t−アミルオキシカルボニル
Z−CI;O−クロロベンジルオキシカルボニ
ル
Bzl;ベンジル
Tos;トシル
OMe;メチルエステル
OEt;エチルエステル
OBzl;ベンジルエステル
OSU;N−ヒドロキシコハク酸イミドエステ
ル
ONP;P−ニトロフエニルエステル
PAC;フエナシルエステル
Acm;アセトアミドメチル
TosOH;P−トルエンスルホン酸
TFA;トリフルオロ酢酸
Et3N;トリエチルアミン
TBA;トリベンジルアミン
NMM;N−メチルモルホリン
HOBT;1−ヒドロキシベンゾトリアゾール
DMF;ジメチルホルムアミド
THF;テトラヒドロフラン
NMP;N−メチル−2−ピロリドン
MeOH;メタノール
EtOH;エタノール
BuCH;ブタノール
エーテル;ジエチルエーテル
WSCI;N−エチル、N′−3−ジメチルアミノ
プロピル−カルボジイミド
HOBT;1−ヒドロキシベンゾトリアゾール
次に実施例および参考例をあげて本発明の製造
例を具体的に説明する。
尚、実施例中で使用した薄層クロマトグラフイ
ー(TLC)の担体および展開溶媒は次の通りで
ある。
担体;メルク社製シリカゲルG
展開溶媒;
1;CHCI3−MeOH−酢酸 (95:5:3)
2; 〃 (85:15:5)
3; 〃 (85:10:5)
4; 〃 (80:25:2)
5;ベンゼン−酢酸エチル (1:1)
6; 〃 (2:1)
7;CHCl3−EtOH−酢酸エチル (5:2:5)
8;CHCl3−EtOH−酢酸エチル (10:1:5)
担体;メルク社製セルロース
展開溶媒;
9;BuOH−ピリジン−酢酸−水
(2:2:2:3)
10;BuOH−ピリジン−酢酸−水
(1:1:1:2)
11;BuOH−ピリジン−酢酸−水
(15:10:3:12)
また、アミノ酸分析の条件は次の通りである。
被検体を6N塩酸(保護ペプチドのときは、必
要によりアニソール10%添加)で110℃24〜45時
間封管中で加水分解し、これを減圧乾燥してアミ
ノ酸分析に供した。
参考例 1
[Tyr64]−ペプチド(65−84);H−Tyr−
Lys−Ser−Leu−Gly−Glu−Ala−Asp−Lys
−Ala−Asp−Val−Asn−Val−Leu−Thr−
Lys−Ala−Lys−Ser−Gln−OH
(1) P(83−84);BOC−Ser(Bzl)−Gln−OBzl
[]
BOC−Gln−OBzl81.4g(0.242M)を
TFA270mlに溶かし、室温で45分間撹拌した後
TFAを減圧留去した。残渣にエーテルを加え、
生じた沈澱を集めた。これをDMF270mlに溶か
し、これにHOBT32.67g(0.242M)、BOC−Ser
(Bzl)−OH67.35g(0.242M)およびWSCI44.29
ml(0.242M)を加え、一夜撹拌した。反応後、
DMFを減圧下留去した。残渣を酢酸エチル440ml
に溶かし、1N塩酸、5%重曹水、水の順に洗洗
した。無水芒硝で乾燥し、減圧乾固した。酢酸エ
チル−ヘキサンより再結して
[]101.43g(収率81.6%)を得た。
融点121〜123℃
TLC;Rf7=0.75
[α]27D−14.12(C=1.0、DMF)
元素分析[C27H35O7N3として]
C% H% N%
測定値 62.98 7.03 8.01
計算値 63.14 6.87 8.18
(2) P(82−84);BOC−Lys(Z−Cl)−Ser
(Bzl)−Gln−OBzl [2]
[1]98.87g(192.5mM)をTFA440mlに加
え、室温で30分間撹拌した後、TFAを減圧留去
した。残渣をDMF330mlに溶かし、HOBT28.6
g、BOC−Lys(Z−Cl)−OHのDMF溶液
(BOC−Lys(Z−Cl)−OH・TBA103.33g(1.1
倍M)を酢酸エチル−1N塩酸で処理し、酢酸エ
チル層を無水芒硝で乾燥後、減圧乾固した。残渣
をDMF110mlに溶かす)およびWSCI83.72ml
(1.1倍モル)を加え、室温で2日間撹拌した。反
応後、DMFを減圧留去し、残渣に氷水を加え、
生じた沈澱を集めた。エタノールヘキサンで3回
再結して[2]111.06g(収率71.2%)を得た。
TLC;Rf1=0.32、Rf7=0.76
融点;145〜147℃
[α]27D−13.1(C=1.0、DMF)
元素分析[C41H52O10N5Clとして]
C% H% N%
測定値 61.02 6.65 8.74
計算値 60.77 6.47 8.65
(3) P(80−81);BOC−Lys(Z−Cl)−Ala−
OMe [3]
BOC−Lys(Z−Cl)−OH・TBA234.24gを酢
酸エチルに懸濁し、1N塩酸、水の順に洗浄した。
無水芒硝で乾燥し、減圧乾固した後、DMF400ml
に溶かした。これにH−Ala−OMe・HCl67.0
g、HOBT64.8g、WSCI87.84mlを加え、室温で
一夜撹拌した。反応後、DMFを減圧留去し、残
渣を酢酸エチル2に溶かし、5%重曹水、1N
塩酸、水の順に洗浄した。無水芒硝で乾燥し、減
圧乾固した後、DMF400mlに溶かした。これにH
−Ala−OMe・HCl67.0g、HOBT64.8g、
WSCI87.84mlを加え、室温で一夜撹拌した。反応
後、DMFを減圧留去し、残渣を酢酸エチル2
に溶かし、5%重曹水、1N塩酸、水の順に洗浄
した。
無水芒硝で乾燥後、減圧乾固した。酢酸エチル
−ヘキサンより再結して[3]231.8g(収率
96.6%)を得た。
融点;58〜60℃
TLC;Rf1=0.77
[α]27D−17.16(C=1.0、DMF)
元素分析[C23H34O7N3Clとして]
C% H% N%
測定値 54.96 6.78 8.56
計算値 55.25 6.85 8.40
(4) P(79−81);BOC−Thr(Bzl)−Lys(Z−
Cl)−Ala−OMe [4]
[3]174.99g(0.35M)をTFA500mlに加え、
室温で50分間撹拌した。反応後、TFAを減圧留
去し、残渣を酢酸エチルに溶かした後、5%重曹
水、水の順に洗浄した。無水芒硝で乾燥後、減圧
乾固した。残渣をDMF400mlに溶かし、これに
HOBT49.95g(1.05倍M)、BOC−Thr(Bzl)−
OH114.33g(1.05倍M)およびWSCI67.7ml
(1.05倍M)を加え、室温で一夜撹拌した。反応
後、DMFを減圧留去し、残渣に氷水を加えた。
生じた沈澱を集め熱エタノールで4回再沈澱して
[4]99.31gを得た。
母液か減圧濃縮し、残渣をクロロホルムに溶か
し、5%重曹水(4回)、1N塩酸(2回)、水
(2回)の順に洗浄した。無水芒硝で乾燥後、減
圧乾固した。残渣をシリカゲルカラムクロマトグ
ラフイー〔溶出溶媒クロロホルム−エタノール−
酢酸(5:1:5)〕により精製して[4]35.09
g得た。不純物を含む区分は、次の追加合成の際
のカラムクロマトグラフイーの精製の際に合わせ
て用いた。次に[3]22.5g(45mM)をTFA70
mlに加え、室温で45分間撹拌した。反応後、
TFAを減圧留去し、残渣をDMF50mlに溶かした
後、NMMでPH7に調節した。次いで、
HOBT6.68g(1.1倍M)、BOC−Thr(Bzl)−
OH15.31g(1.1倍M)、WSCI9.06ml(1.1倍M)
を加え、一夜撹拌した。反応後、DMFを減圧留
去し、残渣をクロロホルム200mlに溶かした後、
5%重曹水、1N塩酸、水の順に洗浄した。無水
芒硝で乾燥後、減圧乾固した。残渣を前の不純物
を含む区分と合わせてシリカゲルカラムクロマト
グラフイーにより精製した。相当する区分を減圧
乾固し、クロロホルム−ヘキサンで2回再沈澱を
行い、[4]48.80gを得た。
全量183.2g
融点;132〜134℃
TLC;Rf7=0.85
元素分析[C34H47O9N4Clとして]
C% H% N%
測定値 59.06 7.05 7.41
計算値 59.08 6.85 8.11
(5) P(77−78);BOC−Val−Leu−OEt [5]
BOC−Val−OH101.99g(0.47M)、H−Leu
−OEt・HCl91.98g(0.47M)、HOBT63.45g、
WSCI86.01ml(0.47M)をTHF400mlに溶かし、
一夜撹拌した。反応後、THFを減圧留去し、残
渣を酢酸エチル400mlに溶かした後、5%重曹水、
1N塩酸、水の順に洗浄した。無水芒硝で乾燥後、
減圧乾固した。酢酸エチル−ヘキサンより再結し
て[5]153.7g(収率91.2%)を得た。
融点;108〜110℃
TLC;Rf1=0.63
[α]27D−25.78(C=1.0、DMF)
元素分析[C18H34O5N2として]
C% H% N%
測定値 60.35 9.42 8.39
計算値 60.31 9.56 7.82
(6) P(77−78);BOC−Val−Leu−OH [6]
[5]34.43g(0.375M)をエタノール400ml
に溶かし、氷冷下1N−NaOH412.5ml(1.1倍M)
を加え、撹拌した。1時間半後、1N−
NaOH37.5(0.1倍M)を追加し、1時間撹拌し
た。反応液に1N塩酸75mlを加え、さらに少量の
塩酸でPH5とした。エーテルで洗浄し、水層に
1N塩酸400mlを加えて、酢酸エチルで抽出した。
酢酸エチル層を乾燥後、減圧乾固し、酢酸エチル
−ヘキサンより再結して[6]119.66g(収率
96.6%)を得た。
TLC;Rf1=0.35、Rf7=0.58
元素分析[C16H30O5N2として]
C% H% N%
測定値 57.83 9.40 8.78
計算値 58.16 9.15 8.48
(7) P(77−81);BOC−Val−Leu−Thr(Bzl)
−Lys(Z−Cl)−Ala−OMe [7]
[4]182g(0.263M)をTFA500mlに加え室
温で50分間撹拌した。反応後、TFAを減圧留去
し、残渣にヘキサンを加えた。生じた油状物をデ
カンテ−シヨンにより溶媒と分離し、DMF350ml
に溶かした。これを冷却下NMMでPH6.5に調節
し、HOBT42.61g(1.2倍M)、[6]104.28g
(1.2倍M)およびWSCI57.8ml(1.2倍M)を加え、
室温で1時間半撹拌すると固化し、DMF200ml追
加しても撹拌不能のため、一夜室温で放置し、次
いで30℃で4時間放置した。反応物に氷水を加
え、沈澱物を集めた。これをクロロホルム2.5
に溶かし、5%重曹水、1N塩酸、水の順に洗浄
した。クロロホルムを減圧留去し、残渣をクロロ
ホルム−エーテルヘキサンより再結して[7]
224.68g(収率94.9%)を得た。
融点;219〜221℃
TLC;Rf1=0.15、Rf8=0.68
[α]27D−11.72(C=1.0、DMF)
元素分析[C45H67O11N6Clとして]
C% H% N%
測定値 59.80 7.56 9.83
計算値 59.82 7.48 9.30
(8) P(77−81);BOC−Val−Leu−Thr(Bzl)
−Lys(Z−Cl)−Ala−OH [8]
[7]72.3g(80mM)をクロロホルム720ml
に溶かし、冷却下1N−KCHの90%エタノール溶
液800mlを加え、0〜5℃で40分間撹拌した。次
いで、冷却下1N塩酸800mlを加え、クロロホルム
500mlを追加して抽出した。クロロホルム層を水
洗し、無水芒硝で乾燥後、減圧乾固した。残渣を
シリカゲルカラムクロマトグラフイー〔溶出溶媒
クロロホルム−エタノール−酢酸エチル(5:
1:5)〕により精製した。相当する区分を減圧
乾固してクロロホルム−メタノール−エーテル−
ヘキサンより3回再結して[8]を得た。
上記の操作を3回繰り返し、[7]計216.9gを
加水分解して、[8]156.07g(収率73.1%)を
得た。
融点180〜183℃
TLC;Rf3=0.69
[α]27D−7.54(C=1.0、DMF)
元素分析[C44H65O11N6Cl・1/2H2Oとして]
C% H% N%
測定値 58.94 7.67 9.64
計算値 58.82 7.40 9.35
アミノ酸分析〔試料3.1mg/1ml6N塩酸+0.1ml
アニソール、45時間、110℃加水分解〕;
Thr0.96(1)、Alal、Val0.93(1)、Leu0.94(1)、
Lys1.01(1)
(9) (77−84);BOC−Val−Leu−Thr(Bzl)−
Lys(Z−Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)
−Gln−OBzl [9]
[2]104.5g(129mM)をTFA400mlに加え、
室温で40分間撹拌した。反応後、TFAを減圧留
去し、残渣にエーテルを加えた。生じた沈澱物を
集め、DMF500mlに溶かした。これにHOBT20.9
g(1.2倍M)、[8]137.7g(1.2倍M)、
WSCI28.3ml(1.2倍M)を加え、NMMでPHに調
節し、一夜撹拌した。反応液がゲル状となつたた
め、さらにDMF150mlおよびWSCI12.8mlを追加
し、一夜撹拌した。反応液に氷水を加え、析出し
た沈澱物を集め、熱メタノールで5回洗浄処理し
て[9]185.36g(収率90.68%)を得た。
TLC;Rf2=0.85
[α]27D−12.84(C=1.0、DMF)
元素分析[C80H107O18N11Cl2として]
C% H% N%
測定値 60.61 7.04 10.38
計算値 60.75 6.82 9.74
アミノ酸分析〔試料3.1mg/1ml6N塩酸+0.1ml
アニソール、110℃、45時間加水分解〕;
Thr0.93(1)、Ser0.91(1)、Glu1.01(1)、Alal、
Val0.74(1)、Leu0.75(1)、Lys2.01(2)
(10) P(76−84);BOC−Asn−Val−Leu−Thr
(Bzl)−Lys(Z−C1)−Ala−Lys(Z−Cl)−
Ser(Bzl)−Gln−OBzl [10]
[9]174.0g(110mM)をTFA550mlに加え、
室温で60分撹拌した後、TFAを減圧留去した。
残渣にエーテルを加え、生じた沈澱物を集め、
DMF950mlに溶かした。これに、BOC−Asn−
ONP77.7g(2.0倍M)を加え、NMMでPH7.5に
調整しながら48時間、室温で撹拌した。反応後
DMFを減圧留去し、残渣に氷水を加えた。生じ
た沈澱を集め、熱メタノールで、洗浄処理した。
冷却後、不溶物を集めた。さらに2回、同様の処
理を行い、[10]179.6g(収率96.3%)を得た。
融点;248〜251℃
TLC;Rf2=0.65
Rf3=0.40
元素分析[C84H113O20N13Cl2として]
C% H% N%
測定値 59.23 6.89 10.88
計算値 59.50 6.72 10.74
(11) P(75−84);BOC−Val−Asn−Val−Leu
−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−
Cl)−Ser(Bzl)−Gln−OBzl [11]
[10]169.58g(0.1M)をTFA500mlに加え、
室温で60分間撹拌した後、TFAを減圧留去する。
残渣にエーテルを加え、生じた沈澱物を集め、
DMF1.3に溶かした。これに撹拌しながら
HOBT17.6g(1.3倍M)、BOC−Val−OH28.2
g(1.3倍M)2.4−ジニトロフエノール23.9g
(1.3倍M)、およびWSCI23.8ml(1.3倍M)を加
え、NMMでPH7に調節した後、室温で撹拌し
た。1時間後に反応液がゲル状となつたため一夜
放置した。次いで、NMP400ml、WSCI23.8ml
(1.3倍M)を加えた。約10分間で再度ゲル状とな
り、室温で一夜放置した。反応後、氷と5%重曹
水を加え、生じた沈澱物を集め、水で3回洗浄し
た後、熱メタノールで4回洗浄処理して[11]
171.06g(収率95.3%)を得た。
融点;256〜269℃
TLC;Rf3=0.36
元素分析[C89H122O21N14Cl2・H2Oとして]
C% H% N%
測定値 59.14 6.71 10.86
計算値 58.96 6.89 10.82
アミノ酸分析〔試料3.1mg/1ml6N塩酸+0.1ml
アニソール、48時間、110℃加水分解〕;
Asp1.01(1)、Thr0.82(1)、Ser0.76(1)、Glu1.05(1)、
Ala1.03(1)、Leu1、Val1.85(2)、Lys2.15(2)
(12) P(74−84);BOC−Asp(OBzl)−Val−Asn
−Val−Leu−Thr(Bzl)−Lys(Z−Cl)−Ala
−Lys(Z−Cl)−Ser(Bzl)−Gln−OBzl [12]
[11]143.60g(0.08M)に塩化メチレン100
ml、TFA450mlを加え、室温で40分間撹拌した
後、TFAを減圧留去した。残渣にエーテルを加
え、生じた沈澱物にDMF500mlとNMP1を加え
て溶かした。これに氷、5%重曹水を加え、生じ
た沈澱物を集め、充分水洗した後、乾燥した。こ
れにDMF500mlとNMP1の混液に溶かし、
BOC−Asp(OBzl)−OSU43.7g(1.3倍M)、
HOBT1.14g(0.13倍M)、NMM11.4ml(1.3倍
M)を加え、室温で一夜撹拌した。反応液を氷水
に加え、生じた沈澱物を集め、メタノールを加え
て加熱処理した。この処理を2回繰り返して
[12]149.5g(収率93.4%)を得た。
TLC;Rf3=0.35
元素分析[C100H133O24N15Cl2として]
C% H% N%
測定値 60.01 6.79 10.91
計算値 60.05 6.70 10.50
アミノ酸分析〔6N塩酸/アニリール、110℃、
48時間〕;Asp1.90(2)、Thr0.88(1)、Ser0.75(1)、
Glu1.03(1)、Ala1.01(1)、Val1.95(2)、Leu1、
Lys2.09(2)
(13) P(72−73);BOC−Lys(Z−Cl)−Ala−
OH [13]
[3]48.0g(96mM)をエタノール100mlに
溶かし、これに0℃に冷却下1N−NaOH115.2ml
(1.2倍M)を加え、50分間撹拌した。反応後、
1N塩酸19mlを加えPH6に調節した後、35℃でエ
タノールを減圧留去した。残渣に酢酸エチル、氷
水、1N塩酸96mlを加えて抽出した。酢酸エチル
層を水洗し、無水芒硝で乾燥後、減圧乾固した。
残渣を酢酸エチル−ヘキサンより再結して[13]
45.90g(収率98.4%)を得た。
融点;116〜119℃
TLC;Rf7=0.44
元素分析[C22H32O7N3Clとして]
C% H% N%
測定値 54.57 6.91 8.95
計算値 54.37 6.64 8.65
(14) P(72−84);BOC−Lys(Z−Cl)−Ala−
Asp(OBzl)−Val−Asn−Val−Leu−Thr
(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−Cl)−
Ser(Bzl)−Gln−OBzl [14]
[12]120.01(60mM)に塩化メチレン60ml、
TFA360ml加え、室温で55分間撹拌した後、
TFAを減圧留去した。残渣にエーテルを加え、
生じた沈澱物を集めた。これにDMF600mlと
NMP600mlを加えて溶かした。これを氷+5%
重曹水に加えた。生じた沈澱物を濾取し、3回水
洗した後、メタノール、エーテルで洗浄後、乾燥
した。これにNMP1200mlとDMF600mlを加えて
溶かし、HOBT10.54g(1.3倍M)、[13]37.92g
(1.3倍M)、WSCI14.28ml(1.3倍M)を加え、室
温で3日間撹拌した。反応液を氷水に加え、生じ
た沈澱物を集め、水で3回洗浄後、熱メタノール
で2回洗浄した。次いでエーテルで洗浄した後、
乾燥して[14]135.83g(収率95.6%)を得た。
元素分析[C117H155O28N18Cl3として]
C% H% N%
測定値 59.12 6.73 10.87
計算値 59.35 6.60 10.65
アミノ酸分析〔6N塩酸/アニソール、110℃、
48時間〕;Asp1.09(2)、Thr0.85(1)、Ser0.72(1)、
Glu1.02(1)、Ala1.95(2)、Val1.94(2)、Leu1、
Lys2.99(3)
(15) P(71−84);BOC−Asp(OBzl)−Lys(Z
−Cl)Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z
−Cl)−Ser(Bzl)−Gln−OBzl [15]
[14]118.40g(50mM)をTFA500mlに加え、
室温で55分間撹拌した後、TFAを減圧留去した。
残渣にエーテルを加え、生じた沈澱物を集め、
NMP700mlとDMF700mlを加えて溶かした。これ
を氷+5%重曹水に加え、生じた沈澱物をろ取
し、水で3回、メタノールおよびエーテルで各1
回洗浄した。この沈澱物にNMP800mlとDMF800
mlを加えて溶かし、これに2,4−ジニトロフエ
ノール11.05g(1.2倍M)、HOBT0.81g(0.12倍
M)、BOC−Asp(OBzl)−OSU25.22g(1.2倍
M)、NMM6.60ml(1.4倍M)を加え、室温で2
日間撹拌した。反応液にNMP120ml、DMF60ml
を追加して溶かし、BOC−Asp(OBzl)−
OSU4.20g(0.2倍M)、NMM1.09ml(0.2倍M)
を加え、さらに2日間室温にて撹拌した。反応液
を氷水に加え、生じた沈澱物を集め、水洗した。
次いで、熱メタノールに懸濁し、冷却した後、ろ
取した。この操作を3回繰り返して[15]117.47
g(収率91.3%)を得た。
元素分析[C128H166O31N19Cl3として]
C% H% N%
測定値 59.52 6.32 10.60
計算値 59.75 6.50 10.34
アミノ酸分析〔6N塩酸/アニソール、110℃、
48時間〕;Asp2.71(3)、Thr0.85(1)、Ser0.70(1)、
Glu1.01(1)、Ala1.95(2)、Val1.92(2)、Leu1、
Lys2.92(3)
(16) P(70−84);BOC−Ala−Asp(OBzl)−
Lys(Z−C1)−Ala−Asp(OBzl)−Val−Asn
−Val−Leu−Thr(Bzl)−Lys(Z−Cl)−Ala
−Lys(Z−Cl)−Ser(Bzl)−Gln−OBzl [16]
[15]102.9g(40mM)をTFA400mlに加え、
室温で70分間撹拌した後、TFAを減圧留去した。
残渣にエーテルを加え、生じた沈澱物を集め、
NMP600mlとDMF600mlを加えて溶かした後、5
%重曹水に加えた。生じた沈澱物を集め、水で3
回、メタノールで1回洗浄した。次いで、この沈
澱物にNMP720mlとDMF720mlを加えて溶かし、
これに2,4−ジニトロフエノール11.0g(1.5
倍M)、HOBT0.54g(0.1倍M)、BOC−Ala−
OSU17.18g(1.5倍M)、NMM6.60ml(1.5倍M)
を加え、室温で一夜撹拌した。次いで、BOC−
Ala−OSU2.29g(0.2倍M)、NMM0.88ml(0.2
倍M)を追加し、5日間室温で撹拌した。反応液
を氷水に加え、生じた沈澱物を集め、水で3回、
メタノールで2回洗浄して[16]98.90g(収率
93.5%)を得た。
融点;280℃以上(分解)
アミノ酸分析〔6N塩酸/アニソール、110℃、
48時間〕;Asp2.75(3)、Thr0.84(1)、Ser0.72(1)、
Glu1.01(1)、Ala2.80(3)、Val1.92(2)、Leu1、
Lys2.92(3)
(17) P(69−84);BOC−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [17]
[16]92.55g(35mM)をTFA350mlに加え、
室温で60分間撹拌した後、TFAを減圧留去した。
残渣にエーテルを加え、生じた沈澱物を集め、
DMF600mlとNMP600mlを加えて溶かし、これを
5%重曹水+氷に加えた。生じた沈澱物を集め、
水で3回、メタノールで1回洗浄した。これに
DMF600mlと800mlを加えて溶かし、これに2,
4−ジニトロフエノール7.73g(1.2倍M)、
HOBT0.59g(0.14倍M)、BOC−Glu(OBzl)−
OSU21.29g(1.4倍M)、NMM5.4ml(1.4倍M)
を加え、室温で3日間撹拌した。次いでBOC−
Glu(OBzl)−OSU3.04g(0.2倍M)にDMF60ml
+NMP60mlを加えて溶かした溶液および
NMM0.77ml(0.2倍M)を加え、さらに室温で3
日間撹拌した。次いで先と同量のBOC−Glu
(OBzl)−OSUとNMMを加え、室温で一夜撹拌
した。反応後、反応液を氷水に加えて、生じた沈
澱物を集め、水で3回洗浄した、この沈澱物を熱
メタノールに懸濁し、冷却した後、ろ取した。こ
の操作を3回繰り返して[17]92.71g(収率
92.5%)を得た。
アミノ酸分析〔6N塩酸/アニソール、110℃、
24時間〕;Asp2.72(3)、Thr0.85(1)、Ser0.76(1)、
Glu1.85(2)、Ala2.80(3)、Val1.93(2)、Leu1、
Lys2.95(3)
(18) P(66−68);BOC−Ser(Bzl)−Leu−Gly
−OBzl [18]
BOC−Leu−OH・H2O45.64g、H−Gly−
OBzl・TosOH61.87gおよびHOBT24.87gを
THR200mlに溶かし、これに冷却下WSCI33.69ml
を滴下した後、室温で一夜撹拌した。反応液を減
圧濃縮して油状物を得た。これを酢酸エチル600
mlに溶かし、5%重曹水、1N塩酸、水で各々3
回洗浄する。有機層を無水硫酸ナトリウムで乾燥
し、減圧乾固して油状物69.0g(収率99%)を得
た。これを塩化メチレン10mlに溶かし、5℃に冷
却下TFA250mlを加えた後、撹拌しながら室温で
20分間反応させた。TFAを減圧下留去し、残渣
にDMF200mlを加え、0℃に冷却下NMMを加え
て中和した。これにHOBT20.7g(0.19M)、
BOC−Ser(Bzl)−OH56g(0.19M)および
WSCI34.8ml(0.19M)を加えた後、室温で一夜
撹拌した。DMFを減圧下留去し、残渣に酢酸エ
チルを加え、5%重曹水、1N塩酸、水の順に洗
浄した。無水硫酸マグネシウムで燥後、減圧濃縮
した。残渣にヘキサンを加え、生じた沈澱物を濾
取した。酢酸エチル−ヘキサンで再結晶した後、
酢酸エチル−エーテル−ヘキサンで再結晶して
[18]72.47g(収率72.0%)を得た。
融点;112〜113℃
TLC;Rf5=0.55
元素分析[C30H41O7N3として]
C% H% N%
測定値 65.06 7.75 7.36
計算値 64.84 7.44 7.56
(19) P(65−68);BOC−Lys(Z−Cl)−Ser
(Bzl)−Leu−Gly−OBzl [19]
[18]72.47g(0.13M)に塩化メチレン20ml
を加え、5℃に冷却下TFA250mlを加えた後、室
温で20分間撹拌した。反応後TFAを減圧下留去
し、残渣にエーテルを加えた。生じた沈澱物を集
め、DMF100mlを加えた。これに5℃に冷却下
NMMを加えて中和した。
一方、BOC−Lys(Z−Cl)−OH・TBA70g
(0.143M)に酢酸エチル200mlを加え、1N塩酸、
水で2回洗浄した。酢酸エチル層を無水硫酸マグ
ネシウムで乾燥後、減圧濃縮した。得られた油状
物にDMF100mlを加え、BOC−Lys(Z−Cl)−
OHのDMF溶液とした。
上記の中和したDMF溶液にHOBT19.3g前記
で得たBOC−Lys(Z−Cl)−OHのDMF溶液およ
びWSCI26.2ml(0.143M)を加え、室温で一夜撹
拌した。反応後、DMFを減圧下留去し、残渣に
酢酸エチル400mlを加え、5%重曹水で3回、1N
塩酸で2回、水で2回洗浄した。有機層を無水硫
酸マグネシウムで乾燥後、減圧濃縮した。残渣に
エーテルおよびヘキサンを加え、生じた沈澱物を
集め、酢酸エチル−メタノール−ヘキサンから再
結晶して[19]104g(収率94.6%)を得た。
融点;128〜130℃
TLC;Rf1=0.51、Rf2=0.88
元素分析[C44H58O10N5Clとして]
C% H% N%
測定値 61.96 7.02 7.91
計算値 62.00 6.86 8.22
アミノ酸分析〔1μM/6N塩酸/アニソール、
105℃、48時間〕;Ser0.92(1)、Gly0.98(1)、Leu1、
Lys0.99(1)
(20) P(65−68);BOC−Lys(Z−C1)−Ser
(Bzl)−Leu−Gly−OH [20]
[19]85.3gにメタノール600mlを加え、5℃
で冷却下撹拌しながら、1N−NaOH120mlを加え
た後、室温で3時間撹拌した。反応後、5℃に冷
却下1N塩酸20mlを加えた後、メタノールを減圧
下留去した。残渣の水溶液に5℃に冷却下1N塩
酸100mlを加え、クロロホルム500mlで抽出した。
クロロホルム層を水洗し、無水芒硝で乾燥後、減
圧濃縮した。残渣にヘキサンを加え、生じた沈澱
物を集め、酢酸エチルから再結晶して[20]
66.21g(収率87%)を得た。
融点;156〜158℃
TLC;Rf2=0.63
元素分析[C37H52O10N5Clとして]
C% H% N%
測定値 58.49 6.95 9.09
計算値 58.30 6.88 9.19
アミノ酸分析〔0.5μM/6N塩酸/アニソール、
105℃、48時間〕;Ser0.92(1)、Gly0.97(1)、Leu1、
Lys0.99(1)
(21) P(65−84);BOC−Lys(Z−Cl)−Ser
(Bzl)−Leu−Gly−Glu(OBzl)−Ala−Asp
(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)−
Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z−
Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)Gln−
OBzl [21]
[17]14.32g(5mM)にTFA100mlを加え、
室温で60分間撹拌した。反応後、TFAを減圧留
去し、残渣にエーテルを加え、生じた沈澱物を集
め、NMP100mlを加えて溶解した。これを氷−
5%重曹水に加え、生じた沈澱をろ取し、水、メ
タノールの順に洗浄した。この沈澱物に
NMP200mlを加えて溶かし、これに2,4−ジ
ニトロフエノール1.10g、HOBT0.81g[20]
4.66gを加え、溶解後、−10℃でWSCI1.10mlを加
え、室温で3日間撹拌した。反応後、反応液を氷
−5%重曹水に注ぎ、生じた沈澱をろ取し、水、
メタノール(4回)の順に洗浄し、[21]15.00g
(収率85.5%)を得た。
アミノ酸分析
;Asp2.72(3)、Thr0.93(1)、Ser1.65(2)、Glu1.82
(2)、Gly0.99(1)、Ala2.82(3)、Val1.98(2)、Leu2、
Lys3.92(4)、
(22) [Tyr64]P(64−84);BOC−Tyr(Bzl−
Cl2)−Lys(Z−Cl)−Ser(Bnl)−Leu−Gly−
Glu(OBzl)−*;Asp2.74(3)、Thr0.91(1)、
Ser1.67(2)、Glu1.86(2)、Gly0.98(1)、Ala2.86
(3)、Val1.99(2)、Leu2、Lys3.95(4)、Tyr0.95(1)
(2) [Tyr64]−ペプチド(64−84);
[22]3.06g(0.8mM)にアニソール5mlを加
え、これに無水HF50mlを導入し、0℃で1時間
撹拌した。次いでHFを減圧留去し、残渣にエー
テルを加え、析出した沈澱物を集め、0.1N酢酸
50mlに溶解し、ダウエツクス1×2のカラム
(3.0×40cm、酢酸型)に通し、流出液を凍結乾燥
し、2.41gを得た。これを8M尿素水溶液70mlに
溶解し、アンモニア水でPH9.5に調整した後、0
℃で1時間放置した。次いでこの溶液をCM−セ
ルロースのカラム(3×30cm)にチヤージし、
0.01M酢酸アンモニウム緩衝液(PH4.5)800ml〜
0.2M酢酸アンモニウム緩衝液(PH4.5)800mlの
値線型濃度勾配による溶出を行い、溶出液は10ml
ずつ分画し、79〜99本目を集め、凍結乾燥後セフ
アデツクスLH−20のカラム(3.0×120cm、0.1N
酢酸)に通し、9.8mlずつ分画し、42〜49本目を
集め、凍結乾燥を行つて[Tyr64]−ペプチド
(64−84)483mgを得た。
TLC;Rf11=0.15
アミノ酸分析(6N−塩酸、105℃、24時間);
Asp2.96(3)、Thr0.95(1)、Ser1.79(2)、Glu2.03(2)、
Gly0.97(1)、Ala2.94(3)、Val1.97(2)、Leu2、
Lys4.06(4)、Tyr0.96(1)
実施例 1
ペプチド(53−84);H−Lys−Lys−Glu−
Asp−Asn−Val−Leu−Val−Glu−Ser−His
−Glu−Lys−Ser−Leu−Cly−Glu−Ala−
Asp−Lys−Ala−Asp−Val−Asn−Val−Leu
−Thr−Lys−Ala−Lys−Ser−Gln−OH
(1) P(64−68);BOC−Glu(OBzl)−Lys(Z−
Cl)−Ser(Bzl)−Leu−Gly−OH [23]
参考例1に記載の[20]66.2g(87mM)に塩
化メチレン30mlを加え、5℃に冷却下TFA250ml
を加えた後、室温で45分間撹拌した。反応後、
TFAを減圧下留去し、残渣にエーテルを加えた。
生じた沈澱物を集め、DMF100mlに溶かした。こ
れに5℃に冷却下NMMで中和した。沈澱物が析
出したのでさらにDMF500mlを追加した。この溶
液にBOC−Glu(OBzl)−OSU50g(113mM)、
HOBT1.53g(11.3mM)を加え、NMMで中和
した後、室温で一夜撹拌した。反応後、DMFを
減圧下留去し、残渣を水に入れた。得られた沈澱
物を水洗し、乾燥した。アセトン−メタノールで
2回再結晶して[23]63.85g(収率73.5%)を
得た。
融点;165〜167℃(分解)
TLC;Rf4=0.72
元素分析[C49H65O14N6Clとして]
C% H% N%
測定値 59.61 6.76 8.31
計算値 59.00 6.57 8.42
アミノ酸分解〔0.927mg/0.3ml6N塩酸/アニソ
ール、105℃48時間〕;Ser0.92(1)、Glu0.99(1)、
Gly0.97(1)、Leu1、Lys0.99(1)
(2) P(62−63);BOC−Ser(Bzl)−His−
NHNH2 [24]
BOC−Ser(Bzl)−OH37g(0.125M)に
THF150ml、H−His−OMe・2HCl31.5g
(0.13M)およびHOBT17.6g(0.13M)を加え
て、これに5℃に冷却下WSCI23.8ml(0.13M)
を加えた後、DMF150mlを加え、室温で一夜撹拌
した。さらにHOBT4.4gおよびWSCI6mlを追加
し、室温で一夜撹拌した。反応後、溶媒を減圧下
留去し、残渣の油状物を酢酸エチルに溶かした
後、5%重曹水で3回、水で3回洗浄した。無水
硫酸マグネシウムで乾燥し、減圧濃縮した。残渣
にヘキサンを加え、生じた沈澱物を集め、酢酸エ
チル−エーテル−ヘキサンから再結晶して粗製の
BOC−Ser(Bzl)−His−OMe(TlC;Rf3=0.56)
46.1gを得た。
上記の生成物44.6g(0.1M)をDMF300mlに溶
かし、これにヒドラジン水化物(100%)100mlを
加え、室温で一夜撹拌した。反応後、DMFを減
圧下留去した。残渣を酢酸エチルで8回抽出を繰
り返し、抽出液を少量の水で洗浄した後、無水硫
酸マグネシウムで乾燥した。減圧濃縮し、残渣に
ヘキサンを加え、生じた沈澱物を集めた。これを
シリカゲルカラムクロマトグラフイー〔溶出溶
媒;クロロホルム−酢酸エチル(1:1)からク
ロロホルム−メタノール−酢酸エチル(5:1:
5)〕を用いて精製した。相当する区分を減圧乾
固し、残渣をベンゼン−ヘキサン(非常に少量)
から結晶させた。氷室に収置した後、析出した結
晶を酢酸エチル−メタノール−ヘキサンで2回再
結晶して[24]を得た。
融点;125〜129℃
TLC;Rf4=0.70、Rf7=0.14
元素分析[C21H30O5N6として]
C% H% N%
測定値 56.30 6.98 18.54
計算値 56.49 6.77 18.82
(3) P(62−68);BOC−Ser(Bzl)−His−Glu
(OBzl)−Lys−(Z−C1)−Ser(Bzl)−Leu−
Gly−OH [25]
[24]33.5gをDMRF200mlに溶かし、これに
−50℃に冷却下4.32N塩化水素のジオキサン溶液
52mlとイソアミルニトリト20mlを加えた後、−20
℃で10分間撹拌した。次いで−50℃に冷却し、
Et3N31.6mlを加えた。
一方、[23]63.85g(64mM)に塩化メチレン
20mlを加え、これに5℃に冷却下TFA200を加え
た後、室温で50分間撹拌した。反応後、TFAを
減圧下留去し、残渣の油状物にエーテルを加えた
後、生じた沈澱物を集めた。これをDMF200mlに
溶かし、5℃に冷却下NMMで中和した。
中和したDMF溶液を0℃に冷却した前記のト
リエチルアミンで処理した溶液に加え、氷室で一
夜、室温で一夜撹拌した。反応後、DMFを減圧
下留去し、残渣をメタノールに溶かした。これを
水に入れ、得られた沈澱物をろ取、水洗、乾燥し
た。DMF−エーテルで再結し、メタノールで2
回洗浄して[25]59.16g(収率60.1%)を得た。
融点;209〜213℃(分解)
TLC;Rf4=0.66
元素分析[C65H83O17N10Clとして]
C% H% N%
測定値 59.43 6.58 10.67
計算値 59.51 6.38 10.68
アミノ酸分析〔1.549mg/0.5ml6N塩酸/アニソ
ール、105℃、45時間〕;Ser1.82(2)、Glu1.01(1)、
Gly0.98(1)、Leu1、Lys1.01(1)、His0.94(1)
(4) P(62−84);BOC−Ser(Bzl)−His−Glu
(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu−Gly
−Glu(OBzl)−Ala−Asp(OBzl)−Lys(Z−
Cl)−Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z
−Cl)−Ser(Bzl)−Gln−OBzl [26]
[17]71.59g(25.0mM)にTFA250mlを加
え、室温で60分間撹拌した。反応後、TFAを減
圧下留去し、残渣にエーテルを加えた。生じた沈
澱物を集め、NMP500mlとDMF500mlを加えて溶
かした。これを氷−5%重曹水に加え、生じた沈
澱物をろ取し、水、メタノールの順に洗浄した。
この沈澱物にNMPlとDMF1を加えて溶か
し、これに2,4−ジニトロフエノール5.52g
(1.2倍M)、HOBT4.05g(12倍M)、[25]38.84
g(1.2倍M)およびWSCI5.5ml(1.2倍M)を加
え、室温で4日間撹拌した。反応後、反応液を5
%重曹水−氷に注ぎ、生じた沈澱物をろ取した。
水、熱メタノール、メタノール(2回)の順に洗
浄して[26]89.21g(収率88.3%)を得た。
アミノ酸分析[0.5μM/6N塩酸−アニソール
110℃48時間];Asp2.90(3)、Thr0.91(1)、Ser1.92
(3)、Glu2.89(3)、Gly0.89(1)、Ala2.95(3)、
Val2.20、Leu2、Lys4.02(4)、His0.88(1)
(5) P(61−84);BOC−Glu(OBzl)−Ser(Bzl)
−His−Glu(OBzl)−Lys(Z−Cl)−Ser(Bzl)
−Leu−Gly−Glu(OBzl)−Ala−Asp(OBzl)
−Lys−(Z−Cl)−Ala−Asp(OBzl)−Val−
Asn−Val−Leu−Thr(Bzl)Lys(Z−Cl)−
Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−OBzl
[27]
[26]48.49g(12mM)にTFA250mlを加え、
室温で60分間撹拌した後、TFAを減圧下留去し
た。残渣にエーテルを加え、生じた沈澱物を集
め、DMF350mlとNMP550mlを加えて溶かした。
これを5%重曹水−氷に注ぎ、生じた沈澱物をろ
取し、水洗後、メタノールで洗浄した。この沈澱
物にDMF800mlとNMP700mlを加えて溶かし、こ
れに2,4−ジニトロフエノール2.7g(1.2倍
M)、BOC−Glu(OBzl)−OSU7.30g(1.4倍M)、
HOBT0.23g(0.14倍M)およびNMM1.85ml
(1.4倍M)を加え、室温で一夜撹拌した。次い
で、この反応液にBOC−Glu(OBzl)−OSU1.04
g(0.2倍M)およびNMM0.26ml(0.2倍M)を
追加し、さらに一夜撹拌した。反応液を氷−5%
重曹に注ぎ、生じた沈澱物をろ取し、充分に水洗
した後、熱メタノールで3回洗浄して[27]45.3
g(収率88.6%)を得た。
アミノ酸分析〔/6N塩酸、アニソール、110
℃、48時間〕;Asp2.98(3)、Thr0.93(1)、Ser1.83
(1)、Glu3.62(4)、Gly0.89(1)、Ala2.97(3)、
Val2.23、Leu2、Lys4.06(4)、His0.85(1)
(6) P(59−60);BOC−Leu−Val−OBzl [28]
H−Val−OBzl・TOSOH17.8g(47mM)に
酢酸エチル100mlを加え、5%重曹水、水の順に
洗浄し、酢酸エチル層を無水芒硝で乾燥後、酢酸
エチルを減圧下留去した。残渣をDMF100mlに溶
かし、これにBOC−Leu−OH・H2O11.7g
(56.4mM)、HOBT9.3g(1.2倍M)および
WSCI10.3ml(1.3倍M)を加え、室温で一夜撹拌
した。反応後、DMFを減圧下留去し、残渣を酢
酸エチル300mlに溶かし、5%重曹水、1N塩酸、
水の順に洗浄した。無水芒硝で乾燥後、減圧乾固
した。残渣を酢酸エチル−ヘキサンより結晶化し
て[28]17.55g(収率88.8%)を得た。
TLC;Rf6=0.85
(7) P(58−60);BOC−Val−Leu−Val−OBzl
[29]
[28]17.2g(41mM)TFA50mlを加え、室温
で30分間撹拌した後、TFAを減圧下留去した。
残渣にエーテルを加え、生じた結果をろ取した
後、DMF60mlに溶かした。これにHOBT7.7g
(1.2倍M)、BOC−Val−OH10.7g(1.2倍M)お
よびWSCI9.0ml(1.2倍M)を加え、NMMでPH
7に調節した後、室温で一夜撹拌した。反応後、
DMFを減圧下留去し、残渣を酢酸エチル300mlに
溶かした後、5%重曹水、IN塩酸、水の順に洗
浄した。無水芒硝で乾燥し、減圧乾固した。残渣
を酢酸エチル−ヘキサンより2回再結晶して
[29]17.38g(収率81.6%)を得た。
融点;149〜152℃
TLC;Rf5=0.82
[α]D22;−32.36(C=1.0DMF)
元素分析[C28H45O6N3として]
C% H% N%
測定値 64.80 8.81 8.20
計算値 64.71 8.73 8.09
(8) P(57−60);BOC−Asn−Val−Leu−Val
−OBzl [30]
[29]17.15g(33mM)にTFA50mlを加え、
室温で25分間撹拌した後、TFAを減圧下留去し
た。残渣にエーテルを加え、生じた沈澱物を集
め、DMF100mlに溶かした。これにHOBT0.62g
(0.14倍M)BOC−Asn−ONP16.32g(1.4倍M)
を加え、NMMでPH7に調節した後、室温で2日
間撹拌した。反応後、DMFを減圧下留去し、残
渣を5%重曹水−氷に注く。生じた沈澱物をクロ
ロホルムに溶かし、5%重曹水、水の順に洗浄し
た。無水芒硝で乾燥し、減圧乾固した。残渣をメ
タノール−エーテルから2回再結晶して[30]
13.82g(収率79.5%)を得た。
TLC;Rf2=0.70
元素分析[C32H51O8N5として]
C% H% N%
測定値 60.83 8.19 11.09
計算値 60.64 8.11 11.05
(9) P(57−60);BOC−Asn−Val−Leu−Val
−OH [31]
[30]13.2g(25mM)をエタノール50mlと
DMF60mlの混液に溶かし、これに5%pd/clgを
加え、3時間水素添加した。触媒をろ別し、ろ液
を減圧濃縮した。残渣をエタノール−エーテルよ
り2回再結晶して[31]9.70g(収率71.4%)を
得た。
TLC;Rf2=0.56
アミノ酸分析〔0.5μM/6N塩酸−アニソール、
110℃48時間〕;Asp1.02(1)、Val1.95(2)、Leu1(1)
元素分析[C25H45O8N5として]
C% H% N%
測定値 55.02 8.13 13.06
計算値 55.23 8.34 12.88
(10) P(57−84);BOC−Asn−Val−Leu−Val
−Glu(0Bzl)−Ser(Bzl)−His−Glu(OBzl)−
Lys(Z−Cl)−Ser(Bzl)−Leu−Gly−Glu
(OBzl)−Ala−Asp(OBzl)−Lys(Z−Cl)−
Ala−Asp(OBzl)−Val−Asn−Val−Leu−
Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−Cl)
−Ser(Bzl)−Gln−OBzl [32]
[27]42.60g(10mM)にTFA220mlを加え、
室温で60分間撹拌した。反応後、TFAを減圧下
留去し、残渣にエーテルを加え、生じた沈澱を集
め、DMF600mlとNMP600mlを加えて溶かした。
これを氷−5%重曹水に加え、生じた沈澱物をろ
取した後、水で3回、メタノールで1回洗浄し
た。この沈澱物にNMP1.2とDMF1.2を加え
て溶かし、これにHOBT1.76g(0.3倍M)、2,
4−ジニトロフエノール2.39g(1.3倍M)、[31]
7.05(1.3倍M)およびWSCI4.76ml(2.6倍M)を
加え、室温で2日間撹拌した。さらに[31]1.09
g(0.2倍M)をDMF100mlに溶解した溶液を加
え、室温で一夜撹拌した。反応液を5%重曹水−
氷に加え、生じた沈澱物を集め、DMF100mlに懸
濁し、加熱処理した。冷却後、不溶物をろ取し
た。さらにメタノールおよびエタノールの順に
各々上記と同様に加熱処理して[32]43.30g
(収率92.4%)を得た。
アミノ酸分析〔0.5μM/6N塩酸−アニソール、
110℃48時間〕;Asp3.81(4)、Thr0.90(1)、Ser1.82
(3)、Glu3.62(4)、Gly0.88(1)、Ala3、Val3.65(4)、
Leu2.58(3)、Lys4.21(4)、His0.86(1)
(11) P(56−84);BOC−Asp(OBzl)−Asn−Val
−Leu−ValGlu(OBzl)−Ser(Bzl)−His−Glu
(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu−Gly
−Glu(OBzl)−Ala−Asp(OBzl)−Lys(Z−
Cl)−Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)Ala−Lys(Z
−Cl)−Ser(Bzl)−Gln−OBzl [33]
[32]42.2g(9mM)にTFA220mlを加え、室
温で50分間撹拌した。反応後、TFAを減圧下留
去し、残渣にエーテルを加え、生じた沈澱物を集
めた後、一夜NaOHデシケーター中で乾燥した。
この沈澱物にDMF400mlとNMP600mlを加えて溶
かし、これにHOBT0.24g(0.2倍M)、BOC−
Asp(OBzl)−OSU8.00g(2倍M)を加え、
NMMでPH7.0に調節した後、室温で一夜撹拌し
た。さらにBOC−Asp(OBzl)−OSU4.00g(1
倍M)を追加し、一夜撹拌した。反応液を氷水に
注ぎ、生じた沈澱物を集め、水洗後、メタノール
に加え、加熱処理した。冷却後、不溶物をろ取し
た。上記の加熱処理を3回行い[33]39.97g
(収率90.8%を得た。
アミノ酸分析〔0.5μM/6N塩酸−アニソール、
110℃48時間〕;Asp4.82(5)、Thr0.95(1)、Ser1.90
(3)、Glu3.72(4)、Gly0.92(1)、Ala3、Val3.67(4)、
Leu2.73(3)、Lys4.10(4)、His0.78(1)
(12) P(55−84);BOC−Glu(OBzl)−Asp
(OBzl)−Asn−Val−Leu−Val−Glu(OBzl)
−Ser(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)
−Ser(Bzl)−Leu−Gly−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)Gln−
OBzl [34]
[33]39.13g(8.0mM)にTFA220mlを加え、
室温で60分間撹拌した。反応後、TFAを減圧下
留去し、残渣にエーテルを加え、生じた沈澱物を
集めた後、NaOHデシケータ中で2日間乾燥し
た。この沈澱物にDMF500mlとNMP600mlを加え
て溶かし、これに2,4−ジニトロフエノール
1.47g(1倍M)、HOBT0.11g(0.10倍M)およ
びBOC−Glu(OBzl)−OSU4.52g(1.3倍M)を
加え、室温で一夜撹拌した。さらにBOC−Glu
(OBzl)−OSU4.52g(1.3倍M)を追加し、2日
撹拌した。反応液を氷+5%重曹水に注ぎ、生じ
た沈澱物を5%重曹水で2回、水で3回洗浄し
た。次いでメタノールを加え、加熱処理し、冷却
後不溶物をろ取した。上記の加熱処理を3回行い
[34]37.25g(収率91.1%)を得た。
アミノ酸分析〔0.5μM/6M塩酸−アニソール、
110℃48時間〕;Asp4.78(5)、Thr0.96(1)、Ser1.95
(3)、Glu4.79(5)、Gly0.89(1)、Ala3、Val3.70(4)、
Leu2.71(3)、Lys4.09(4)、His0.77(1)
(13) P(53−54);BOC−Lys(Z−Cl)−Lys(Z
−Cl)PAC [35]
BOC−Lys(Z−Cl)−OH・TBA36.6g
(75mM)を酢酸エチル300mlに懸濁し、氷+1N
塩酸で洗浄後、水洗した。酢酸エチル層を無水芒
硝で乾燥し、減圧乾固した後、残渣をDMF50ml
に溶かした。これに0℃に冷却下フエナシルブロ
マイド19.40gおよびEt3N13.60ml(1.3倍M)を
加えた後、室温で4時間撹拌した。反応液に酢酸
ナトリウム3.68g(0.5倍M)を酢酸エチル500ml
に溶かした溶液を加えた後、5%重曹水、1N塩
酸、水の順に各3回ずつ洗浄した。酢酸エチル層
を無水芒硝で乾燥後、減圧乾固した。残渣をシリ
カゲルカラムクロマトグラフイー〔溶出溶媒ベン
ゼン−酢酸エチル(2:1)〕により精製し、
TLC上Rf1=0.77付近の区分を集めて減圧乾固し
た。残渣をエーテル−ヘキサンより再結晶して
BOC−Lys(Z−Cl)−PAC23.46g(収率60.5%)
を得た。
融点;52〜54℃
TLC;Rf1=0.86
上記の生成物20.68g(40mM)にTFA60mlを
加え、室温で20分間撹拌した。反応後、TFAを
減圧下留去し、残渣にエーテルを加え、生じた沈
澱物を集めた後、DMF50mlに溶かしてDMF溶液
Aとした。
一方、BOC−Lys(Z−Cl)−OH・TBA23.42
g(1.2倍M)を酢酸エチル200mlに懸濁し、氷+
1N塩酸200ml、水100mlで洗浄した。酢酸エチル
層を無水芒硝で乾燥後、減圧乾固した。得られた
油状物をDMF50mlに溶かしてDMF溶液Bとし
た。
前記DMF溶液Aに調整した溶液B、
HOBT6.48g(1.2倍M)、WSCI8.78ml(1.2倍M)
を加え、NMMでPH7に調節した後、室温で一夜
撹拌した。反応後、DMFを減圧下留去し、残渣
をエーテル500mlに溶かした後、5%重曹水で3
回洗浄した。エーテル層に酢酸エチル300mlを追
加し、1N塩酸で2回、水で3回洗浄した。有機
層を無水芒硝で乾燥し、減圧濃縮した。残渣をエ
ーテルから3回再結晶して[35]18.73g(収率
57.5%)を得た。
融点;72〜75℃
元素分析[C41H50O10N4Cl2として]
C% H% N%
測定値 59.22 5.98 6.81
計算値 59.35 6.07 6.75
(14) P(53−54);BOC−Lys(Z−Cl)−Lys(Z
−Cl)−OH [36]
[33]4.07g(5mM)を酢酸30mlに溶かし、
これを亜鉛末20g/酢酸30mlに加え、室温で1時
間半撹拌した。反応後、亜鉛末をろ別し、ろ液は
減圧下酢酸を留去した。残渣をエーテル100mlに
溶かし、これを5%重曹水70mlで3回抽出した。
水層を氷冷下1N塩酸でPH2に調節し、酢酸エチ
ルで抽出した。酢酸エチル層を水洗し、無水芒硝
で乾燥後、減圧乾固した。残渣をエーテル−ヘキ
サンより再結晶して[36]3.08g(収率85.8%)
を得た。
融点;59〜62℃
TLC;Rf2=0.45
元素分析[C33H44O9N4Cl2として]
C% H% N%
測定値 55.58 6.40 7.58
計算値 55.69 6.23 7.87
(15) P(53−84);BOC−Lys(Z−Cl)−Lys(Z
−Cl)−Glu(OBzl)−Asp(OBzl)−Asn−Val
−Leu−Val−Glu(OBzl)−Ser(Bzl)−His−
Glu(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu−
Gly−Glu(OBzl)−Ala−Asp(OBzl)−Lys(Z
−Cl)−Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z
−Cl)−Ser(Bzl)−Gln−OBzl [37]
[34]10.22g(2mM)にTFA80mlを加え、室
温55分間撹拌した。反応後、TFAを減圧下留去
し、残渣にエーテルを加え、生じた沈澱物を集め
た後、DMF200mlとNMP200mlを加えて溶かし
た。これに氷冷下HOBT0.41g(1.5倍M)、[36]
2.13g(1.5倍M)およびWSCI0.55ml(1.5倍M)
を加え、5〜10℃で3日間撹拌した。反応液を氷
水に注ぎ、生じた沈澱物を集め、水洗した後、メ
タノールを加熱処理した。冷却後、不溶物をろ取
した。この加熱処理を3回行い[37]10.41g
(収率91.25%)を得た。
アミノ酸分析〔0.5μM/6N塩酸−アニソール、
110℃48時間〕;Asp4.82(5)、Thr0.92(1)、Ser1.89
(3)、Glu4.77(5)、Gly0.91(1)、Ala3.00、Val3.79
(4)、Leu2.62(3)、Lys5.83(6)、His0.75(1)
(16) ペプチド(53−84)
[37]3.4g(0.6mM)にアニソール5mlを加
え、これに無水弗化水素(HF)50mlを導入し、
0℃で60分間撹拌した。反応後、HFを減圧下留
去し、残渣にエーテルを加える。析出した沈澱を
集め、0.1N酢酸50mlに溶かし、ダウエツクス1
×2のカラム(2.7×36cm酢酸型)に通す。流出
液を凍結乾燥して粗生成物2.1gを得た。これを
8M尿素水溶液50mlに溶かし、アンモニア水でPH
9.5に調整した後、0℃で1時間放置した。次い
でこの溶液を、CM−セルロースのカラム(4.4×
12cm)にチヤージし、0.01M酢酸アンモニウム緩
衝液(PH4.5)200mlで洗浄後、0.01M酢酸アンモ
ニウム緩衝液(PH4.5)700ml〜0.1M酢酸アンモ
ニウム緩衝液(PH4.5)700mlの直線型濃度勾配に
よる溶出を行い、次いで0.2M酢酸アンモニウム
緩衝液(PH4.5)300mlで溶出する。溶出液は13.5
mlずつ分画し、各分画はFolin−Lowry法
(750nm)により測定し、76〜110本目を集め、凍
結乾燥を行い、600mgを得た。これをセフアデツ
クスLH−20のカラム(3.4×120cm、0.1N酢酸)
に通し脱塩する。8.5mlずつ分画し、47〜53本目
の溶出液を集め、凍結乾燥を行い、415mgを得た。
さらにCM−セルロースのカラム(4.4×15cm)に
チヤージし、0.01M酢酸アンモニウム緩衝液(PH
4.5)700ml〜0.1M酢酸アンモニウム緩衝液(PH
4.5)700mlの直線型濃度勾配による溶出を行い、
13.5mlずつ分画し、80〜96本目を集め、凍結乾燥
後、セフアデツクスLH−20カラム(3.4×12cm)
にチヤージし、0.1N酢酸で溶出し、5mlずつ分
画し、76〜85本目を集め、凍結乾燥をしてペプチ
ド(53−84)220mgを得た。
TLC;Rf9=0.76
アミノ酸分析;Asp4.80(5)、Thr0.95(1)、
Ser2.34(3)、Glu4.99(5)、Gly0.95(1)、Ala3、
Val3.95(4)、Leu2.96(3)、Lys6.28(6)、His0.97(1)
参考例 2
[Tyr52]−ペプチド(52−84);H−Tyr−
Lys−Lys−Glu−Asp−Asn−Val−Leu−Val
−Glu−Ser−His−Glu−Lys−Ser−Leu−
Gly−Glu−Ala−Asp−Lys−Ala−Asp−Val
−Asn−Val−Leu−Thr−Lys−Ala−Lys−
Ser−Gln−OH
(1) [Tyr52]P(52−84);BOC−Tyr(Bzl−
Cl2)−Lys(Z−Cl)−Lys(Z−Cl)−Glu
(OBzl)−Asp(OBzl)−Asn−Val−Leu−Val
−Glu(OBzl)−Ser(Bzl)−His−Glu(OBzl)−
Lys(Z−Cl)−Ser(Bzl)−Leu−Gly−Glu
(OBzl)−Ala−Asp(OBzl)−Lys(Z−Cl)−
Ala−Asp(OBzl)−Val−Asn−Val−Leu−
Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−Cl)
−Ser(Bzl)−Gln−OBzl [38]。
実施例1に記載の[37]5.82g(1.0mM)に
TFA50mlを加え、室温で50分間撹拌した。減圧
下で、TFAを留去し、残渣にエーテルを加え、
生じた沈澱を集めた後、DMF150mlとMNP150ml
を加え、溶解した。HOBT0.27g(2倍M)と
BOC−Tyr(Bzl−Cl2)−OH0.88g(2倍M)を
加え溶解した後、−20℃で冷却して、WSCI0.37g
(2倍M)を加え、室温で、2日間かきまぜた。
反応液を氷水に注ぎ、生じた沈澱を集め、水洗し
た後、メタノールに懸濁し、加熱後、冷却し、不
溶物をろ取した。この沈澱をさらにメタノール加
熱懸濁後、冷却して沈澱を集めて、[38]5.15g
(収率88.4%)を得た。
TLC;R9=0.75
アミノ酸分析
Asp4.43(5)、Thr0.88(1)、Ser1.86(3)、Glu4.63
(5)、Gly0.92(1)、Ala3(3)、Val3.59(4)、Leu2.62
(3)、Tyr0.88(1)、Lys5.58(6)、His0.76(1)、
(2) [Tyr52]−ペプチド(52−84)
無水弗化水素(HF)50mlに0℃に冷却下(1)
3.68g(0.6mM)とアニソール10mlを加え、0℃
で60分間かきまぜた。反応後HFを減圧留去し、
残渣にエーテルを加え、生じた沈澱物を集め、
0.1N酢城50mlに溶解し、ダウエツクス1のカラ
ム(アセテート型、3×48cm)に通す。0.1N酢
酸で流出させ、流出液を凍結乾燥して粗生成物
2.43gを得た。これを8M尿素水溶液50mlに溶解
し、アンモニア水でPH9.5に調節した後、0℃で
60分放置した。さらに、この溶液を8M尿素水溶
液で充填したCM−セルロースのカラム(3×30
cm)にチヤージし、0.01M酢酸アンモニウム水溶
液(PH4.5)約100mlで流出した後、0.01M酢酸ア
ンモニウム水溶液(PH4.5)700ml〜0.1M酢酸ア
ンモニウム水溶液(PH4.5)700mlの直線型濃度勾
配による溶出を行い、次いで0.2M酢酸アンモニ
ウム水溶液300mlで溶出した。溶出液は、13.5ml
ずつ分画し、各分画はUV280nmで測定し、75〜
121本目の溶出液を集め、凍結乾燥した。この凍
結乾燥物を0.1N−酢酸5mlに溶解し、セフアデ
ツクスLH−20(3.4×120cm)のカラムに通し、流
出液を8.5mlずつ分画し、46〜53本目の溶出液を
集め、凍結乾燥して532mgを得た。これを0.1N酢
酸40mlに溶解し、CM−セルロースのカラム(4.5
×11cm)にチヤージし、0.01M酢酸アンモニウム
水溶液(PH4.5)500ml−0.1M酢酸アンモニウム
水溶液(PH4.5)500mlの直線型濃度勾配による溶
出を行う。溶出液は、6.0mlずつ分画し、各分画
はUV280nmで測定して、121〜133本目の溶出液
を集め、凍結乾燥を行つた。この凍結乾燥物を
0.1N−酢酸5mlで溶解し、セフアデツクスLH−
20のカラム(3.4×120cm)に通し、8.4mlずつ分
画し、47〜52本目の区分を集集め、凍結乾燥し
て、[Tyr52]−ペプチド(52−84)129mgを得た。
TLC,RF9=0.75 1スポツト
アミノ酸分析
Asp4.78(5)、Thr0.95(1)、Ser2.48(3)、Glu5.01
(5)、Gly0.96(1)、Ala3、Val3.97(4)、Leu2.95(3)、
Tyr0.91(1)、Lys6.03(6)、His0.98(1)、
参考例 3
ペプチド(51−84);H−Pro−Arg−Lys−
Lys−Glu−AspAsn−Val−Leu−Val−Glu−
Ser−His−Glu−Lys−Ser−Leu−Gly−Glu
−Ala−Asp−Lys−Ala−Asp−Val−Asn−
Val−Leu−Thr−Lys−Ala−Lys−Ser−Gln
−OH
(1) P(52−54);AOC−Arg(Tos)−Lys(Z−
Cl)−Lys(Z−Cl)−PAC [39]
実施例1に記載の[35]14.65g(18mM)に
TFA50mlを加え、室温で30分間撹拌した。反応
後、TFAを減圧下留去し、残渣にエーテルを加
えた。生じた沈澱物を集め、DMF10mlに溶かし
た。これにAOC−Arg(Tos)−OH9.19g(1.2倍
M)−HOBT2.92g(1.2倍M)およびWSCI3.95
ml(1.2倍M)を加え、室温で一夜撹拌した。反
応後、DMFを減圧下留去し、残渣を酢酸エチル
300mlに溶かした後、5%重曹水、1N塩酸、水の
順に各々3回ずつ洗浄した。酢酸エチル層を無水
芒硝で乾燥後、減圧乾固した。酢酸エチル−エー
テルより再結晶して[39]14.46g(収率69.6%)
を得た。
融点;79〜82℃
TLC;Rf7=0.76
元素分析[C55H70O13N8SCIとして]
C% H% N%
測定値 57.06 6.26 9.82
計算値 57.23 6.11 9.71
(2) P(51−54);BOC−Pro−Arg(Tos)−Lys
(Z−Cl)−Lys(Z−Cl)−PAC [40]
[39]14.43g(12.5mM)にTFA40mlを加え、
室温で20分間撹拌した。反応後、TFAを減圧下
留去し、残渣にエーテルを加えた。生じた沈澱物
を集め、DMF80mlに溶かした。これに
HOBT2.03g(1.2倍M)、BOC−Pro−OH3.23
g(1.2倍M)およびWSCI2.75ml(1.2倍M)を加
え、室温で一夜撹拌した。反応後、DMFを減圧
下留去し、残渣を酢酸エチル300mlに溶かした後、
5%重曹水、1N塩酸水の順に洗浄した。酢酸エ
チル層を無水芒硝で乾燥後、減圧乾固した。残渣
を酢酸エチル−エーテルより2回再結晶して
[40]14.71g(収率95.1%)を得た。
融点;90〜93℃
TLC;Rf7=0.64
元素分析[C59H75O14N9SCI2として]
C% H% N%
測定値 57.33 6.20 9.79
計算値 57.27 6.11 10.19
(3) P(51−54);BOC−Pro−Arg(Tos)−Lys
(Z−Cl)−Lys(Z−Cl)−OH [41]
亜鉛末20g/酢酸30mlに[40]6.19g(5mM)
を酢酸40mlに溶かした溶液を加え、室温で2時間
撹拌した。反応後、亜鉛末をろ別し、ろ液を減圧
濃縮した。残渣に5%重曹水とエーテルを加えて
抽出し、分離した水層を1N塩酸でH2に調節した
後、酢酸エチルで抽出した。酢酸エチル層を水で
3回洗浄し、無水芒硝で乾燥後、減圧乾固した。
残渣を酢酸エチル−エーテルより再結晶して
[41]5.40g(収率96.5%)を得た。
融点;110〜113℃
TLC;Rf4=0.43
元素分析[C51H69O13N9SCI2として]
C% H% N%
測定値 54.56 6.46 11.22
計算値 54.73 6.21 11.27
(4) P(51−84);BOC−Pro−Arg(Tos)−Lys
(Z−Cl)−Lys(Z−Cl)−Glu(OBzl)−Asp
(OBzl)−Asn−Val−Leu−Val−Glu(OBzl)
−Ser(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)
−Ser(Bzl)−Leu−Gly−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [42]
実施例1に記載の[34]10.22(2.0mM)に
TFA80mlを加え、室温で60分間撹拌した。反応
後、TFAを減圧下留去し、残渣にエーテルを加
えた。生じた沈澱物を集め、DMF180mlと
NMP′180mlを加えて溶かした。これに
HOBT0.41g(1.5倍M)、[41]3.35g(1.5倍M)
およびWSCI0.55ml(1.5倍M)を加え、室温で2
日間撹拌した。反応液を氷水に加え、生じた沈澱
物を水洗後、メタノールを加えて加熱処理した。
冷却後不溶物を集めた。上記の加熱処理を2回繰
り返した後、エーテルで洗浄して[42]10.65g
(収率87.1%)を得た。
アミノ酸分析(0.5μM/6N塩酸−アニソール、
110℃48時間);Asp4.62(5)、Thr0.98(1)、Ser2.32
(3)、Glu4.52(5)、Pro0.83(1)、Gly0.94(1)、Ala3、
Val3.82(4)、Leu2.68(3)、Lys5.81(6)、His0.78(1)、
Arg0.86(1)
(5) ペプチド(51−84)
[42]3.7g(0.6mM)にアニソール5mlを加
え、これに無水弗化水素(HF)60mlを導入し、
0℃で60分撹拌した。反応後、HFを減圧下留去
し、残渣にエーテルを加え、析出した沈澱を集
め、0.1N酢酸50mlに溶かし、ダウエツクス1×
2のカラム(2.7×40cm酢酸型)に通し、流出液
を凍結乾燥して、粗生成物2.2gを得た。これを
8M尿素水溶液50mlに溶解し、アンモニウア水で
PH9.5に調整した後、0℃で1時間放置した。次
いでこの溶液を、CM−セルロースのカラム(4.2
×13cm)にチヤージし、0.01M酢酸アンモニウム
緩衝液(PH4.5)200mlで洗浄後、0.01M酢酸アン
モニウム緩衝液(PH4.5)700ml〜0.1M酢酸アン
モニウム緩衝液(PH4.5)700mlの直線型濃度勾配
による溶出を行い、次いで0.2M酢酸アンモニウ
ム緩衝液(PH4.5)300mlで溶出した。溶出液は、
8.5mlずつ分画し、120本〜160本目を集め、凍結
乾燥を行た後、セフアデツクスLH−20のカラム
(3.4×110cm0.1N酢酸)に通し、5.2mlずつ分画
し、51〜62本目を集め凍結乾燥を行い、392mgを
得た。さらに同様にCM−セルロースのカラム
(2.0×36cm)にチヤージし、0.01M酢酸アンモニ
ウム緩衝液(PH4.5)500ml〜0.2M酢酸アンモニ
ウム緩衝液(PH4.5)500mlの直線型濃度勾配によ
る溶出を行う。溶出液は、7.5mlずつ分画し、92
〜110本目の区分を集め、凍結乾燥後、セフアデ
ツクスLH−20のカラム(3.0×123cm0.1N酢酸)
に通し、溶出液は6mlずつ分画し、37〜47本目を
集め、凍結乾燥して、ペプチド(51−84)213mg
を得た。
TLC;R10=0.89
アミノ酸分析;Asp4.98(5)、Thr0.92(1)、
Ser2.45(3)、Glu5.13(5)、Gly1.00(1)、Ala3、
Val3.98(4)、Leu2.99(3)、Lys6.08(6)、His0.97(1)、
Arg0.99(1)、Pro1.02(1)
参考例 4
[Tyr50]ペプチド(50−84);H−Tyr−Pro
−Arg−Lys−Glu−Asp−Asn−Val−Leu−
Val−Glu−Ser−His−Glu−Lys−Ser−Leu
−Gly−Glu−Ala−Asp−Lys−Ala−Asp−
Val−Asn−Val−Leu−Thr−Lys−Ala−Lys
−Ser−Gln−OH
(1) [Tyr50]P(50−84);BOC−Tyr(Bzl−
Cl2)−Pro−Arg(Tos)−Lys(Z−Cl)−Lys
(Z−Cl)−Glu(OBzl)−Asp(OBzl)−Asn−
Val−Leu−Val−Glu(OBzl)−Ser(Bzl)−His
−Glu(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu
−Gly−Glu(OBzl)−Ala−Asp(OBzl)−Lys
(Z−Cl)−Ala−Asp(OBzl)−Val−Asn−
Val−Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−
Lys(Z−Cl)−Ser(Bzl)−Gln−OBzl [43]
参考例3に記載の[42]6.31g(1.0mM)に
TFA50mlを加え、室温で55分間かきまぜた。減
圧下で、TFAを留去し、残渣にエーテルを加え、
生じた沈澱を集めた後、DMF160mlとNMP160ml
を加え、溶解した。HOBT0.27g(2倍M)と
BOC−Tyr(Bzl−Cl2)−OH0.88g(2倍M)を
加え溶解した後、−20℃に冷却して、WSCI0.37g
(2倍M)を加え、室温で3日間かきまぜた。反
応液を氷中に注ぎ、生じた沈澱を集め、水洗した
後、メタノールに懸濁し、加熱後、冷却し、不溶
物をろ取した。この沈澱をさらにメタノール加熱
懸濁後、冷却して沈澱を集めた。さらにこの操作
を1回おこなつた後、エーテルで洗浄して[43]
5.97g(収率90%)を得た。
アミノ酸分析
Asp4.45(5)、Thr0.94(1)、Ser2.25(3)、Glu4.67
(5)、Pro0.89(1)、Gly0.92(1)、Ala3、Val3.66(4)、
Leu2.81(3)、Tyr0.81(1)、Lys5.53(6)、His0.77(1)、
Arg0.79(1)
(2) [Tyr50]h−PTH(50−84)
無水HF60mlに0℃冷却下[43]3.98g
(0.6mM)およびアニソール10mlを加え、0℃60
分間かきまぜた。反応後、HFを減圧留去し、残
渣にエーテルを加え、生じた沈澱を集めた。この
沈澱を0.1N−酢酸50mlに溶解し、ダウエツクス
1×2のカラム(アセテート型、3×45cm)に通
した。流出液を凍結乾燥して粗生成物2.41gを得
た。これを8M尿素水溶液60mlに溶解し、アンモ
ニア水でPH9.5に調節した後、0℃で60分間放置
した。次いでこの溶液を8M尿素水溶液で充填し
たCM−セルロースのカラム(3×30cm)にチヤ
ージし、0.01M酢酸アンモニウム水溶液(PH4.5)
で尿素を流出した後、0.01M酢酸アンモニウム水
溶液(PH4.5)700ml〜0.1M酢酸アンモニウム水
溶液(PH4.5)700mlの直線型濃度勾配による溶出
を行い、次いで0.2M酢酸アンモニウム水溶液
(PH4.5)250mlで溶出した。溶出液は、8.5mlずつ
分画し、各分画はUV280nmで測定して142本〜
171本目の流出液を集め、凍結乾燥した。
この凍結乾燥物を0.1M酢酸6mlに溶解し、セ
フアデツクスLH−20のカラム(3.4×120cm)に
通し、8.5mlずつ分画し、46〜52本目の流出液を
集め凍結乾燥して、410mgを得た。これを0.1N酢
酸30mlに溶解し、CM−セルロースのカラム(2.0
×35cm)にチヤージし、0.01M酢酸アンモニウム
水溶液(PH4.5)500ml〜0.2M酢酸アンモニウム
水溶液(PH4.5)500mlの直線型濃度勾配による溶
出を行う。溶出液は7.5mlずつ分画し、112本〜
136本目の流出液を集め、凍結乾燥した後、0.1N
酢酸6mlで溶解し、セフアデツクスLH−20カラ
ム(3.0×120cm)に通して、流出液を6mlずつ分
画し、35本〜43本目の区分を集め、凍結乾燥し
て、[Tyr50]ペプチド(50−84)134mgを得た。
TLC;Rf10=0.88 1スポツト
アミノ酸分析
Asp4.98(5)、Thr0.94(1)、Ser2.43(3)、Glu5.11
(5)、Pro0.97(1)、Gly0.97(1)、Ala3、Val3.98(4)、
Leu2.96(3)、Tyr0.91(1)、LyS6.05(6)、His0.93(1)、
Arg0.98(1)
参考例 5
ペプチド(46−84);H−Ala−Gly−Ser−
Gln−Arg−Pro−Arg−Lys−Lys−Glu−Asp
−Asn−Val−Leu−Val−Glu−Ser−His−
Glu−Lys−Ser−Leu−Gly−Glu−Ala−Asp
−Lys−Ala−Asp−Val−Asn−Val−Leu−
Thr−Lys−Ala−Lys−Ser−Gln−OH
(1) P(49−50);BOC−Gln−Arg(Tos)−OMe
[44]
H−Arg(Tos)−OMe・HCl11.37g(30mM)
とBOC−Gln−ONP13.21g(1.2倍M)を
DMF200mlに溶かし、0℃に冷却下NMMでPH7
に調節した後、一夜撹拌した。反応後、DMFを
減圧下留去し、残渣をクロロホルムに溶かした
後、5%重曹水で3回、1M塩酸で2回、水で3
回洗浄した。クロロホルム層を無水芒硝で乾燥
し、クロロホルムで充填したシリカゲルのカラム
でクロマトグラフイーを行つた。クロロホルム−
メタノール−酢酸メチルで流し、目的物が溶出し
始めるとクロロホルム−エタノール−酢酸エチル
(1:1:1)で溶出した。相当する区分を集め
て減圧濃縮した。残渣を酢酸エチルに溶かし、0
℃に冷却下ヘキサンを加えて結晶化させて[44]
を得る。
収量11.86g
融点;103〜107℃
(2) P(48−50);BOC−Ser(Bzl)−Gln−Arg
(Tos)−OMe [45]
[44]9.39g(16.5mM)にTFA50mlを加え室
温で20分間撹拌した後、TFAを減圧下留去した。
残渣にエーテルを加え、生じた沈澱物をろ取し、
DMF50mlに溶かした。この溶液にHOBT3.24g
(1.45倍M)、BOC−Ser(Bzl)−OH7.07g(1.45
倍M)およびWSCI4.39ml(1.45倍M)を加え、
室温で一夜撹拌した。反応後、DMFを減圧下留
去し、残渣を酢酸エチル300mlに溶かした後、5
%重曹、1N塩酸、水の順に洗浄した。酢酸エチ
ル層を無水芒硝で乾燥後、減圧濃縮した。残渣を
酢酸エチル−エーテルから結晶化を2回行い、
[45]10.0g(収率81.0%)を得た。
融点;97〜102℃
元素分析[C34H49O10N7S・1/2H2Oとして]
C% H% N%
測定値 54.07 6.90 13.29
計算値 53.95 6.66 13.00
(3) P(46−47);BOC−Ala−Gly−OH [46]
BOC−Ala−OH7.57g、HOBT5.4gを
THF60mlに溶解し、H−Gly−OET・HCl5.58g
を加えた後、−20℃で冷却下、WSCI8.05mlを5分
間で滴下し、そのまま一時間撹拌後、室温で24時
間撹拌した。反応液を減圧留去後、酢酸エチル
100mlを加え、5%重曹水(3回)、水、N−塩酸
水(3回)、飽和食塩水(3回)、水で順次洗浄
後、酢酸エチル層を分離し、無水Na2SO4で乾燥
した。乾燥剤を除き、濃縮乾固して、淡黄色油状
のBOC−Ala−Gly−OET(Rf1=0.77)を得た。
これをそのままエタノール20mlに溶解し、0℃で
N−NaOH44mlを10分間で加え、室温で1時間
30分撹拌した。4mlのN−塩酸水を0℃で加え、
エタノールを減圧留去した後、0℃でN−塩酸水
42mlを加え、酢酸エチル200mlで油出した。酢酸
エチル層を洗浄後、濃縮し、析出した結晶を、
ETOH−エーテル−n−ヘキサンで再結晶を行
つて無色結晶の[46]6.12g(収率5.08%)を得
た。
TLC;Rf1=0.14
融点;85〜89℃(分解)
[α]26D−9.28(C=1.0、DMF)
元素分析[C10H18O5N2・H2Oとして]
C% H% N%
測定値 45.49 7.71 10.78
計算値 45.45 7.63 10.60
(4) P(46−50);BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−OMe [47]
[45]9.72g(13mM)にTFA50mlを加え、室
温で30分間撹拌した。反応後、TFAを減圧下で
留去し、残渣にエーテルを加えた。生じた沈澱物
をろ取し、DMF100mlに溶かした。この溶液に
BOC−Ala−Gly−OH[46]3.84g(1.2倍M)、
HOBT2.11g(1.2倍M)およびWSCI2.85ml(1.2
倍M)を加え、室温で2日間撹拌した。反応後、
DMFを減圧下留去し、残渣を酢酸エチル200mlに
溶かした後、水洗した。無水芒硝で乾燥し、減圧
濃縮した後、残渣をエタノール−エーテルで2回
結晶化して[47]10.46g(収率91.9%)を得た。
融点;154−157℃
元素分析[C39H57O12N9Sとして]
C% H% N%
測定値 53.21 6.90 14.38
計算値 53.47 6.56 14.39
(5) P(46−50);BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−NH・NH2 [48]
[47]9.64g(11mM)をエタノール50mlに溶
かし、これに50%NH2MH26.4mlを加え室温で一
夜撹拌した。反応液にエタノール100mlを加え、
不溶物をろ取した。これをエタノール100mlに懸
濁し、加熱した。冷却後、ろ過して[48]9.02g
(収率93.6%)を得た。
融点;178−180℃
元素分析[C38H57O11N11Sとして]
C% H% N%
測定値 52.13 6.86 16.65
計算値 52.10 6.56 17.59
(6) P(46−50);BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−Pro−Arg(Tos)−Lys(Z−
Cl)−Lys(Z−Cl)−PAC [49]
参考例3に記載の[40]8.04g(6.6mM)に
TFA40mlを加え、室温で20分間撹拌した後、
TFAを減圧下留去した。残渣にエーテルを加え、
生じた沈澱物をろ取して粗製のH−Pro−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−PAC・
TFAを得た。
一方、[49]6.83g(7.8mM)をDMF30mlに溶
かし、これに−50℃に冷却下4.32N塩化水素のジ
オキサン溶液5.42ml(23.4mM)とイソアミルニ
トリル1.10ml(8.09mM)を加えた後、−20℃で20
分間撹拌した。次いで上記H−Pro−Arg(Tos)
−Lys(Z−Cl)−PAC・TFAを加え、−35℃で
Et3N5.46ml(39mM)を加えた後、0〜5℃で2
日間撹拌した。反応後、DMFを減圧下留去し、
残渣をクロロホルム300mlに溶かした後、5%重
曹水、1N塩酸、水の順に洗浄した。クロロホル
ム層を無水芒硝で乾燥し、減圧濃縮した。エタノ
ール−エーテルおよびクロロホルム−エーテルに
より精製して[50]13.42gを得た。
TLC;Rf=0.64[クロロホルム−メタノール−
酢酸(83:18:3.5)]
元素分析[C92H120O22N18Cl2S・3H2Oとして]
C% H% N%
測定値 54.68 6.21 12.72
計算値 54.72 6.29 12.49
アミノ酸分析(0.5μM/塩酸、アニソール、
110℃48時間);Ser0.65(1)、Glu1.10(1)、Pro1(1)、
Gly1.02(1)、Ala1.00(1)、Lys1.89(2)、Arg2.02(2)
(7) P(46−54);BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−Pro−Arg(Tos)−Lys(Z−
Cl)−Lys(Z−Cl)−OH [50]
亜鉛末30g/酢酸60mlに[49]10.62gの酢酸
40ml溶液を加え、室温で2時間撹拌した。反応
後、亜鉛末をろ別し、ろ液を減圧濃縮した。残渣
にエーテルを加え、生じた沈澱物をエタノール−
エーテルで1回、エタノール−酢酸エチルで2回
精製して[50]9.60g(収率91.4%)を得た。
TLC;Rf4=0.22
元素分析[C84H114O22N18S2Cl2・2H2Oとして]
C% H% N%
測定値 52.89 6.16 13.22
計算値 53.12 6.26 13.28
アミノ酸分析(0.5μM/6N−塩酸−アニソー
ル、110℃48時間);Ser0.88(1)、Glu1.11(1)、
Pro1.02(1)、Gly1.02(1)、Ala1(1)、Lys2.00(2)、
Arg2.09(2)
(8) P(46−84);BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−Pro−Arg(Tos)−Lys(Z−
Cl)−Lys(Z−Cl)−Glu(OBzl)−Asp(OBzl)
−Asn−Val−Leu−Val−Glu(OBzl)−Ser
(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)−Ser
(Bzl)−Leu−Gly−Glu(OBzl)−Ala−Asp
(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)−
Val−Ash−Val−Leu−Thr(Bzl)−Lys(Z−
Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [51]
実施例1に記載の[34]15.33g(3mM)に
TFA130mlを加え、室温で60分間撹拌した後、
TFAを減圧下留去した。残渣にエーテルを加え、
生じた沈澱物をDMF200mlとNMP200mlの混液に
溶かした。これに0℃に冷却下[50]6.70(1.2倍
M)、HOBT0.49g(1.2倍M)およびWSCI0.66
ml(1.2倍M)を加えた後、室温で2日間撹拌し
た。反応後、DMFを減圧下留去し、残渣に氷水
を加えた後、生じた沈澱物をろ取した。これにメ
タノール300mlを加えて加熱し、冷却後不溶物を
ろ取する操作を2回繰り返して[51]18.30g
(収率89.0%)を得た。
(7) ペプチド(46−84)
[51]4.11g(0.6mM)にアニソール3mlを加
え、これに無水弗化水素(HF)60mlを導入し、
0℃にて60分撹拌した。反応後HFを減圧下留去
し、残渣にエーテルを加え、生じた沈澱を集め、
1M酢酸50mlに溶解し、ダウエツクス1×2のカ
ラム(3.0×45cm酢酸型)に通す。流出液を凍結
乾燥して粗生成物2.8gを得た。次いでこれを8M
尿素水溶液50mlに溶解し、アンモニア水にてPH
9.5に調整した後、0℃で60分放置した。次いで
この溶液をCM−セルロースのカラム(2.0×36
cm)にチヤージし、0.01M酢酸アンモニウム緩衝
液(PH4.5)200mlにて洗浄後、同じ緩衝液500ml
〜0.3M酢酸アンモニウム緩衝液(PH4.5)500ml
の直線型濃度勾配による溶出を行う。溶出液は
7.5mlずつ分画し、56〜84本目を集め、凍結乾燥
後、セフアデツクスLH−20のカラム(3.0×120
cm)に通し、0.1N酢酸で溶出し、6mlずつ分画
し、41〜52本目を集め、凍結乾燥して、620mlを
得た。さらにこれをCM−セルロースの再カラム
(2.0×38cm)にチヤージし、同様に0.01N酢酸ア
ンモニウム緩衝液(PH4.5)500ml〜0.3M酢酸ア
ンモニウム緩衝液(PH4.5)500mlの直線型濃度勾
配による溶出を行つた。各7.5mlずつ分画し、59
〜80本目を集め、凍結乾燥後、セフアデツクス
LH−20のカラム(3.0×120cm0.1N酢酸)に通し、
8mlずつ分画し、31〜36本目を集め、凍結乾燥し
て、ペプチド(46−84)235mgを得た。
TLC;Rf=0.77
アミノ酸分析;Asp4.98(5)、Thr0.95(1)、
Ser3.62(4)、Glu6.14(6)、Pro0.99(1)、Gly1.96(2)、
Ala4、Val4.01(4)、Leu2.98(3)、Lys6.12(6)、
His0.93(1)、Arg1.92(2)
参考例 6
[Tyr45]−ペプチド(45−84);H−Tyr−
Ala−Gly−SerGln−Arg−Pro−Arg−Lys−
Lys−Glu−Asp−Asn−Val−Leu−Val−Glu
−Ser−His−Glu−LysSer−Leu−Gly−Glu
−Ala−Asp−Lys−Ala−Asp−Val−Asn−
Val−Leu−Thr−Lys−Ala−Lys−Ser−Gln
−OH
(1) P(45−84);BOC−Tyr(Bzl−Cl2)−Ala−
Gly−Ser(Bzl)−Gln−Arg(Tos)−Pro−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Glu
(OBzl)−Asp(OBzl)−Asn−Val−Leu−Val
−Glu(OBzl)−Ser(Bzl)−His−Glu(OBzl)−
Lys(Z−Cl)−Ser(Bzl)−Leu−Gly−Glu
(OBzl)−Ala−Asp(OBzl)−Lys(Z−Cl)−
Ala−Asp(OBzl)−Val−Asn−Val−Leu−
Thr(Bzl)−Lys(Z−C1)−Ala−Lys(Z−Cl)
−Ser(Bzl)−Gln−OBzl [52]
参考例5に記載の[51]13.71g(2.0mM)に
TFA180mlを加え、室温で60分間撹拌した。反応
後、TFAを減圧下留去し、残渣にエーテルを加
えた。生じた沈澱物をろ取して脱BOC化物13.80
gを得た。
上記脱BOC化物6.90g(1mM)をDMF135ml
とNMP135mlの混液に溶かし、これに0℃に冷
却下BOC−Tyr(Bzl−Cl2)−OH0.53g(1.2倍
M)、HOBT0.16g(1.2倍M)およびWSCI0.22
ml(1.2倍M)を加えた後、室温で一夜撹拌した。
反応後、DMFを減圧下留去し、残渣に氷水を加
えた。生じた沈澱物をろ取し、DMF−メタノー
ル−エーテルで洗浄して[52]6.12g(収率85.3
%)を得た。
(2) [Tyr45]−ペプチド(45−84)
[52]4.31g(0.60mM)にアニソール1.5mlを
加え、無水HFを導入し、0℃で1時間かきまぜ
た。次いでHFを減圧下留去し、残渣にエーテル
を加え、析出した沈澱を集め、0.1N酢酸25mlに
溶かし、ダウエツクス1×2カラム(酢酸型、
2.5×30cm)に通す。流出液を凍結乾燥して、粗
生成物3.21gを得た。これに8M尿素水溶液(PH
9.5)50mlに溶かし、0℃で1時間放置する。次
いでこの溶液をCMセルロースのカラム(4.3×16
cm)にチヤージし、0.01M酢酸アンモニウム緩衝
液(PH4.5)800ml−0.3M酢酸アンモニウム緩衝
液(PH4.5)800mlの直線型濃度勾配による溶出を
行う。溶出液は6.5mlずつ分画し、118〜151本目
を集め、凍結乾燥後、セフアデツクスLH−20の
カラム(3.0×120cm、0.1N酢酸)にチヤージし、
流出液を7.5mlずつ分画し、26〜37本目を集め、
凍結乾燥して、521mgを得た。これをさらにCM
−セルロースのカラム(2.1×48cm)にチヤージ
し、0.01N酢酸アンモニウム緩衝液(PH4.5)500
ml〜0.3M酢酸アンモニウム緩衝液(PH4.5)500
mlの直線型濃度勾配による溶出を行い、800mlず
つ分画し、59〜70本目を集め、凍結乾燥後、セフ
アデツクスLH−20のカラム(3.0×92cm、0.1N酢
酸)にチヤージし、流出液を8.0mlずつ分画し、
21−30本目を集め、凍結乾燥して、[Tyr45]−ペ
プチド(45−84)281mgを得た。
TLC;Rf9=0.75
アミノ酸分析;Asp4.97(5)、Thr0.97(1)、
Ser3.62(4)、Glu6.11(6)、Pro0.96(1)、Gly1.93(2)、
Ala4、Val3.98(4)、Leu2.95(3)、Thr0.91(1)、
Lys6.04(6)、His0.92(1)、Arg1.91(2)、
参考例 7
[Cys45]−ペプチド(46−84);
H−Cys−Ala−Gly−Ser−Gln−Arg−Pro−
Arg−Lys−Lys−Glu−Asp−Asn−Val−Leu
−Val−Glu−Ser−His−Glu−Lys−Ser−
Leu−Gly−Glu−Ala−Asp−Lys−Ala−Asp
−Val−Asn−Val−Leu−Thr−Lys−Ala−
Lys−Ser−Glu−OH
(1) P(45−84);BOC−Cys(Acm)−Ala−Gly
−Ser(Bzl)−Gln−Arg(Tos)−Pro−Arg
(Tos)−Lys(Z−Cl)−Glu(OBzl)−Asp
(OBzl)−Asn−Val−Leu−Val−Glu(OBzl)
−Ser(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)
−Ser(Bzl)−Leu−Gly−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl)−Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [53]
参考例6で得た残りの脱BOC化物6.90g
(1.0mM)をDMF130mlとNMP130mlの混液に溶
かし、これに0℃に冷却下HOBT0.16g(1.2倍
M)、BOC−Cys(Acm)−OH0.35g(1.2倍M)
およびWSCI0.22ml(1.2倍M)を加えた後、室温
で一夜撹拌した。反応後、DMFを減圧下留去し、
残渣に氷水を加え、生じた沈澱物を集めた。これ
をエタノールに懸濁して加熱し、冷却した後、不
溶物をろ取した。この操作を2回繰り返して
[53]5.93g(収率84.4%)を得た。
(2) [Cys(Acm)45]−ペプチド(45−84)
[53]4.22g(0.6mM)にアニソール15mlを加
え、これに無水HF80mlを導入し、0℃で1時間
撹拌した。次いでHFを減圧留去し、残渣にエー
テルを加え、生じた沈澱を集め、20%酢酸50mlに
溶解し、ダウエツクス1×2のカラム(2.8×45
cm、酢酸型)に通す。流出液を凍結乾燥し、これ
を8M尿素水溶液60mlに溶解し、アンモニウア水
でPH9.5に調節後、CM−セルロース(3×45cm)
にチヤージし、0.01M酢酸アンモニウム緩衝液
(PH4.5)700ml〜0.3M酢酸アンモニウム緩衝液
(PH4.5)700mlの直線型濃度勾配による溶出を行
い、溶出液を8.0mlずつ分画し、45〜55本目を集
め、凍結乾燥後、セフアデツクスLH−20のカラ
ム(3.0×120cm、0.1N酢酸)に通し、35〜41本目
を集め、凍結乾燥を行い、580mgを得た。
これをさらにCM−セルロースのカラム(5×
13cm)にチヤージし、0.01M酢酸アンモニウム緩
衝液(PH4.5)400ml〜0.3M酢酸アンモニウム緩
衝液(PH4.5)400mlの直線型濃度勾配による溶出
を行つた。溶出液を6.0mlずつ分画し、120〜131
本目を集め、凍結乾燥後、セフアデツクスLH−
20のカラム(4.0×120cm、0.1N酢酸)に通し、
8.0mlずつ流出液を分画し、38−53本目を集め、
凍結乾燥して、[Cys(Acm)45]−ペプチド(46−
84)233mgを得た。
TLC;Rf9=0.74
アミノ酸分析;Asp4.97(5)、Thr1.00(1)、
Ser3.67(4)、Glu6.07、Pro1.01(1)、Gly1.96(2)、
Ala4、Val3.99(4)、Cys0.43(0.5)、Leu2.94(3)、
Lys6.03(6)、His0.91(1)、Arg1.92(2)、
(3) [CysAcm)45]−ペプチド(45−84)mg
(0.02mM)に58mgの酢酸第二水銀を溶解した
50%酢酸2mlを加えて溶かし、室温で90分撹拌
後、β−メルカプトエタノール4mlを加え、室
温で24時間撹拌した。反応液を遠心分離し、上
澄液をセフアデツクスG−25(3.0×90cm、0.1N
酢酸)にチヤージし、溶出液を10.5mlずつ分画
し、24〜29本目を集め、凍結乾燥を行つて、
[Cys45]−ペプチド(45−84)64.1mgを得た。
TLC;Rf9=0.73[Table] As a result, both labeled antigens showed that the C of h-PTH
It shows good reactivity with end-specific antibodies,
It was found to be useful as a labeled antigen for RIA. (4) Immunoreactivity with various h-PTH-related substances [Extraction and purification of h-PTH (1-84)] h-PTH (1-84) was extracted from patients with hyperparathyroidism. The parathyroid gland was removed and extracted and purified according to the method of Keutmann et al. (ACS, 17, 26 , 1978). [Preparation method of natural h-PTH (53-84)] The purified h-PTH (1-84) described above was digested with trypsin, and the method of Keutmann et al. (ACS, 17, 26 ,
(1978). [Synthesis [Asp 76 ]-h-PTH (53-84)] Synthesis [Asp 76 ]-h-PTH (53-84)
It was synthesized according to the specification of No. 53-187686. [Measurement of immunological cross-reactivity] Various h-PTH related substances (natural h-PTH (1-
84), natural h-PTH (53-84), synthetic [ Asp76 ]-h
-PTH (53-84), peptide of the present invention (53-84)
each containing 0.2 to 2000 fmoles) solution 100 μ, β
-galactosidase- [Cys 45 ] peptide (45-
84) (approximately 10 pg as [Cys 45 ] peptide (45−84)
containing) solution 100μ, and antiserum diluted solution (A is
Add 100μ of a 15,000-fold dilution, B: a 5,000-fold dilution, and C: a 9,000-fold dilution) to a reaction test tube and allow to react at 5°C for 24 hours, then add 100μ of a 100-fold dilution of guinea pig normal serum, anti-guinea pig gamma
- 100 μl of a 10-fold dilution of globulin serum (rabbit)
was added, and the reaction was further carried out at 5°C for 24 hours. After adding 3 mml of 0.5M NaCl to the reaction solution, it was heated at 3000 rpm for 15 minutes.
The precipitate was collected by centrifugation for a minute. Next, 200μ of the β-galactosidase activity measurement solution (described above) was added to the precipitate, and the mixture was reacted at 37°C for 120 minutes.
After the reaction is complete, add 2.3 ml of the reaction stop solution (above),
The reaction solution was stopped, and the absorbance of the reaction solution at 420 nm was measured. The results are as shown in Figure 1 (antiserum-A), Figure 2 (antiserum-B), and Figure 3 (antiserum C).
In each figure, 〇-〇 indicates the case of the peptide of the present invention (53-84), ●-● indicates the case of natural h-PTH (53-84), and △-△ indicates the case of the synthetic [Asp 76 ]- h-PTH
(53-84) is shown, □-□ is natural h-
The case of PTH (1-84) is shown. From the results of the above immune reactions, etc., various peptides represented by the formula [] of the present invention are peptide hormones consisting of 84 amino acids, h-
It was a useful reagent for diagnosing PTH-related diseases in measuring the blood concentration of PTH on the C-terminal side. Therefore, these various peptides are also known
It may be appropriately used in various quantitative methods in EIA and RIA, such as competitive methods, Sand-Deutsch methods, and combinations of these with solid-phase methods and antibody methods. Furthermore, in EIA, enzyme-labeled peptides may be obtained by appropriately selecting and using various known enzymes, such as peroxidase and alkaline phosphatase, as labels in addition to β-galactosidase, which is the labeling compound described above. Next, the present invention will be specifically described with reference to Examples, but the present invention is not limited thereto. In addition, the abbreviations described in this specification have the following meanings. Gln; L-glutamine Ser; L-serine Lys; L-lysine Ala; L-alanine Thr; L-threonine Leu; L-leucine Val; L-valine Asp; L-aspartic acid Glu; L-glutamic acid Gly; glycine His ; L-histidine Asn; L-asparagine Arg; L-arginine Pro: L-proline Tyr; L-tyrosine Cys; L-cysteine BOC; t-butyloxycarbonyl AOC; t-amyloxycarbonyl Z-CI; O-chloro Benzyloxycarbonyl Bzl; benzyl Tos; tosyl OMe; methyl ester OEt; ethyl ester OBzl; benzyl ester OSU; N-hydroxysuccinimide ester ONP; P-nitrophenyl ester PAC; phenacyl ester Acm; acetamidomethyl TosOH; P -Toluenesulfonic acid TFA; trifluoroacetic acid Et3N ; triethylamine TBA; tribenzylamine NMM; N-methylmorpholine HOBT; 1-hydroxybenzotriazole DMF; dimethylformamide THF; tetrahydrofuran NMP; N-methyl-2-pyrrolidone MeOH; Methanol EtOH; Ethanol BuCH; Butanol ether; Diethyl ether WSCI; N-ethyl, N'-3-dimethylaminopropyl-carbodiimide HOBT; 1-hydroxybenzotriazole Next, examples of the production of the present invention will be described with reference to Examples and Reference Examples. I will explain in detail. The carrier and developing solvent for thin layer chromatography (TLC) used in the examples are as follows. Support: Silica Gel G manufactured by Merck & Co., Ltd. Developing solvent: 1; CHCI 3 -MeOH-acetic acid (95:5:3) 2; 〃 (85:15:5) 3; 〃 (85:10:5) 4; 〃 (80 :25:2) 5; Benzene-ethyl acetate (1 : 1) 6; 〃 (2:1) 7; CHCl 3 -EtOH-ethyl acetate (5:2:5) 8; 10:1:5) Support: Cellulose manufactured by Merck & Co., Ltd. Developing solvent: 9; BuOH-pyridine-acetic acid-water
(2:2:2:3) 10;BuOH-pyridine-acetic acid-water
(1:1:1:2) 11; BuOH-pyridine-acetic acid-water
(15:10:3:12) The conditions for amino acid analysis are as follows. The specimen was hydrolyzed with 6N hydrochloric acid (10% anisole was added if necessary in the case of a protected peptide) at 110°C for 24 to 45 hours in a sealed tube, dried under reduced pressure, and subjected to amino acid analysis. Reference example 1 [Tyr 64 ]-peptide (65-84); H-Tyr-
Lys−Ser−Leu−Gly−Glu−Ala−Asp−Lys
−Ala−Asp−Val−Asn−Val−Leu−Thr−
Lys−Ala−Lys−Ser−Gln−OH (1) P(83−84); BOC−Ser(Bzl)−Gln−OBzl
[] BOC−Gln−OBzl81.4g (0.242M)
Dissolved in 270ml of TFA and stirred at room temperature for 45 minutes.
TFA was distilled off under reduced pressure. Add ether to the residue,
The resulting precipitate was collected. Dissolve this in 270ml of DMF, add 32.67g of HOBT (0.242M) and BOC-Ser.
(Bzl)-OH67.35g (0.242M) and WSCI44.29
ml (0.242M) and stirred overnight. After the reaction,
DMF was distilled off under reduced pressure. Add the residue to 440ml of ethyl acetate.
The solution was washed with 1N hydrochloric acid, 5% aqueous sodium bicarbonate, and water in this order. It was dried with anhydrous sodium sulfate and evaporated to dryness. Recrystallization from ethyl acetate-hexane gave 101.43 g (yield: 81.6%). Melting point 121-123℃ TLC; Rf 7 = 0.75 [α] 27 D-14.12 (C = 1.0, DMF) Elemental analysis [as C 27 H 35 O 7 N 3 ] C% H% N% Measured value 62.98 7.03 8.01 Calculation Value 63.14 6.87 8.18 (2) P(82−84);BOC−Lys(Z−Cl)−Ser
(Bzl)-Gln-OBzl [2] [1] 98.87g (192.5mM) was added to 440ml of TFA, and after stirring at room temperature for 30 minutes, TFA was distilled off under reduced pressure. Dissolve the residue in 330ml of DMF, HOBT28.6
g, DMF solution of BOC-Lys(Z-Cl)-OH (BOC-Lys(Z-Cl)-OH・TBA103.33g(1.1
M) was treated with ethyl acetate-1N hydrochloric acid, and the ethyl acetate layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. Dissolve the residue in 110ml DMF) and 83.72ml WSCI
(1.1 times the mole) was added, and the mixture was stirred at room temperature for 2 days. After the reaction, DMF was distilled off under reduced pressure, ice water was added to the residue,
The resulting precipitate was collected. Reconsolidation was performed three times with ethanol-hexane to obtain 111.06 g (yield 71.2%) of [2]. TLC; Rf 1 = 0.32, Rf 7 = 0.76 Melting point; 145-147°C [α] 27 D-13.1 (C = 1.0, DMF) Elemental analysis [as C 41 H 52 O 10 N 5 Cl] C% H% N % Measured value 61.02 6.65 8.74 Calculated value 60.77 6.47 8.65 (3) P(80−81);BOC−Lys(Z−Cl)−Ala−
OMe [3] 234.24 g of BOC-Lys(Z-Cl)-OH·TBA was suspended in ethyl acetate and washed successively with 1N hydrochloric acid and water.
After drying with anhydrous sodium sulfate and drying under reduced pressure, 400ml of DMF
It was dissolved in To this, H-Ala-OMe・HCl67.0
g, 64.8 g of HOBT, and 87.84 ml of WSCI were added, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in ethyl acetate 2, and 5% aqueous sodium bicarbonate, 1N
Washed with hydrochloric acid and water in that order. After drying with anhydrous sodium sulfate and drying under reduced pressure, it was dissolved in 400 ml of DMF. H to this
-Ala-OMe・HCl67.0g, HOBT64.8g,
87.84 ml of WSCI was added and stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was diluted with ethyl acetate.
The solution was washed with 5% sodium bicarbonate solution, 1N hydrochloric acid, and water in this order. After drying with anhydrous sodium sulfate, it was dried under reduced pressure. Recrystallized from ethyl acetate-hexane to give 231.8 g of [3] (yield
96.6%). Melting point: 58-60℃ TLC; Rf 1 = 0.77 [α] 27 D-17.16 (C = 1.0, DMF) Elemental analysis [as C 23 H 34 O 7 N 3 Cl] C% H% N% Measured value 54.96 6.78 8.56 Calculated value 55.25 6.85 8.40 (4) P(79−81); BOC−Thr(Bzl)−Lys(Z−
Cl)-Ala-OMe [4] [3] Add 174.99g (0.35M) to 500ml of TFA,
Stirred at room temperature for 50 minutes. After the reaction, TFA was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate, followed by washing with 5% aqueous sodium bicarbonate and water in this order. After drying with anhydrous sodium sulfate, it was dried under reduced pressure. Dissolve the residue in 400ml of DMF and add
HOBT49.95g (1.05x M), BOC−Thr(Bzl)−
OH114.33g (1.05x M) and WSCI67.7ml
(1.05 times M) was added and stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and ice water was added to the residue.
The resulting precipitate was collected and reprecipitated four times with hot ethanol to obtain 99.31 g of [4]. The mother liquor was concentrated under reduced pressure, and the residue was dissolved in chloroform and washed successively with 5% sodium bicarbonate solution (4 times), 1N hydrochloric acid (2 times), and water (2 times). After drying with anhydrous sodium sulfate, it was dried under reduced pressure. The residue was subjected to silica gel column chromatography [eluent: chloroform-ethanol-
Acetic acid (5:1:5)] [4] 35.09
I got g. The fraction containing impurities was used for column chromatography purification in the next additional synthesis. Next, [3] 22.5g (45mM) of TFA70
ml and stirred at room temperature for 45 minutes. After the reaction,
After TFA was distilled off under reduced pressure and the residue was dissolved in 50 ml of DMF, the pH was adjusted to 7 with NMM. Then,
HOBT6.68g (1.1x M), BOC−Thr(Bzl)−
OH15.31g (1.1xM), WSCI9.06ml (1.1xM)
was added and stirred overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 200 ml of chloroform.
It was washed with 5% sodium bicarbonate solution, 1N hydrochloric acid, and water in this order. After drying with anhydrous sodium sulfate, it was dried under reduced pressure. The residue was purified by silica gel column chromatography together with the previous impure fraction. The corresponding fraction was dried under reduced pressure and reprecipitated twice with chloroform-hexane to obtain 48.80 g of [4]. Total amount 183.2g Melting point: 132-134℃ TLC; Rf 7 = 0.85 Elemental analysis [as C 34 H 47 O 9 N 4 Cl] C% H% N% Measured value 59.06 7.05 7.41 Calculated value 59.08 6.85 8.11 (5) P( 77-78); BOC-Val-Leu-OEt [5] BOC-Val-OH101.99g (0.47M), H-Leu
−OEt・HCl91.98g (0.47M), HOBT63.45g,
Dissolve WSCI86.01ml (0.47M) in THF400ml,
Stir overnight. After the reaction, THF was distilled off under reduced pressure, the residue was dissolved in 400 ml of ethyl acetate, and then 5% aqueous sodium bicarbonate solution,
Washed with 1N hydrochloric acid and water in that order. After drying with anhydrous sodium sulfate,
It was dried under reduced pressure. Recrystallization from ethyl acetate-hexane gave 153.7 g (yield 91.2%) of [5]. Melting point: 108-110℃ TLC; Rf 1 = 0.63 [α] 27 D-25.78 (C = 1.0, DMF) Elemental analysis [as C 18 H 34 O 5 N 2 ] C% H% N% Measured value 60.35 9.42 8.39 Calculated value 60.31 9.56 7.82 (6) P (77-78); BOC-Val-Leu-OH [6] [5] 34.43g (0.375M) in 400ml of ethanol
Dissolve in 1N-NaOH412.5ml (1.1x M) under ice-cooling.
was added and stirred. After an hour and a half, 1N−
NaOH37.5 (0.1xM) was added and stirred for 1 hour. 75 ml of 1N hydrochloric acid was added to the reaction solution, and the pH was adjusted to 5 with a small amount of hydrochloric acid. Wash with ether and aqueous layer
400 ml of 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate.
After drying the ethyl acetate layer, it was dried under reduced pressure and reconsolidated from ethyl acetate-hexane to give 119.66 g (yield) of [6].
96.6%). TLC; Rf 1 = 0.35, Rf 7 = 0.58 Elemental analysis [as C 16 H 30 O 5 N 2 ] C% H% N% Measured value 57.83 9.40 8.78 Calculated value 58.16 9.15 8.48 (7) P (77−81); BOC−Val−Leu−Thr(Bzl)
-Lys(Z-Cl)-Ala-OMe [7] [4] 182 g (0.263 M) was added to 500 ml of TFA and stirred at room temperature for 50 minutes. After the reaction, TFA was distilled off under reduced pressure, and hexane was added to the residue. The resulting oil was separated from the solvent by decantation and added to 350 ml of DMF.
It was dissolved in Adjust this to PH6.5 with NMM under cooling, HOBT42.61g (1.2 times M), [6] 104.28g
(1.2x M) and WSCI57.8ml (1.2x M) were added.
After stirring for 1.5 hours at room temperature, the mixture solidified and could not be stirred even after adding 200 ml of DMF, so it was left at room temperature overnight and then at 30°C for 4 hours. Ice water was added to the reaction mixture and the precipitate was collected. Add this to chloroform 2.5
The solution was washed with 5% sodium bicarbonate solution, 1N hydrochloric acid, and water in this order. Chloroform was distilled off under reduced pressure, and the residue was reconsolidated from chloroform-etherhexane [7]
224.68g (yield 94.9%) was obtained. Melting point: 219-221℃ TLC; Rf 1 = 0.15, Rf 8 = 0.68 [α] 27 D-11.72 (C = 1.0, DMF) Elemental analysis [as C 45 H 67 O 11 N 6 Cl] C% H% N % Measured value 59.80 7.56 9.83 Calculated value 59.82 7.48 9.30 (8) P(77−81); BOC−Val−Leu−Thr(Bzl)
-Lys(Z-Cl)-Ala-OH [8] [7] 72.3g (80mM) in 720ml of chloroform
800 ml of a 90% ethanol solution of 1N-KCH was added under cooling, and the mixture was stirred at 0 to 5°C for 40 minutes. Next, add 800ml of 1N hydrochloric acid under cooling, and add chloroform.
Added 500 ml and extracted. The chloroform layer was washed with water, dried over anhydrous sodium sulfate, and then dried under reduced pressure. The residue was subjected to silica gel column chromatography [eluent: chloroform-ethanol-ethyl acetate (5:
1:5)]. The corresponding fractions were dried under reduced pressure to form chloroform-methanol-ether.
[8] was obtained by recrystallization three times from hexane. The above operation was repeated three times, and a total of 216.9 g of [7] was hydrolyzed to obtain 156.07 g of [8] (yield 73.1%). Melting point 180-183℃ TLC; Rf 3 = 0.69 [α] 27 D-7.54 (C = 1.0, DMF) Elemental analysis [as C 44 H 65 O 11 N 6 Cl・1/2H 2 O] C% H% N % Measured value 58.94 7.67 9.64 Calculated value 58.82 7.40 9.35 Amino acid analysis [Sample 3.1 mg/1 ml 6N hydrochloric acid + 0.1 ml
Anisole, 45 hours, 110℃ hydrolysis]; Thr0.96(1), Alal, Val0.93(1), Leu0.94(1),
Lys1.01(1) (9) (77−84);BOC−Val−Leu−Thr(Bzl)−
Lys(Z-Cl)-Ala-Lys(Z-Cl)-Ser(Bzl)
-Gln-OBzl [9] [2] Add 104.5g (129mM) to 400ml of TFA,
Stirred at room temperature for 40 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. The resulting precipitate was collected and dissolved in 500 ml of DMF. This includes HOBT20.9
g (1.2 times M), [8] 137.7 g (1.2 times M),
28.3 ml of WSCI (1.2 times M) was added, the pH was adjusted with NMM, and the mixture was stirred overnight. Since the reaction solution became gel-like, 150 ml of DMF and 12.8 ml of WSCI were further added and stirred overnight. Ice water was added to the reaction solution, and the precipitate was collected and washed five times with hot methanol to obtain 185.36 g (yield: 90.68%) of [9]. TLC; Rf 2 = 0.85 [α] 27 D-12.84 (C = 1.0, DMF) Elemental analysis [as C 80 H 107 O 18 N 11 Cl 2 ] C% H% N% Measured value 60.61 7.04 10.38 Calculated value 60.75 6.82 9.74 Amino acid analysis [sample 3.1 mg/1 ml 6N hydrochloric acid + 0.1 ml
Anisole, 110℃, 45 hours hydrolysis]; Thr0.93(1), Ser0.91(1), Glu1.01(1), Alal,
Val0.74(1), Leu0.75(1), Lys2.01(2) (10) P(76−84); BOC−Asn−Val−Leu−Thr
(Bzl)−Lys(Z−C1)−Ala−Lys(Z−Cl)−
Ser(Bzl)-Gln-OBzl [10] [9] Add 174.0g (110mM) to 550ml of TFA,
After stirring at room temperature for 60 minutes, TFA was distilled off under reduced pressure.
Add ether to the residue, collect the resulting precipitate,
Dissolved in 950ml of DMF. In addition, BOC−Asn−
77.7 g (2.0 times M) of ONP was added, and the mixture was stirred at room temperature for 48 hours while adjusting the pH to 7.5 with NMM. After reaction
DMF was distilled off under reduced pressure, and ice water was added to the residue. The resulting precipitate was collected and washed with hot methanol.
After cooling, insoluble matter was collected. The same treatment was performed two more times to obtain 179.6 g (yield: 96.3%) of [10]. Melting point; 248-251℃ TLC; Rf 2 = 0.65 Rf 3 = 0.40 Elemental analysis [as C 84 H 113 O 20 N 13 Cl 2 ] C% H% N% Measured value 59.23 6.89 10.88 Calculated value 59.50 6.72 10.74 (11) P(75−84); BOC−Val−Asn−Val−Leu
−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−
Cl)-Ser(Bzl)-Gln-OBzl [11] [10] Add 169.58g (0.1M) to 500ml of TFA,
After stirring at room temperature for 60 minutes, TFA is removed under reduced pressure.
Add ether to the residue, collect the resulting precipitate,
Dissolved in DMF1.3. While stirring this
HOBT17.6g (1.3x M), BOC-Val-OH28.2
g (1.3xM) 2.4-dinitrophenol 23.9g
(1.3 times M) and 23.8 ml of WSCI (1.3 times M) were added, the pH was adjusted to 7 with NMM, and the mixture was stirred at room temperature. After 1 hour, the reaction solution became gel-like, so it was left overnight. Next, NMP400ml, WSCI23.8ml
(1.3xM) was added. It became gel-like again in about 10 minutes, and was left overnight at room temperature. After the reaction, ice and 5% sodium bicarbonate solution were added, and the resulting precipitate was collected, washed three times with water, and then washed four times with hot methanol [11]
171.06g (yield 95.3%) was obtained. Melting point: 256-269℃ TLC; Rf 3 = 0.36 Elemental analysis [as C 89 H 122 O 21 N 14 Cl 2・H 2 O] C% H% N% Measured value 59.14 6.71 10.86 Calculated value 58.96 6.89 10.82 Amino acid analysis [ Sample 3.1mg/1ml 6N hydrochloric acid + 0.1ml
Anisole, 48 hours, 110℃ hydrolysis]; Asp1.01(1), Thr0.82(1), Ser0.76(1), Glu1.05(1),
Ala1.03(1), Leu1, Val1.85(2), Lys2.15(2) (12) P(74−84); BOC−Asp(OBzl)−Val−Asn
−Val−Leu−Thr(Bzl)−Lys(Z−Cl)−Ala
-Lys(Z-Cl)-Ser(Bzl)-Gln-OBzl [12] [11] 143.60g (0.08M) of methylene chloride 100
After adding 450 ml of TFA and stirring at room temperature for 40 minutes, TFA was distilled off under reduced pressure. Ether was added to the residue, and 500 ml of DMF and NMP1 were added to the resulting precipitate to dissolve it. Ice and 5% sodium bicarbonate solution were added to this, and the resulting precipitate was collected, thoroughly washed with water, and then dried. Dissolve this in a mixture of 500ml of DMF and NMP1,
BOC-Asp(OBzl)-OSU43.7g (1.3x M),
1.14 g of HOBT (0.13 times M) and 11.4 ml of NMM (1.3 times M) were added, and the mixture was stirred at room temperature overnight. The reaction solution was added to ice water, the resulting precipitate was collected, methanol was added, and the mixture was heated. This treatment was repeated twice to obtain 149.5 g (yield 93.4%) of [12]. TLC; Rf 3 = 0.35 Elemental analysis [as C 100 H 133 O 24 N 15 Cl 2 ] C% H% N% Measured value 60.01 6.79 10.91 Calculated value 60.05 6.70 10.50 Amino acid analysis [6N hydrochloric acid/anilyl, 110℃,
48 hours]; Asp1.90(2), Thr0.88(1), Ser0.75(1),
Glu1.03(1), Ala1.01(1), Val1.95(2), Leu1,
Lys2.09(2) (13) P(72−73); BOC−Lys(Z−Cl)−Ala−
OH [13] [3] Dissolve 48.0g (96mM) in 100ml of ethanol, and add 115.2ml of 1N-NaOH to this while cooling to 0℃.
(1.2xM) and stirred for 50 minutes. After the reaction,
After adjusting the pH to 6 by adding 19 ml of 1N hydrochloric acid, ethanol was distilled off under reduced pressure at 35°C. Ethyl acetate, ice water, and 96 ml of 1N hydrochloric acid were added to the residue for extraction. The ethyl acetate layer was washed with water, dried over anhydrous sodium sulfate, and then dried under reduced pressure.
The residue was reconsolidated from ethyl acetate-hexane [13]
45.90g (yield 98.4%) was obtained. Melting point: 116-119℃ TLC; Rf 7 = 0.44 Elemental analysis [as C 22 H 32 O 7 N 3 Cl] C% H% N% Measured value 54.57 6.91 8.95 Calculated value 54.37 6.64 8.65 (14) P (72-84 );BOC−Lys(Z−Cl)−Ala−
Asp(OBzl)−Val−Asn−Val−Leu−Thr
(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−Cl)−
Ser(Bzl)−Gln−OBzl [14] [12] 120.01 (60mM) with 60ml of methylene chloride,
After adding 360ml of TFA and stirring at room temperature for 55 minutes,
TFA was distilled off under reduced pressure. Add ether to the residue,
The resulting precipitate was collected. Add 600ml of DMF to this
600ml of NMP was added and dissolved. Add this to ice +5%
Added to baking soda solution. The resulting precipitate was collected by filtration, washed with water three times, then washed with methanol and ether, and then dried. Add 1200ml of NMP and 600ml of DMF to this and dissolve, HOBT10.54g (1.3x M), [13] 37.92g
(1.3 times M) and 14.28 ml of WSCI (1.3 times M) were added, and the mixture was stirred at room temperature for 3 days. The reaction solution was added to ice water, and the resulting precipitate was collected, washed three times with water, and then twice with hot methanol. Then after washing with ether,
After drying, 135.83 g (yield 95.6%) of [14] was obtained. Elemental analysis [as C 117 H 155 O 28 N 18 Cl 3 ] C% H% N% Measured value 59.12 6.73 10.87 Calculated value 59.35 6.60 10.65 Amino acid analysis [6N hydrochloric acid/anisole, 110℃,
48 hours]; Asp1.09(2), Thr0.85(1), Ser0.72(1),
Glu1.02(1), Ala1.95(2), Val1.94(2), Leu1,
Lys2.99(3) (15) P(71−84); BOC−Asp(OBzl)−Lys(Z
−Cl)Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z
-Cl)-Ser(Bzl)-Gln-OBzl [15] [14] Add 118.40g (50mM) to 500ml of TFA,
After stirring at room temperature for 55 minutes, TFA was distilled off under reduced pressure.
Add ether to the residue, collect the resulting precipitate,
700 ml of NMP and 700 ml of DMF were added and dissolved. This was added to ice + 5% sodium bicarbonate solution, the resulting precipitate was collected by filtration, and 3 times with water and 1 time each with methanol and ether.
Washed twice. Add 800ml of NMP and 800ml of DMF to this sediment.
11.05 g of 2,4-dinitrophenol (1.2 times M), 0.81 g of HOBT (0.12 times M), 25.22 g of BOC-Asp(OBzl)-OSU (1.2 times M), and 6.60 ml of NMM. (1.4x M) and
The mixture was stirred for several days. 120ml of NMP and 60ml of DMF in the reaction solution
Add and dissolve BOC−Asp(OBzl)−
OSU4.20g (0.2xM), NMM1.09ml (0.2xM)
was added, and the mixture was further stirred at room temperature for 2 days. The reaction solution was added to ice water, and the resulting precipitate was collected and washed with water.
Next, it was suspended in hot methanol, cooled, and collected by filtration. Repeat this operation three times to obtain [15] 117.47
g (yield 91.3%) was obtained. Elemental analysis [as C 128 H 166 O 31 N 19 Cl 3 ] C% H% N% Measured value 59.52 6.32 10.60 Calculated value 59.75 6.50 10.34 Amino acid analysis [6N hydrochloric acid/anisole, 110℃,
48 hours]; Asp2.71(3), Thr0.85(1), Ser0.70(1),
Glu1.01(1), Ala1.95(2), Val1.92(2), Leu1,
Lys2.92(3) (16) P(70−84); BOC−Ala−Asp(OBzl)−
Lys(Z−C1)−Ala−Asp(OBzl)−Val−Asn
−Val−Leu−Thr(Bzl)−Lys(Z−Cl)−Ala
-Lys(Z-Cl)-Ser(Bzl)-Gln-OBzl [16] [15] Add 102.9g (40mM) to 400ml of TFA,
After stirring at room temperature for 70 minutes, TFA was distilled off under reduced pressure.
Add ether to the residue, collect the resulting precipitate,
After adding and dissolving 600ml of NMP and 600ml of DMF,
% sodium bicarbonate solution. Collect the resulting precipitate and dilute with water
Washed once with methanol. Next, 720ml of NMP and 720ml of DMF were added to this precipitate and dissolved.
Add to this 11.0 g (1.5 g) of 2,4-dinitrophenol.
xM), HOBT0.54g (0.1xM), BOC-Ala-
OSU17.18g (1.5x M), NMM6.60ml (1.5x M)
was added and stirred at room temperature overnight. Then, BOC−
Ala-OSU2.29g (0.2xM), NMM0.88ml (0.2
M) was added and stirred at room temperature for 5 days. The reaction solution was added to ice water, the resulting precipitate was collected and diluted with water three times.
Washed twice with methanol [16] 98.90g (yield
93.5%). Melting point: 280℃ or higher (decomposition) Amino acid analysis [6N hydrochloric acid/anisole, 110℃,
48 hours]; Asp2.75(3), Thr0.84(1), Ser0.72(1),
Glu1.01(1), Ala2.80(3), Val1.92(2), Leu1,
Lys2.92(3) (17) P(69−84); BOC−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl) −Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
Add 92.55g (35mM) of OBzl [17] [16] to 350ml of TFA,
After stirring at room temperature for 60 minutes, TFA was distilled off under reduced pressure.
Add ether to the residue, collect the resulting precipitate,
600 ml of DMF and 600 ml of NMP were added and dissolved, and this was added to 5% sodium bicarbonate water + ice. Collect the resulting precipitate,
Washed three times with water and once with methanol. to this
Add 600ml and 800ml of DMF and dissolve, add 2,
4-dinitrophenol 7.73g (1.2x M),
HOBT0.59g (0.14x M), BOC-Glu(OBzl)-
OSU21.29g (1.4xM), NMM5.4ml (1.4xM)
was added and stirred at room temperature for 3 days. Then BOC−
Glu (OBzl) - OSU3.04g (0.2x M) and DMF60ml
+NMP60ml added and dissolved solution and
Add 0.77ml of NMM (0.2x M) and
The mixture was stirred for several days. Next, add the same amount of BOC-Glu as before.
(OBzl)-OSU and NMM were added and stirred at room temperature overnight. After the reaction, the reaction solution was added to ice water, and the resulting precipitate was collected and washed three times with water. This precipitate was suspended in hot methanol, cooled, and collected by filtration. This operation was repeated three times [17]92.71g (yield
92.5%). Amino acid analysis [6N hydrochloric acid/anisole, 110℃,
24 hours]; Asp2.72(3), Thr0.85(1), Ser0.76(1),
Glu1.85(2), Ala2.80(3), Val1.93(2), Leu1,
Lys2.95(3) (18) P(66−68); BOC−Ser(Bzl)−Leu−Gly
−OBzl [18] BOC−Leu−OH・H 2 O45.64g, H−Gly−
OBzl・TosOH61.87g and HOBT24.87g
Dissolve in 200ml of THR and cool with 33.69ml of WSCI.
was added dropwise, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated under reduced pressure to obtain an oily substance. Add this to ethyl acetate 600
ml, 5% sodium bicarbonate solution, 1N hydrochloric acid, and water.
Wash twice. The organic layer was dried over anhydrous sodium sulfate and dried under reduced pressure to obtain 69.0 g (yield: 99%) of an oily substance. Dissolve this in 10 ml of methylene chloride, add 250 ml of TFA while cooling to 5°C, and then heat at room temperature while stirring.
The reaction was allowed to proceed for 20 minutes. TFA was distilled off under reduced pressure, and 200 ml of DMF was added to the residue, which was neutralized by adding NMM while cooling to 0°C. This includes HOBT20.7g (0.19M),
BOC-Ser(Bzl)-OH56g (0.19M) and
After adding 34.8 ml of WSCI (0.19 M), the mixture was stirred at room temperature overnight. DMF was distilled off under reduced pressure, ethyl acetate was added to the residue, and the mixture was washed successively with 5% aqueous sodium bicarbonate, 1N hydrochloric acid, and water. After drying over anhydrous magnesium sulfate, it was concentrated under reduced pressure. Hexane was added to the residue, and the resulting precipitate was collected by filtration. After recrystallizing from ethyl acetate-hexane,
Recrystallization from ethyl acetate-ether-hexane gave 72.47 g (yield 72.0%) of [18]. Melting point: 112-113℃ TLC; Rf 5 = 0.55 Elemental analysis [as C 30 H 41 O 7 N 3 ] C% H% N% Measured value 65.06 7.75 7.36 Calculated value 64.84 7.44 7.56 (19) P (65-68) ;BOC−Lys(Z−Cl)−Ser
(Bzl)-Leu-Gly-OBzl [19] [18] 72.47g (0.13M) and 20ml of methylene chloride
After cooling to 5° C., 250 ml of TFA was added, and the mixture was stirred at room temperature for 20 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. The resulting precipitate was collected and 100 ml of DMF was added. This is cooled to 5℃.
Neutralized by adding NMM. On the other hand, BOC-Lys(Z-Cl)-OH・TBA70g
(0.143M), add 200ml of ethyl acetate, add 1N hydrochloric acid,
Washed twice with water. The ethyl acetate layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. Add 100 ml of DMF to the obtained oil, and add BOC-Lys(Z-Cl)-
It was made into a DMF solution of OH. To the above neutralized DMF solution were added 19.3 g of HOBT, the DMF solution of BOC-Lys(Z-Cl)-OH obtained above, and 26.2 ml (0.143 M) of WSCI, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, 400 ml of ethyl acetate was added to the residue, and the mixture was diluted with 5% aqueous sodium bicarbonate (1N) three times.
Washed twice with hydrochloric acid and twice with water. The organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. Ether and hexane were added to the residue, and the resulting precipitate was collected and recrystallized from ethyl acetate-methanol-hexane to obtain 104 g (yield 94.6%) of [19]. Melting point: 128-130℃ TLC: Rf 1 = 0.51, Rf 2 = 0.88 Elemental analysis [as C 44 H 58 O 10 N 5 Cl] C% H% N% Measured value 61.96 7.02 7.91 Calculated value 62.00 6.86 8.22 Amino acid analysis [ 1μM/6N hydrochloric acid/anisole,
105℃, 48 hours]; Ser0.92(1), Gly0.98(1), Leu1,
Lys0.99(1) (20) P(65−68); BOC−Lys(Z−C1)−Ser
(Bzl)-Leu-Gly-OH [20] [19] Add 600 ml of methanol to 85.3 g and heat at 5℃.
While stirring under cooling, 120 ml of 1N-NaOH was added, and the mixture was stirred at room temperature for 3 hours. After the reaction, 20 ml of 1N hydrochloric acid was added while cooling to 5°C, and methanol was distilled off under reduced pressure. 100 ml of 1N hydrochloric acid was added to the aqueous solution of the residue while cooling at 5°C, and the mixture was extracted with 500 ml of chloroform.
The chloroform layer was washed with water, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. Hexane was added to the residue, the resulting precipitate was collected, and recrystallized from ethyl acetate [20]
66.21 g (yield 87%) was obtained. Melting point: 156-158℃ TLC; Rf 2 = 0.63 Elemental analysis [as C 37 H 52 O 10 N 5 Cl] C% H% N% Measured value 58.49 6.95 9.09 Calculated value 58.30 6.88 9.19 Amino acid analysis [0.5 μM/6N hydrochloric acid / Anisole,
105℃, 48 hours]; Ser0.92(1), Gly0.97(1), Leu1,
Lys0.99(1) (21) P(65−84); BOC−Lys(Z−Cl)−Ser
(Bzl)−Leu−Gly−Glu(OBzl)−Ala−Asp
(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)−
Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z−
Cl) −Ala−Lys(Z−Cl)−Ser(Bzl)Gln−
Add 100ml of TFA to OBzl [21] [17] 14.32g (5mM),
Stirred at room temperature for 60 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, the resulting precipitate was collected, and 100 ml of NMP was added to dissolve it. Ice this
It was added to 5% sodium bicarbonate solution, and the resulting precipitate was collected by filtration and washed with water and methanol in that order. to this precipitate
Add and dissolve 200ml of NMP, add 1.10g of 2,4-dinitrophenol, and 0.81g of HOBT [20]
After 4.66 g was added and dissolved, 1.10 ml of WSCI was added at -10°C, and the mixture was stirred at room temperature for 3 days. After the reaction, the reaction solution was poured into ice-5% sodium bicarbonate solution, the resulting precipitate was collected by filtration, and water,
Wash with methanol (4 times), [21] 15.00g
(yield 85.5%). Amino acid analysis; Asp2.72(3), Thr0.93(1), Ser1.65(2), Glu1.82
(2), Gly0.99(1), Ala2.82(3), Val1.98(2), Leu2,
Lys3.92(4), (22) [Tyr 64 ]P(64−84); BOC−Tyr(Bzl−
Cl 2 )−Lys(Z−Cl)−Ser(Bnl)−Leu−Gly−
Glu(OBzl)−*;Asp2.74(3), Thr0.91(1),
Ser1.67(2), Glu1.86(2), Gly0.98(1), Ala2.86
(3), Val1.99(2), Leu2, Lys3.95(4), Tyr0.95(1) (2) [ Tyr64 ]-peptide (64-84); [22] 3.06g (0.8mM) 5 ml of anisole was added to the mixture, and 50 ml of anhydrous HF was introduced thereinto, followed by stirring at 0° C. for 1 hour. Next, HF was distilled off under reduced pressure, ether was added to the residue, the precipitate was collected, and 0.1N acetic acid was added.
The solution was dissolved in 50 ml and passed through a Dowex 1×2 column (3.0×40 cm, acetic acid type), and the effluent was freeze-dried to obtain 2.41 g. Dissolve this in 70ml of 8M urea aqueous solution, adjust the pH to 9.5 with aqueous ammonia, and then
It was left at ℃ for 1 hour. This solution was then charged to a CM-cellulose column (3 x 30 cm),
0.01M ammonium acetate buffer (PH4.5) 800ml~
Elution was performed using a value linear concentration gradient of 800 ml of 0.2 M ammonium acetate buffer (PH4.5), and the eluate was 10 ml.
The 79th to 99th fractions were collected, and after freeze-drying, they were separated using a Sephadex LH-20 column (3.0 x 120 cm, 0.1N
acetic acid), fractionated into 9.8 ml portions, collected the 42nd to 49th portions, and freeze-dried to obtain 483 mg of [Tyr 64 ]-peptide (64-84). TLC; Rf 11 = 0.15 Amino acid analysis (6N-hydrochloric acid, 105°C, 24 hours);
Asp2.96(3), Thr0.95(1), Ser1.79(2), Glu2.03(2),
Gly0.97(1), Ala2.94(3), Val1.97(2), Leu2,
Lys4.06(4), Tyr0.96(1) Example 1 Peptide (53-84); H-Lys-Lys-Glu-
Asp-Asn-Val-Leu-Val-Glu-Ser-His
−Glu−Lys−Ser−Leu−Cly−Glu−Ala−
Asp−Lys−Ala−Asp−Val−Asn−Val−Leu
−Thr−Lys−Ala−Lys−Ser−Gln−OH (1) P(64−68); BOC−Glu(OBzl)−Lys(Z−
Cl)-Ser(Bzl)-Leu-Gly-OH [23] Add 30 ml of methylene chloride to 66.2 g (87 mM) of [20] described in Reference Example 1, and add 250 ml of TFA while cooling to 5°C.
was added, and the mixture was stirred at room temperature for 45 minutes. After the reaction,
TFA was distilled off under reduced pressure, and ether was added to the residue.
The resulting precipitate was collected and dissolved in 100 ml of DMF. This was neutralized with NMM while cooling to 5°C. Since a precipitate had separated out, an additional 500 ml of DMF was added. BOC-Glu(OBzl)-OSU 50g (113mM) was added to this solution.
After adding 1.53 g (11.3 mM) of HOBT and neutralizing with NMM, the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure and the residue was poured into water. The obtained precipitate was washed with water and dried. Recrystallization was performed twice from acetone-methanol to obtain 63.85 g (yield: 73.5%) of [23]. Melting point: 165-167℃ (decomposition) TLC; Rf 4 = 0.72 Elemental analysis [as C 49 H 65 O 14 N 6 Cl] C% H% N% Measured value 59.61 6.76 8.31 Calculated value 59.00 6.57 8.42 Amino acid decomposition [0.927 mg /0.3ml 6N hydrochloric acid/anisole, 105℃ 48 hours]; Ser0.92(1), Glu0.99(1),
Gly0.97(1), Leu1, Lys0.99(1) (2) P(62−63); BOC−Ser(Bzl)−His−
NHNH 2 [24] BOC−Ser(Bzl)−OH37g (0.125M)
THF150ml, H-His-OMe・2HCl31.5g
(0.13M) and HOBT17.6g (0.13M), and WSCI23.8ml (0.13M) under cooling to 5℃.
After adding 150 ml of DMF, the mixture was stirred at room temperature overnight. Further, 4.4 g of HOBT and 6 ml of WSCI were added, and the mixture was stirred at room temperature overnight. After the reaction, the solvent was distilled off under reduced pressure, and the residual oil was dissolved in ethyl acetate and washed three times with 5% aqueous sodium bicarbonate and three times with water. It was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Hexane was added to the residue, the resulting precipitate was collected, and recrystallized from ethyl acetate-ether-hexane to obtain the crude product.
BOC−Ser(Bzl)−His−OMe(TlC; Rf 3 =0.56)
46.1g was obtained. 44.6 g (0.1 M) of the above product was dissolved in 300 ml of DMF, 100 ml of hydrazine hydrate (100%) was added thereto, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure. The residue was extracted eight times with ethyl acetate, the extract was washed with a small amount of water, and then dried over anhydrous magnesium sulfate. It was concentrated under reduced pressure, hexane was added to the residue, and the resulting precipitate was collected. This was subjected to silica gel column chromatography [elution solvent: chloroform-ethyl acetate (1:1) to chloroform-methanol-ethyl acetate (5:1:
5)]. The corresponding sections were dried under reduced pressure, and the residue was dissolved in benzene-hexane (very small amount).
It was crystallized from After being placed in an ice chamber, the precipitated crystals were recrystallized twice from ethyl acetate-methanol-hexane to obtain [24]. Melting point: 125-129℃ TLC: Rf 4 = 0.70, Rf 7 = 0.14 Elemental analysis [as C 21 H 30 O 5 N 6 ] C% H% N% Measured value 56.30 6.98 18.54 Calculated value 56.49 6.77 18.82 (3) P (62−68);BOC−Ser(Bzl)−His−Glu
(OBzl)−Lys−(Z−C1)−Ser(Bzl)−Leu−
Dissolve 33.5g of Gly-OH [25] [24] in 200ml of DMRF, and add 4.32N hydrogen chloride in dioxane solution while cooling to -50℃.
After adding 52 ml and 20 ml of isoamyl nitrite, −20
Stirred at °C for 10 minutes. Then cooled to -50°C,
Added 31.6 ml of Et3N . On the other hand, [23] 63.85g (64mM) was added to methylene chloride.
After adding 20 ml of TFA to this while cooling to 5° C., the mixture was stirred at room temperature for 50 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residual oil, and the resulting precipitate was collected. This was dissolved in 200 ml of DMF and neutralized with NMM while cooling to 5°C. The neutralized DMF solution was added to the triethylamine-treated solution cooled to 0° C. and stirred overnight in an ice chamber and overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in methanol. This was poured into water, and the resulting precipitate was collected by filtration, washed with water, and dried. Reconcrete with DMF-ether and methanol
After washing twice, 59.16 g (yield 60.1%) of [25] was obtained. Melting point: 209-213℃ (decomposition) TLC; Rf 4 = 0.66 Elemental analysis [as C 65 H 83 O 17 N 10 Cl] C% H% N% Measured value 59.43 6.58 10.67 Calculated value 59.51 6.38 10.68 Amino acid analysis [1.549 mg /0.5ml 6N hydrochloric acid/anisole, 105℃, 45 hours]; Ser1.82(2), Glu1.01(1),
Gly0.98(1), Leu1, Lys1.01(1), His0.94(1) (4) P(62−84); BOC−Ser(Bzl)−His−Glu
(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu−Gly
−Glu(OBzl)−Ala−Asp(OBzl)−Lys(Z−
Cl) −Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z
-Cl)-Ser(Bzl)-Gln-OBzl [26] [17] 250ml of TFA was added to 71.59g (25.0mM) and stirred at room temperature for 60 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. The resulting precipitate was collected and dissolved by adding 500 ml of NMP and 500 ml of DMF. This was added to ice-5% sodium bicarbonate solution, and the resulting precipitate was collected by filtration and washed successively with water and methanol.
Add NMPl and DMF1 to this precipitate, dissolve it, and add 5.52 g of 2,4-dinitrophenol.
(1.2xM), HOBT4.05g (12xM), [25] 38.84
g (1.2 times M) and 5.5 ml of WSCI (1.2 times M) were added and stirred at room temperature for 4 days. After the reaction, the reaction solution was
% sodium bicarbonate water-ice, and the resulting precipitate was collected by filtration.
Washing with water, hot methanol, and methanol (twice) in this order gave 89.21 g (yield: 88.3%) of [26]. Amino acid analysis [0.5μM/6N hydrochloric acid-anisole
110℃ 48 hours]; Asp2.90(3), Thr0.91(1), Ser1.92
(3), Glu2.89(3), Gly0.89(1), Ala2.95(3),
Val2.20, Leu2, Lys4.02(4), His0.88(1) (5) P(61−84); BOC−Glu(OBzl)−Ser(Bzl)
-His-Glu(OBzl)-Lys(Z-Cl)-Ser(Bzl)
−Leu−Gly−Glu(OBzl)−Ala−Asp(OBzl)
−Lys−(Z−Cl)−Ala−Asp(OBzl)−Val−
Asn−Val−Leu−Thr(Bzl)Lys(Z−Cl)−
Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−OBzl
[27] [26] Add 250ml of TFA to 48.49g (12mM),
After stirring at room temperature for 60 minutes, TFA was distilled off under reduced pressure. Ether was added to the residue, the resulting precipitate was collected, and 350 ml of DMF and 550 ml of NMP were added to dissolve it.
This was poured into 5% sodium bicarbonate water-ice, and the resulting precipitate was collected by filtration, washed with water, and then with methanol. Add and dissolve 800 ml of DMF and 700 ml of NMP to this precipitate, add 2.7 g of 2,4-dinitrophenol (1.2 times M), 7.30 g of BOC-Glu (OBzl)-OSU (1.4 times M),
HOBT0.23g (0.14xM) and NMM1.85ml
(1.4xM) was added and stirred at room temperature overnight. Next, BOC-Glu(OBzl)-OSU1.04 was added to this reaction solution.
g (0.2 times M) and 0.26 ml of NMM (0.2 times M) were added, and the mixture was further stirred overnight. Add reaction solution to ice-5%
Pour into baking soda, filter the resulting precipitate, wash thoroughly with water, and then wash with hot methanol three times [27] 45.3
g (yield: 88.6%). Amino acid analysis [/6N hydrochloric acid, anisole, 110
°C, 48 hours]; Asp2.98(3), Thr0.93(1), Ser1.83
(1), Glu3.62(4), Gly0.89(1), Ala2.97(3),
Val2.23, Leu2, Lys4.06(4), His0.85(1) (6) P(59−60); BOC−Leu−Val−OBzl [28] H−Val−OBzl・TOSOH17.8g (47mM ) was added with 100 ml of ethyl acetate, washed successively with 5% sodium bicarbonate solution and water, and the ethyl acetate layer was dried over anhydrous sodium sulfate, and then ethyl acetate was distilled off under reduced pressure. Dissolve the residue in 100ml of DMF and add 11.7g of BOC-Leu-OH・H 2 O to this.
(56.4mM), HOBT9.3g (1.2x M) and
10.3 ml of WSCI (1.3 times M) was added and stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in 300 ml of ethyl acetate, and 5% aqueous sodium bicarbonate, 1N hydrochloric acid,
Washed with water. After drying with anhydrous sodium sulfate, it was dried under reduced pressure. The residue was crystallized from ethyl acetate-hexane to obtain 17.55 g (yield: 88.8%) of [28]. TLC; Rf 6 = 0.85 (7) P (58-60); BOC-Val-Leu-Val-OBzl
[29] [28] 17.2g (41mM) of TFA (50ml) was added, and after stirring at room temperature for 30 minutes, TFA was distilled off under reduced pressure.
Ether was added to the residue, and the resulting product was collected by filtration and then dissolved in 60 ml of DMF. 7.7g of HOBT for this
(1.2xM), BOC-Val-OH10.7g (1.2xM) and WSCI9.0ml (1.2xM), and PH with NMM.
After adjusting the temperature to 7, the mixture was stirred at room temperature overnight. After the reaction,
DMF was distilled off under reduced pressure, and the residue was dissolved in 300 ml of ethyl acetate, and then washed successively with 5% aqueous sodium bicarbonate, IN hydrochloric acid, and water. It was dried with anhydrous sodium sulfate and evaporated to dryness. The residue was recrystallized twice from ethyl acetate-hexane to obtain 17.38 g (yield: 81.6%) of [29]. Melting point; 149-152℃ TLC; Rf 5 = 0.82 [α] D 22 ; -32.36 (C = 1.0DMF) Elemental analysis [as C 28 H 45 O 6 N 3 ] C% H% N% Measured value 64.80 8.81 8.20 Calculated value 64.71 8.73 8.09 (8) P(57−60); BOC−Asn−Val−Leu−Val
−OBzl [30] [29] Add 50ml of TFA to 17.15g (33mM),
After stirring at room temperature for 25 minutes, TFA was distilled off under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected and dissolved in 100 ml of DMF. HOBT0.62g for this
(0.14xM) BOC-Asn-ONP16.32g (1.4xM)
was added, the pH was adjusted to 7 with NMM, and the mixture was stirred at room temperature for 2 days. After the reaction, DMF was distilled off under reduced pressure, and the residue was poured into 5% sodium bicarbonate water-ice. The resulting precipitate was dissolved in chloroform and washed successively with 5% sodium bicarbonate water and water. It was dried with anhydrous sodium sulfate and evaporated to dryness. The residue was recrystallized twice from methanol-ether [30]
13.82g (yield 79.5%) was obtained. TLC; Rf 2 = 0.70 Elemental analysis [as C 32 H 51 O 8 N 5 ] C% H% N% Measured value 60.83 8.19 11.09 Calculated value 60.64 8.11 11.05 (9) P (57−60); BOC−Asn−Val −Leu−Val
−OH [31] [30] 13.2g (25mM) with 50ml of ethanol
It was dissolved in a mixture of 60 ml of DMF, 5% PD/clg was added thereto, and hydrogenated for 3 hours. The catalyst was filtered off, and the filtrate was concentrated under reduced pressure. The residue was recrystallized twice from ethanol-ether to obtain 9.70 g (yield 71.4%) of [31]. TLC; Rf 2 = 0.56 Amino acid analysis [0.5 μM/6N hydrochloric acid-anisole,
110℃ 48 hours]; Asp1.02(1), Val1.95(2), Leu1(1) Elemental analysis [as C 25 H 45 O 8 N 5 ] C% H% N% Measured value 55.02 8.13 13.06 Calculated value 55.23 8.34 12.88 (10) P(57−84); BOC−Asn−Val−Leu−Val
−Glu(0Bzl)−Ser(Bzl)−His−Glu(OBzl)−
Lys(Z−Cl)−Ser(Bzl)−Leu−Gly−Glu
(OBzl)-Ala-Asp(OBzl)-Lys(Z-Cl)-
Ala−Asp(OBzl)−Val−Asn−Val−Leu−
Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−Cl)
-Ser(Bzl)-Gln-OBzl [32] [27] Add 220ml of TFA to 42.60g (10mM),
Stirred at room temperature for 60 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, the resulting precipitate was collected, and 600 ml of DMF and 600 ml of NMP were added and dissolved.
This was added to ice-5% sodium bicarbonate solution, and the resulting precipitate was filtered and washed three times with water and once with methanol. Add and dissolve NMP1.2 and DMF1.2 to this precipitate, add 1.76 g of HOBT (0.3 times M), 2,
4-dinitrophenol 2.39g (1.3x M), [31]
7.05 (1.3 times M) and 4.76 ml of WSCI (2.6 times M) were added and stirred at room temperature for 2 days. Furthermore [31] 1.09
A solution of g (0.2 times M) dissolved in 100 ml of DMF was added, and the mixture was stirred at room temperature overnight. The reaction solution was mixed with 5% sodium bicarbonate water.
The resulting precipitate was collected on ice, suspended in 100 ml of DMF, and heated. After cooling, insoluble matter was filtered off. Furthermore, heat-treated methanol and ethanol in the same manner as above [32] 43.30g
(yield 92.4%). Amino acid analysis [0.5μM/6N hydrochloric acid-anisole,
110℃ 48 hours]; Asp3.81(4), Thr0.90(1), Ser1.82
(3), Glu3.62(4), Gly0.88(1), Ala3, Val3.65(4),
Leu2.58(3), Lys4.21(4), His0.86(1) (11) P(56−84); BOC−Asp(OBzl)−Asn−Val
−Leu−ValGlu(OBzl)−Ser(Bzl)−His−Glu
(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu−Gly
−Glu(OBzl)−Ala−Asp(OBzl)−Lys(Z−
Cl) −Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)Ala−Lys(Z
-Cl)-Ser(Bzl)-Gln-OBzl [33] [32] 220 ml of TFA was added to 42.2 g (9 mM), and the mixture was stirred at room temperature for 50 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, and the resulting precipitate was collected and dried overnight in a NaOH desiccator.
Add and dissolve 400 ml of DMF and 600 ml of NMP to this precipitate, add 0.24 g of HOBT (0.2 times M), BOC-
Add Asp(OBzl)-OSU8.00g (2xM),
After adjusting the pH to 7.0 with NMM, the mixture was stirred at room temperature overnight. In addition, BOC-Asp(OBzl)-OSU4.00g (1
M) was added and stirred overnight. The reaction solution was poured into ice water, and the resulting precipitate was collected, washed with water, added to methanol, and heated. After cooling, insoluble matter was filtered off. The above heat treatment was performed three times [33] 39.97g
(Yield 90.8% was obtained. Amino acid analysis [0.5 μM/6N hydrochloric acid-anisole,
110℃ 48 hours]; Asp4.82(5), Thr0.95(1), Ser1.90
(3), Glu3.72(4), Gly0.92(1), Ala3, Val3.67(4),
Leu2.73(3), Lys4.10(4), His0.78(1) (12) P(55−84); BOC−Glu(OBzl)−Asp
(OBzl) −Asn−Val−Leu−Val−Glu(OBzl)
−Ser(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)
−Ser(Bzl)−Leu−Gly−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl) −Ala−Lys(Z−Cl)−Ser(Bzl)Gln−
Add 220ml of TFA to OBzl [34] [33] 39.13g (8.0mM),
Stirred at room temperature for 60 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, and the resulting precipitate was collected and dried in a NaOH desiccator for 2 days. Add 500 ml of DMF and 600 ml of NMP to this precipitate, dissolve it, and add 2,4-dinitrophenol.
1.47g (1xM), 0.11g HOBT (0.10xM) and 4.52g (1.3xM) of BOC-Glu(OBzl)-OSU were added and stirred overnight at room temperature. Furthermore, BOC−Glu
(OBzl)-OSU 4.52 g (1.3 times M) was added and stirred for 2 days. The reaction solution was poured into ice + 5% aqueous sodium bicarbonate, and the resulting precipitate was washed twice with 5% aqueous sodium bicarbonate and three times with water. Next, methanol was added, heat treated, and after cooling, insoluble matter was filtered off. The above heat treatment was performed three times to obtain 37.25 g (yield: 91.1%) of [34]. Amino acid analysis [0.5μM/6M hydrochloric acid-anisole,
110℃ 48 hours]; Asp4.78(5), Thr0.96(1), Ser1.95
(3), Glu4.79(5), Gly0.89(1), Ala3, Val3.70(4),
Leu2.71(3), Lys4.09(4), His0.77(1) (13) P(53−54); BOC−Lys(Z−Cl)−Lys(Z
−Cl) PAC [35] BOC−Lys(Z−Cl)−OH・TBA36.6g
(75mM) in 300ml of ethyl acetate, ice + 1N
After washing with hydrochloric acid, it was washed with water. The ethyl acetate layer was dried over anhydrous sodium sulfate, dried under reduced pressure, and the residue was dissolved in 50 ml of DMF.
It was dissolved in To this were added 19.40 g of phenacyl bromide and 13.60 ml of Et 3 N (1.3 times M) while cooling at 0° C., and the mixture was stirred at room temperature for 4 hours. Add 3.68 g of sodium acetate (0.5 times M) to the reaction solution and 500 ml of ethyl acetate.
After adding a solution dissolved in water, the solution was washed three times each with 5% sodium bicarbonate solution, 1N hydrochloric acid, and water in that order. The ethyl acetate layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. The residue was purified by silica gel column chromatography [eluent benzene-ethyl acetate (2:1)],
The fractions near Rf 1 =0.77 on TLC were collected and dried under reduced pressure. The residue was recrystallized from ether-hexane.
BOC-Lys(Z-Cl)-PAC23.46g (yield 60.5%)
I got it. Melting point: 52-54°C TLC: Rf 1 =0.86 60 ml of TFA was added to 20.68 g (40 mM) of the above product, and the mixture was stirred at room temperature for 20 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, and the resulting precipitate was collected and dissolved in 50 ml of DMF to obtain DMF solution A. On the other hand, BOC−Lys(Z−Cl)−OH・TBA23.42
g (1.2 times M) in 200 ml of ethyl acetate, and
Washed with 200 ml of 1N hydrochloric acid and 100 ml of water. The ethyl acetate layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. The obtained oil was dissolved in 50 ml of DMF to obtain DMF solution B. Solution B adjusted to the DMF solution A,
HOBT6.48g (1.2xM), WSCI8.78ml (1.2xM)
was added, the pH was adjusted to 7 with NMM, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in 500 ml of ether, and then diluted with 5% sodium bicarbonate solution for 30 minutes.
Washed twice. 300 ml of ethyl acetate was added to the ether layer, and the mixture was washed twice with 1N hydrochloric acid and three times with water. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was recrystallized three times from ether to give [35] 18.73 g (yield
57.5%). Melting point: 72-75℃ Elemental analysis [as C 41 H 50 O 10 N 4 Cl 2 ] C% H% N% Measured value 59.22 5.98 6.81 Calculated value 59.35 6.07 6.75 (14) P (53-54); BOC-Lys (Z−Cl)−Lys(Z
-Cl)-OH [36] [33] Dissolve 4.07g (5mM) in 30ml of acetic acid,
This was added to 20 g of zinc powder/30 ml of acetic acid and stirred at room temperature for 1.5 hours. After the reaction, the zinc dust was filtered off, and acetic acid was distilled off from the filtrate under reduced pressure. The residue was dissolved in 100 ml of ether and extracted three times with 70 ml of 5% aqueous sodium bicarbonate.
The aqueous layer was adjusted to pH 2 with 1N hydrochloric acid under ice cooling, and extracted with ethyl acetate. The ethyl acetate layer was washed with water, dried over anhydrous sodium sulfate, and then dried under reduced pressure. The residue was recrystallized from ether-hexane to give [36] 3.08 g (yield 85.8%)
I got it. Melting point: 59-62℃ TLC; Rf 2 = 0.45 Elemental analysis [as C 33 H 44 O 9 N 4 Cl 2 ] C% H% N% Measured value 55.58 6.40 7.58 Calculated value 55.69 6.23 7.87 (15) P(53− 84);BOC−Lys(Z−Cl)−Lys(Z
−Cl)−Glu(OBzl)−Asp(OBzl)−Asn−Val
−Leu−Val−Glu(OBzl)−Ser(Bzl)−His−
Glu(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu−
Gly−Glu(OBzl)−Ala−Asp(OBzl)−Lys(Z
−Cl)−Ala−Asp(OBzl)−Val−Asn−Val−
Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z
-Cl)-Ser(Bzl)-Gln-OBzl [37] [34] 80 ml of TFA was added to 10.22 g (2 mM), and the mixture was stirred at room temperature for 55 minutes. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, the resulting precipitate was collected, and 200 ml of DMF and 200 ml of NMP were added and dissolved. Add to this HOBT0.41g (1.5x M) under ice cooling, [36]
2.13g (1.5xM) and WSCI0.55ml (1.5xM)
was added and stirred at 5 to 10°C for 3 days. The reaction solution was poured into ice water, and the resulting precipitate was collected, washed with water, and then heat-treated with methanol. After cooling, insoluble matter was filtered off. This heat treatment was performed three times [37] 10.41g
(yield 91.25%). Amino acid analysis [0.5μM/6N hydrochloric acid-anisole,
110℃ 48 hours]; Asp4.82(5), Thr0.92(1), Ser1.89
(3), Glu4.77(5), Gly0.91(1), Ala3.00, Val3.79
(4), Leu2.62(3), Lys5.83(6), His0.75(1) (16) Peptide (53−84) [37] Add 5ml of anisole to 3.4g (0.6mM), and add Introducing 50ml of anhydrous hydrogen fluoride (HF),
Stirred at 0°C for 60 minutes. After the reaction, HF is distilled off under reduced pressure, and ether is added to the residue. Collect the precipitate, dissolve it in 50ml of 0.1N acetic acid, and add Dowex 1
Pass through 2 x columns (2.7 x 36 cm acetic acid type). The effluent was freeze-dried to obtain 2.1 g of crude product. this
Dissolve in 50ml of 8M urea solution and adjust pH with ammonia water.
After adjusting the temperature to 9.5, it was left at 0°C for 1 hour. This solution was then applied to a CM-cellulose column (4.4×
After washing with 200ml of 0.01M ammonium acetate buffer (PH4.5), 700ml of 0.01M ammonium acetate buffer (PH4.5) to 700ml of 0.1M ammonium acetate buffer (PH4.5) linear type. Elution is performed with a concentration gradient and then with 300 ml of 0.2M ammonium acetate buffer (PH4.5). Eluate is 13.5
The mixture was fractionated in ml portions, each fraction was measured by the Folin-Lowry method (750 nm), and the 76th to 110th fractions were collected and freeze-dried to obtain 600 mg. Column of Sephadex LH-20 (3.4 x 120 cm, 0.1N acetic acid)
to desalinate. The eluate was fractionated into 8.5 ml portions, and the 47th to 53rd eluates were collected and freeze-dried to obtain 415 mg.
Furthermore, it was charged to a CM-cellulose column (4.4 x 15 cm) and 0.01M ammonium acetate buffer (PH
4.5) 700ml ~ 0.1M ammonium acetate buffer (PH
4.5) Perform elution with a 700 ml linear concentration gradient,
Fractionate into 13.5ml portions, collect 80th to 96th tubes, freeze-dry, and apply to Sephadex LH-20 column (3.4 x 12cm).
The mixture was charged to 100 ml, eluted with 0.1N acetic acid, fractionated into 5 ml portions, and the 76th to 85th fractions were collected and freeze-dried to obtain 220 mg of peptide (53-84). TLC; Rf 9 = 0.76 Amino acid analysis; Asp4.80(5), Thr0.95(1),
Ser2.34(3), Glu4.99(5), Gly0.95(1), Ala3,
Val3.95(4), Leu2.96(3), Lys6.28(6), His0.97(1) Reference example 2 [Tyr 52 ]-peptide (52-84); H-Tyr-
Lys−Lys−Glu−Asp−Asn−Val−Leu−Val
−Glu−Ser−His−Glu−Lys−Ser−Leu−
Gly−Glu−Ala−Asp−Lys−Ala−Asp−Val
−Asn−Val−Leu−Thr−Lys−Ala−Lys−
Ser−Gln−OH (1) [Tyr 52 ]P(52−84); BOC−Tyr(Bzl−
Cl 2 )−Lys(Z−Cl)−Lys(Z−Cl)−Glu
(OBzl)−Asp(OBzl)−Asn−Val−Leu−Val
−Glu(OBzl)−Ser(Bzl)−His−Glu(OBzl)−
Lys(Z−Cl)−Ser(Bzl)−Leu−Gly−Glu
(OBzl)-Ala-Asp(OBzl)-Lys(Z-Cl)-
Ala−Asp(OBzl)−Val−Asn−Val−Leu−
Thr(Bzl)−Lys(Z−Cl)−Ala−Lys(Z−Cl)
−Ser(Bzl)−Gln−OBzl [38]. [37] 5.82g (1.0mM) described in Example 1
50 ml of TFA was added and stirred at room temperature for 50 minutes. TFA was distilled off under reduced pressure, ether was added to the residue,
After collecting the resulting precipitate, add 150ml of DMF and 150ml of MNP.
was added and dissolved. HOBT0.27g (2xM) and
After adding and dissolving 0.88 g of BOC-Tyr (Bzl-Cl 2 )-OH (2x M), cool it at -20°C, and add 0.37 g of WSCI.
(2xM) was added and stirred at room temperature for 2 days.
The reaction solution was poured into ice water, the resulting precipitate was collected, washed with water, suspended in methanol, heated, cooled, and the insoluble matter was filtered off. This precipitate was further heated and suspended in methanol, then cooled and collected to give 5.15 g of [38]
(yield 88.4%). TLC; R9=0.75 Amino acid analysis Asp4.43(5), Thr0.88(1), Ser1.86(3), Glu4.63
(5), Gly0.92(1), Ala3(3), Val3.59(4), Leu2.62
(3), Tyr0.88(1), Lys5.58(6), His0.76(1), (2) [ Tyr52 ]-peptide (52-84) in 50ml of anhydrous hydrogen fluoride (HF) at 0°C. under cooling (1)
Add 3.68g (0.6mM) and 10ml of anisole and cool at 0°C.
and stirred for 60 minutes. After the reaction, HF was distilled off under reduced pressure,
Add ether to the residue, collect the resulting precipitate,
Dissolve in 50 ml of 0.1N vinegar and pass through a Dowex 1 column (acetate type, 3 x 48 cm). Elute with 0.1N acetic acid and lyophilize the effluent to obtain the crude product.
2.43g was obtained. Dissolve this in 50ml of 8M urea aqueous solution, adjust the pH to 9.5 with aqueous ammonia, and then store at 0℃.
It was left for 60 minutes. Furthermore, this solution was added to a CM-cellulose column (3 x 30
cm) and drained with about 100ml of 0.01M ammonium acetate solution (PH4.5), then linear concentration of 700ml of 0.01M ammonium acetate solution (PH4.5) to 700ml of 0.1M ammonium acetate solution (PH4.5). Gradient elution was performed, followed by elution with 300 ml of 0.2M aqueous ammonium acetate. Eluate: 13.5ml
Each fraction was measured at UV280nm, and 75~
The 121st eluate was collected and lyophilized. This lyophilized product was dissolved in 5 ml of 0.1N acetic acid, passed through a column of Sephadex LH-20 (3.4 x 120 cm), the effluent was fractionated into 8.5 ml portions, the 46th to 53rd eluates were collected, and lyophilized. and obtained 532 mg. Dissolve this in 40 ml of 0.1N acetic acid, and add a CM-cellulose column (4.5
x 11 cm) and elute with a linear concentration gradient of 500 ml of 0.01 M ammonium acetate aqueous solution (PH4.5) - 500 ml of 0.1 M ammonium acetate aqueous solution (PH4.5). The eluate was fractionated into 6.0 ml portions, each fraction was measured at UV 280 nm, and the 121st to 133rd eluates were collected and freeze-dried. This freeze-dried product
Dissolve in 5 ml of 0.1N acetic acid and add Sephadex LH-
The mixture was passed through 20 columns (3.4 x 120 cm), fractionated into 8.4 ml portions, and the 47th to 52nd fractions were collected and lyophilized to obtain 129 mg of [Tyr 52 ]-peptide (52-84). TLC, RF 9 =0.75 1 spot Amino acid analysis Asp4.78(5), Thr0.95(1), Ser2.48(3), Glu5.01
(5), Gly0.96(1), Ala3, Val3.97(4), Leu2.95(3),
Tyr0.91(1), Lys6.03(6), His0.98(1), Reference example 3 Peptide (51-84); H-Pro-Arg-Lys-
Lys−Glu−AspAsn−Val−Leu−Val−Glu−
Ser−His−Glu−Lys−Ser−Leu−Gly−Glu
−Ala−Asp−Lys−Ala−Asp−Val−Asn−
Val−Leu−Thr−Lys−Ala−Lys−Ser−Gln
−OH (1) P(52−54); AOC−Arg(Tos)−Lys(Z−
Cl)-Lys(Z-Cl)-PAC [39] 14.65g (18mM) of [35] described in Example 1
50 ml of TFA was added and stirred at room temperature for 30 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. The resulting precipitate was collected and dissolved in 10 ml of DMF. To this, AOC-Arg(Tos)-OH9.19g (1.2x M)-HOBT2.92g (1.2x M) and WSCI3.95
ml (1.2xM) and stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure and the residue was dissolved in ethyl acetate.
After dissolving in 300 ml, the solution was washed three times each in the order of 5% sodium bicarbonate solution, 1N hydrochloric acid, and water. The ethyl acetate layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. Recrystallized from ethyl acetate-ether [39] 14.46g (yield 69.6%)
I got it. Melting point: 79-82℃ TLC; Rf 7 = 0.76 Elemental analysis [as C 55 H 70 O 13 N 8 SCI] C% H% N% Measured value 57.06 6.26 9.82 Calculated value 57.23 6.11 9.71 (2) P (51-54 );BOC−Pro−Arg(Tos)−Lys
(Z-Cl)-Lys(Z-Cl)-PAC [40] [39] Add 40ml of TFA to 14.43g (12.5mM),
Stirred at room temperature for 20 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. The resulting precipitate was collected and dissolved in 80 ml of DMF. to this
HOBT2.03g (1.2x M), BOC-Pro-OH3.23
g (1.2 times M) and 2.75 ml of WSCI (1.2 times M) were added and stirred overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 300 ml of ethyl acetate.
It was washed with 5% sodium bicarbonate solution and 1N hydrochloric acid solution in this order. The ethyl acetate layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. The residue was recrystallized twice from ethyl acetate-ether to obtain 14.71 g (yield 95.1%) of [40]. Melting point: 90-93℃ TLC; Rf 7 = 0.64 Elemental analysis [as C 59 H 75 O 14 N 9 SCI 2 ] C% H% N% Measured value 57.33 6.20 9.79 Calculated value 57.27 6.11 10.19 (3) P(51− 54);BOC−Pro−Arg(Tos)−Lys
(Z-Cl)-Lys(Z-Cl)-OH [41] 6.19 g (5mM) in 20 g of zinc powder/30 ml of acetic acid [40]
A solution of 40 ml of acetic acid was added thereto, and the mixture was stirred at room temperature for 2 hours. After the reaction, the zinc dust was filtered off, and the filtrate was concentrated under reduced pressure. The residue was extracted with 5% aqueous sodium bicarbonate and ether, and the separated aqueous layer was adjusted to H2 with 1N hydrochloric acid, and then extracted with ethyl acetate. The ethyl acetate layer was washed three times with water, dried over anhydrous sodium sulfate, and then dried under reduced pressure.
The residue was recrystallized from ethyl acetate-ether to obtain 5.40 g (yield 96.5%) of [41]. Melting point: 110-113℃ TLC; Rf 4 = 0.43 Elemental analysis [as C 51 H 69 O 13 N 9 SCI 2 ] C% H% N% Measured value 54.56 6.46 11.22 Calculated value 54.73 6.21 11.27 (4) P (51− 84);BOC−Pro−Arg(Tos)−Lys
(Z-Cl)-Lys(Z-Cl)-Glu(OBzl)-Asp
(OBzl) −Asn−Val−Leu−Val−Glu(OBzl)
−Ser(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)
−Ser(Bzl)−Leu−Gly−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl) −Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [42] [34]10.22 (2.0mM) described in Example 1
80 ml of TFA was added and stirred at room temperature for 60 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. Collect the resulting precipitate and add with 180ml of DMF.
180ml of NMP' was added and dissolved. to this
HOBT0.41g (1.5xM), [41]3.35g (1.5xM)
and 0.55 ml of WSCI (1.5x M) and
The mixture was stirred for several days. The reaction solution was added to ice water, and the resulting precipitate was washed with water, then methanol was added and heat treated.
After cooling, insoluble matter was collected. After repeating the above heat treatment twice, wash with ether [42] 10.65g
(yield 87.1%). Amino acid analysis (0.5μM/6N hydrochloric acid-anisole,
110℃ 48 hours); Asp4.62(5), Thr0.98(1), Ser2.32
(3), Glu4.52(5), Pro0.83(1), Gly0.94(1), Ala3,
Val3.82(4), Leu2.68(3), Lys5.81(6), His0.78(1),
Arg0.86(1) (5) Peptide (51-84) [42] Add 5 ml of anisole to 3.7 g (0.6 mM), introduce 60 ml of anhydrous hydrogen fluoride (HF),
The mixture was stirred at 0°C for 60 minutes. After the reaction, HF was distilled off under reduced pressure, ether was added to the residue, the precipitate was collected, dissolved in 50 ml of 0.1N acetic acid, and washed with Dowex 1x.
2 column (2.7×40 cm acetic acid type) and the effluent was lyophilized to obtain 2.2 g of crude product. this
Dissolve in 50ml of 8M urea solution and add with ammonia water.
After adjusting the pH to 9.5, it was left at 0°C for 1 hour. This solution was then applied to a CM-cellulose column (4.2
x 13cm), washed with 200ml of 0.01M ammonium acetate buffer (PH4.5), and then a straight line between 700ml of 0.01M ammonium acetate buffer (PH4.5) and 700ml of 0.1M ammonium acetate buffer (PH4.5). Elution was performed using a type concentration gradient, followed by elution with 300 ml of 0.2M ammonium acetate buffer (PH4.5). The eluate is
Fractionate into 8.5 ml portions, collect the 120th to 160th tubes, freeze-dry, pass through a Sephadex LH-20 column (3.4 x 110 cm, 0.1N acetic acid), fractionate into 5.2 ml portions, and collect the 51st to 62nd tubes. was collected and freeze-dried to obtain 392 mg. Furthermore, charge a CM-cellulose column (2.0 x 36 cm) in the same manner, and elute with a linear concentration gradient of 500 ml of 0.01 M ammonium acetate buffer (PH4.5) to 500 ml of 0.2 M ammonium acetate buffer (PH4.5). conduct. The eluate was fractionated into 7.5 ml portions and 92
~Collect the 110th section, freeze-dry it, and apply it to a Sephadex LH-20 column (3.0 x 123cm 0.1N acetic acid).
The eluate was fractionated into 6 ml portions, the 37th to 47th tubes were collected, and lyophilized to yield 213 mg of peptide (51-84).
I got it. TLC; R 10 = 0.89 Amino acid analysis; Asp4.98(5), Thr0.92(1),
Ser2.45(3), Glu5.13(5), Gly1.00(1), Ala3,
Val3.98(4), Leu2.99(3), Lys6.08(6), His0.97(1),
Arg0.99(1), Pro1.02(1) Reference example 4 [Tyr 50 ] peptide (50-84); H-Tyr-Pro
−Arg−Lys−Glu−Asp−Asn−Val−Leu−
Val−Glu−Ser−His−Glu−Lys−Ser−Leu
−Gly−Glu−Ala−Asp−Lys−Ala−Asp−
Val−Asn−Val−Leu−Thr−Lys−Ala−Lys
−Ser−Gln−OH (1) [Tyr 50 ]P(50−84); BOC−Tyr(Bzl−
Cl 2 )−Pro−Arg(Tos)−Lys(Z−Cl)−Lys
(Z−Cl)−Glu(OBzl)−Asp(OBzl)−Asn−
Val−Leu−Val−Glu(OBzl)−Ser(Bzl)−His
−Glu(OBzl)−Lys(Z−Cl)−Ser(Bzl)−Leu
−Gly−Glu(OBzl)−Ala−Asp(OBzl)−Lys
(Z−Cl)−Ala−Asp(OBzl)−Val−Asn−
Val−Leu−Thr(Bzl)−Lys(Z−Cl)−Ala−
Lys(Z-Cl)-Ser(Bzl)-Gln-OBzl [43] 6.31g (1.0mM) of [42] described in Reference Example 3
50 ml of TFA was added and stirred at room temperature for 55 minutes. TFA was distilled off under reduced pressure, ether was added to the residue,
After collecting the resulting precipitate, add 160ml of DMF and 160ml of NMP.
was added and dissolved. HOBT0.27g (2xM) and
After adding and dissolving 0.88 g of BOC-Tyr (Bzl-Cl 2 )-OH (2x M), it was cooled to -20°C, and 0.37 g of WSCI was added.
(2xM) was added and stirred at room temperature for 3 days. The reaction solution was poured into ice, and the resulting precipitate was collected, washed with water, suspended in methanol, heated, cooled, and the insoluble matter was filtered off. This precipitate was further heated and suspended in methanol, and then cooled to collect the precipitate. After performing this operation once more, wash with ether [43]
5.97g (yield 90%) was obtained. Amino acid analysis Asp4.45(5), Thr0.94(1), Ser2.25(3), Glu4.67
(5), Pro0.89(1), Gly0.92(1), Ala3, Val3.66(4),
Leu2.81(3), Tyr0.81(1), Lys5.53(6), His0.77(1),
Arg0.79(1) (2) [Tyr 50 ] h-PTH (50-84) 3.98 g in 60 ml of anhydrous HF at 0°C cooling [43]
(0.6mM) and 10ml of anisole, and
Stir for a minute. After the reaction, HF was distilled off under reduced pressure, ether was added to the residue, and the resulting precipitate was collected. This precipitate was dissolved in 50 ml of 0.1N acetic acid and passed through a 1×2 Dowex column (acetate type, 3×45 cm). The effluent was freeze-dried to obtain 2.41 g of crude product. This was dissolved in 60 ml of 8M urea aqueous solution, adjusted to pH 9.5 with aqueous ammonia, and then left at 0° C. for 60 minutes. Next, this solution was charged to a CM-cellulose column (3 x 30 cm) packed with 8M urea aqueous solution, and 0.01M ammonium acetate aqueous solution (PH4.5) was charged.
After draining the urea, elution was performed using a linear concentration gradient of 700 ml of 0.01M ammonium acetate solution (PH4.5) to 700 ml of 0.1M ammonium acetate solution (PH4.5), and then 0.2M ammonium acetate solution (PH4.5). ) eluted at 250 ml. The eluate was fractionated into 8.5ml portions, and each fraction was measured at UV280nm to yield ~142 fractions.
The 171st effluent was collected and freeze-dried. This lyophilized product was dissolved in 6 ml of 0.1M acetic acid, passed through a Cephadex LH-20 column (3.4 x 120 cm), fractionated into 8.5 ml portions, and the 46th to 52nd effluent was collected and lyophilized to obtain 410 mg. Obtained. Dissolve this in 30 ml of 0.1N acetic acid, and
x 35cm) and elute with a linear concentration gradient of 500ml of 0.01M aqueous ammonium acetate (PH4.5) to 500ml of 0.2M aqueous ammonium acetate (PH4.5). The eluate is fractionated into 7.5 ml portions, 112 or more.
The 136th effluent was collected and lyophilized, then 0.1N
The effluent was dissolved in 6 ml of acetic acid and passed through a Sephadex LH-20 column (3.0 x 120 cm) into 6 ml fractions. The 35th to 43rd fractions were collected and lyophilized to obtain [Tyr 50 ] peptide ( 50−84) 134 mg was obtained. TLC; Rf 10 = 0.88 1 spot Amino acid analysis Asp4.98(5), Thr0.94(1), Ser2.43(3), Glu5.11
(5), Pro0.97(1), Gly0.97(1), Ala3, Val3.98(4),
Leu2.96(3), Tyr0.91(1), LyS6.05(6), His0.93(1),
Arg0.98(1) Reference example 5 Peptide (46-84); H-Ala-Gly-Ser-
Gln−Arg−Pro−Arg−Lys−Lys−Glu−Asp
−Asn−Val−Leu−Val−Glu−Ser−His−
Glu−Lys−Ser−Leu−Gly−Glu−Ala−Asp
−Lys−Ala−Asp−Val−Asn−Val−Leu−
Thr−Lys−Ala−Lys−Ser−Gln−OH (1) P(49−50); BOC−Gln−Arg(Tos)−OMe
[44] H-Arg(Tos)-OMe・HCl11.37g (30mM)
and BOC-Gln-ONP13.21g (1.2x M)
Dissolve in 200ml of DMF and cool to 0℃ with NMM to pH7
After adjusting the temperature, the mixture was stirred overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in chloroform, and then diluted with 5% sodium bicarbonate solution three times, 1M hydrochloric acid twice, and water three times.
Washed twice. The chloroform layer was dried with anhydrous sodium sulfate, and chromatography was performed on a silica gel column filled with chloroform. Chloroform-
The mixture was flushed with methanol-methyl acetate, and when the target product began to elute, it was eluted with chloroform-ethanol-ethyl acetate (1:1:1). Corresponding fractions were collected and concentrated under reduced pressure. Dissolve the residue in ethyl acetate and
Crystallize by adding hexane under cooling at °C [44]
get. Yield: 11.86g Melting point: 103-107℃ (2) P(48-50); BOC-Ser(Bzl)-Gln-Arg
After adding 50 ml of TFA to 9.39 g (16.5 mM) of (Tos)-OMe [45] [44] and stirring at room temperature for 20 minutes, TFA was distilled off under reduced pressure.
Add ether to the residue, filter the resulting precipitate,
Dissolved in 50ml of DMF. 3.24g of HOBT in this solution
(1.45 times M), BOC-Ser(Bzl)-OH7.07g (1.45
Add 4.39 ml of WSCI (1.45 times M) and
Stir overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 300 ml of ethyl acetate.
% sodium bicarbonate, 1N hydrochloric acid, and water in this order. The ethyl acetate layer was dried over anhydrous sodium sulfate and then concentrated under reduced pressure. The residue was crystallized twice from ethyl acetate-ether,
[45] 10.0 g (yield 81.0%) was obtained. Melting point: 97-102℃ Elemental analysis [as C34H49O10N7S・1 / 2H2O ] C% H% N% Measured value 54.07 6.90 13.29 Calculated value 53.95 6.66 13.00 (3) P (46−47 ); BOC−Ala−Gly−OH [46] BOC−Ala−OH7.57g, HOBT5.4g
Dissolved in THF60ml, H-Gly-OET・HCl5.58g
After that, 8.05 ml of WSCI was added dropwise over 5 minutes while cooling at -20°C, and the mixture was stirred for 1 hour and then at room temperature for 24 hours. After distilling the reaction solution under reduced pressure, ethyl acetate
After washing with 5% sodium bicarbonate solution (3 times), water, N-hydrochloric acid solution (3 times), saturated saline solution (3 times), and water, the ethyl acetate layer was separated and anhydrous Na 2 SO 4 was added. It was dried. The desiccant was removed and the mixture was concentrated to dryness to obtain pale yellow oily BOC-Ala-Gly-OET (Rf 1 =0.77).
Dissolve this as it is in 20 ml of ethanol, add 44 ml of N-NaOH over 10 minutes at 0℃, and leave it at room temperature for 1 hour.
Stirred for 30 minutes. Add 4 ml of N-hydrochloric acid at 0°C,
After distilling off ethanol under reduced pressure, add N-hydrochloric acid at 0°C.
42 ml was added, and the oil was extracted with 200 ml of ethyl acetate. After washing the ethyl acetate layer, it was concentrated, and the precipitated crystals were
Recrystallization was performed with ETOH-ether-n-hexane to obtain 6.12 g (yield 5.08%) of colorless crystals [46]. TLC; Rf 1 = 0.14 Melting point; 85-89°C (decomposition) [α] 26 D-9.28 (C = 1.0, DMF) Elemental analysis [as C 10 H 18 O 5 N 2・H 2 O] C% H% N% Measured value 45.49 7.71 10.78 Calculated value 45.45 7.63 10.60 (4) P(46−50);BOC−Ala−Gly−Ser(Bzl)−
50 ml of TFA was added to 9.72 g (13 mM) of Gln-Arg(Tos)-OMe [47] [45], and the mixture was stirred at room temperature for 30 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. The resulting precipitate was collected by filtration and dissolved in 100 ml of DMF. In this solution
BOC-Ala-Gly-OH [46] 3.84g (1.2x M),
HOBT2.11g (1.2xM) and WSCI2.85ml (1.2
M) was added, and the mixture was stirred at room temperature for 2 days. After the reaction,
DMF was distilled off under reduced pressure, the residue was dissolved in 200 ml of ethyl acetate, and then washed with water. After drying over anhydrous sodium sulfate and concentration under reduced pressure, the residue was crystallized twice from ethanol-ether to obtain 10.46 g (yield 91.9%) of [47]. Melting point; 154-157℃ Elemental analysis [as C 39 H 57 O 12 N 9 S] C% H% N% Measured value 53.21 6.90 14.38 Calculated value 53.47 6.56 14.39 (5) P (46-50); BOC-Ala- Gly−Ser(Bzl)−
9.64 g (11 mM) of Gln-Arg(Tos)-NH.NH 2 [48] [47] was dissolved in 50 ml of ethanol, and 6.4 ml of 50% NH 2 MH 2 was added thereto and stirred overnight at room temperature. Add 100ml of ethanol to the reaction solution,
Insoluble matter was filtered off. This was suspended in 100 ml of ethanol and heated. After cooling, filter [48]9.02g
(yield 93.6%). Melting point: 178-180℃ Elemental analysis [as C 38 H 57 O 11 N 11 S] C% H% N% Measured value 52.13 6.86 16.65 Calculated value 52.10 6.56 17.59 (6) P (46-50); BOC-Ala- Gly−Ser(Bzl)−
Gln−Arg(Tos)−Pro−Arg(Tos)−Lys(Z−
Cl)-Lys(Z-Cl)-PAC [49] 8.04g (6.6mM) of [40] described in Reference Example 3
After adding 40 ml of TFA and stirring at room temperature for 20 minutes,
TFA was distilled off under reduced pressure. Add ether to the residue,
The resulting precipitate was collected by filtration to obtain crude H-Pro-Arg.
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−PAC・
Got TFA. On the other hand, 6.83g (7.8mM) of [49] was dissolved in 30ml of DMF, and 5.42ml (23.4mM) of a 4.32N dioxane solution of hydrogen chloride and 1.10ml (8.09mM) of isoamylnitrile were added to this while cooling at -50°C. , 20 at −20℃
Stir for a minute. Then the above H-Pro-Arg(Tos)
-Lys(Z-Cl)-PAC/TFA was added and heated to -35℃.
After adding 5.46ml (39mM) of Et 3 N, the
The mixture was stirred for several days. After the reaction, DMF was distilled off under reduced pressure.
The residue was dissolved in 300 ml of chloroform, and washed successively with 5% sodium bicarbonate, 1N hydrochloric acid, and water. The chloroform layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification with ethanol-ether and chloroform-ether gave 13.42 g of [50]. TLC; Rf=0.64 [chloroform-methanol-
Acetic acid (83:18:3.5)] Elemental analysis [as C 92 H 120 O 22 N 18 Cl 2 S・3H 2 O] C% H% N% Measured value 54.68 6.21 12.72 Calculated value 54.72 6.29 12.49 Amino acid analysis (0.5 μM /Hydrochloric acid, anisole,
110℃ 48 hours); Ser0.65(1), Glu1.10(1), Pro1(1),
Gly1.02(1), Ala1.00(1), Lys1.89(2), Arg2.02(2) (7) P(46−54); BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−Pro−Arg(Tos)−Lys(Z−
Cl)-Lys(Z-Cl)-OH [50] 10.62 g of acetic acid in 30 g of zinc powder/60 ml of acetic acid [49]
40 ml of solution was added and stirred at room temperature for 2 hours. After the reaction, the zinc dust was filtered off, and the filtrate was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was diluted with ethanol.
Purification was performed once with ether and twice with ethanol-ethyl acetate to obtain 9.60 g (91.4% yield) of [50]. TLC; Rf 4 = 0.22 Elemental analysis [as C 84 H 114 O 22 N 18 S 2 Cl 2・2H 2 O] C% H% N% Measured value 52.89 6.16 13.22 Calculated value 53.12 6.26 13.28 Amino acid analysis (0.5μM/6N -Hydrochloric acid-anisole, 110℃ 48 hours); Ser0.88(1), Glu1.11(1),
Pro1.02(1), Gly1.02(1), Ala1(1), Lys2.00(2),
Arg2.09(2) (8) P(46−84); BOC−Ala−Gly−Ser(Bzl)−
Gln−Arg(Tos)−Pro−Arg(Tos)−Lys(Z−
Cl)−Lys(Z−Cl)−Glu(OBzl)−Asp(OBzl)
−Asn−Val−Leu−Val−Glu(OBzl)−Ser
(Bzl)-His-Glu(OBzl)-Lys(Z-Cl)-Ser
(Bzl)−Leu−Gly−Glu(OBzl)−Ala−Asp
(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)−
Val−Ash−Val−Leu−Thr(Bzl)−Lys(Z−
Cl) −Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [51] [34] 15.33g (3mM) described in Example 1
After adding 130 ml of TFA and stirring at room temperature for 60 minutes,
TFA was distilled off under reduced pressure. Add ether to the residue,
The resulting precipitate was dissolved in a mixture of 200 ml of DMF and 200 ml of NMP. This was cooled to 0°C [50] 6.70 (1.2 times M), HOBT 0.49 g (1.2 times M) and WSCI 0.66.
ml (1.2 times M) and stirred at room temperature for 2 days. After the reaction, DMF was distilled off under reduced pressure, ice water was added to the residue, and the resulting precipitate was collected by filtration. Add 300ml of methanol to this, heat it, cool it, and then filter out the insoluble matter twice. [51] 18.30g
(yield 89.0%). (7) Peptide (46-84) [51] Add 3 ml of anisole to 4.11 g (0.6 mM), introduce 60 ml of anhydrous hydrogen fluoride (HF),
The mixture was stirred at 0°C for 60 minutes. After the reaction, HF was distilled off under reduced pressure, ether was added to the residue, and the resulting precipitate was collected.
Dissolve in 50 ml of 1M acetic acid and pass through a Dowex 1 x 2 column (3.0 x 45 cm acetic acid type). The effluent was freeze-dried to obtain 2.8 g of crude product. Then add this to 8M
Dissolve in 50ml of urea aqueous solution and pH with ammonia water.
After adjusting the temperature to 9.5, it was left at 0°C for 60 minutes. This solution was then applied to a CM-cellulose column (2.0 x 36
cm) and washed with 200ml of 0.01M ammonium acetate buffer (PH4.5), then 500ml of the same buffer.
~0.3M ammonium acetate buffer (PH4.5) 500ml
Perform elution using a linear concentration gradient. The eluate is
Fractionate into 7.5 ml portions, collect 56th to 84th tubes, freeze-dry, and transfer to Sephadex LH-20 column (3.0 x 120
cm), eluted with 0.1N acetic acid, fractionated into 6 ml portions, collected 41st to 52nd tubes, and freeze-dried to obtain 620 ml. Further, this was charged to a CM-cellulose recolumn (2.0 x 38 cm), and a linear concentration gradient of 500 ml of 0.01N ammonium acetate buffer (PH4.5) to 500 ml of 0.3M ammonium acetate buffer (PH4.5) was applied in the same manner. Elution was performed using Fractionate 7.5ml each, 59
~Collect the 80th bottle, freeze-dry it, and then ceph-dex.
Pass through LH-20 column (3.0 x 120cm 0.1N acetic acid),
The mixture was fractionated into 8 ml portions, 31st to 36th portions were collected, and lyophilized to obtain 235 mg of peptide (46-84). TLC; Rf=0.77 Amino acid analysis; Asp4.98(5), Thr0.95(1),
Ser3.62(4), Glu6.14(6), Pro0.99(1), Gly1.96(2),
Ala4, Val4.01(4), Leu2.98(3), Lys6.12(6),
His0.93(1), Arg1.92(2) Reference example 6 [Tyr 45 ]-peptide (45-84); H-Tyr-
Ala−Gly−SerGln−Arg−Pro−Arg−Lys−
Lys−Glu−Asp−Asn−Val−Leu−Val−Glu
−Ser−His−Glu−LysSer−Leu−Gly−Glu
−Ala−Asp−Lys−Ala−Asp−Val−Asn−
Val−Leu−Thr−Lys−Ala−Lys−Ser−Gln
−OH (1) P(45−84); BOC−Tyr(Bzl−Cl 2 )−Ala−
Gly−Ser(Bzl)−Gln−Arg(Tos)−Pro−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Glu
(OBzl)−Asp(OBzl)−Asn−Val−Leu−Val
−Glu(OBzl)−Ser(Bzl)−His−Glu(OBzl)−
Lys(Z−Cl)−Ser(Bzl)−Leu−Gly−Glu
(OBzl)-Ala-Asp(OBzl)-Lys(Z-Cl)-
Ala−Asp(OBzl)−Val−Asn−Val−Leu−
Thr(Bzl)−Lys(Z−C1)−Ala−Lys(Z−Cl)
-Ser(Bzl)-Gln-OBzl [52] 13.71g (2.0mM) of [51] described in Reference Example 5
180 ml of TFA was added and stirred at room temperature for 60 minutes. After the reaction, TFA was distilled off under reduced pressure, and ether was added to the residue. Filter the resulting precipitate and remove BOC 13.80
I got g. 6.90g (1mM) of the above BOC removed product in 135ml DMF
Dissolved in a mixture of 135 ml of NMP and 0.53 g of BOC-Tyr(Bzl-Cl 2 )-OH (1.2 times M), 0.16 g of HOBT (1.2 times M) and WSCI0.22 while cooling to 0°C.
ml (1.2 times M) and stirred overnight at room temperature.
After the reaction, DMF was distilled off under reduced pressure, and ice water was added to the residue. The resulting precipitate was collected by filtration and washed with DMF-methanol-ether to give 6.12 g (yield 85.3) [52].
%) was obtained. (2) 1.5 ml of anisole was added to 4.31 g (0.60 mM) of [Tyr 45 ]-peptide (45-84) [52], anhydrous HF was introduced, and the mixture was stirred at 0°C for 1 hour. Next, HF was distilled off under reduced pressure, ether was added to the residue, the precipitate was collected, dissolved in 25 ml of 0.1N acetic acid, and loaded onto a Dowex 1x2 column (acetic acid type,
2.5 x 30cm). The effluent was freeze-dried to obtain 3.21 g of crude product. Add to this 8M urea aqueous solution (PH
9.5) Dissolve in 50ml and leave at 0℃ for 1 hour. This solution was then applied to a CM cellulose column (4.3 x 16
cm) and elute with a linear concentration gradient of 800 ml of 0.01 M ammonium acetate buffer (PH4.5) to 800 ml of 0.3 M ammonium acetate buffer (PH4.5). The eluate was fractionated into 6.5ml portions, 118th to 151st tubes were collected, lyophilized, and charged to a Sephadex LH-20 column (3.0 x 120cm, 0.1N acetic acid).
Fractionate the effluent into 7.5ml portions, collect the 26th to 37th bottles,
Lyophilization yielded 521 mg. CM this further
- Charge a cellulose column (2.1 x 48 cm) and add 0.01N ammonium acetate buffer (PH4.5) at 500%
ml~0.3M ammonium acetate buffer (PH4.5) 500
Perform elution using a linear concentration gradient of 800 ml, collect the 59th to 70th aliquots, freeze-dry, charge to a Sephadex LH-20 column (3.0 x 92 cm, 0.1N acetic acid), and collect the effluent. Fractionate 8.0ml each,
The 21st to 30th strands were collected and freeze-dried to obtain 281 mg of [Tyr 45 ]-peptide (45-84). TLC; Rf 9 = 0.75 Amino acid analysis; Asp4.97(5), Thr0.97(1),
Ser3.62(4), Glu6.11(6), Pro0.96(1), Gly1.93(2),
Ala4, Val3.98(4), Leu2.95(3), Thr0.91(1),
Lys6.04(6), His0.92(1), Arg1.91(2), Reference example 7 [ Cys45 ]-peptide (46-84); H-Cys-Ala-Gly-Ser-Gln-Arg- Pro-
Arg−Lys−Lys−Glu−Asp−Asn−Val−Leu
−Val−Glu−Ser−His−Glu−Lys−Ser−
Leu−Gly−Glu−Ala−Asp−Lys−Ala−Asp
−Val−Asn−Val−Leu−Thr−Lys−Ala−
Lys−Ser−Glu−OH (1) P(45−84); BOC−Cys(Acm)−Ala−Gly
−Ser(Bzl)−Gln−Arg(Tos)−Pro−Arg
(Tos)−Lys(Z−Cl)−Glu(OBzl)−Asp
(OBzl) −Asn−Val−Leu−Val−Glu(OBzl)
−Ser(Bzl)−His−Glu(OBzl)−Lys(Z−Cl)
−Ser(Bzl)−Leu−Gly−Glu(OBzl)−Ala−
Asp(OBzl)−Lys(Z−Cl)−Ala−Asp(OBzl)
−Val−Asn−Val−Leu−Thr(Bzl)−Lys(Z
−Cl) −Ala−Lys(Z−Cl)−Ser(Bzl)−Gln−
OBzl [53] 6.90 g of the remaining BOC removed product obtained in Reference Example 6
(1.0mM) was dissolved in a mixture of 130ml of DMF and 130ml of NMP, and in this was added 0.16g of HOBT (1.2xM) and 0.35g of BOC-Cys(Acm)-OH (1.2xM) under cooling to 0℃.
After adding 0.22 ml of WSCI (1.2 times M), the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure.
Ice water was added to the residue, and the resulting precipitate was collected. This was suspended in ethanol, heated, cooled, and then the insoluble matter was filtered off. This operation was repeated twice to obtain 5.93 g (yield: 84.4%) of [53]. (2) 15 ml of anisole was added to 4.22 g (0.6 mM) of [Cys(Acm) 45 ]-peptide (45-84) [53], 80 ml of anhydrous HF was introduced therein, and the mixture was stirred at 0° C. for 1 hour. Next, HF was distilled off under reduced pressure, ether was added to the residue, the resulting precipitate was collected, dissolved in 50 ml of 20% acetic acid, and transferred to a Dowex 1 x 2 column (2.8 x 45
cm, acetic acid form). Freeze-dry the effluent, dissolve it in 60 ml of 8M urea aqueous solution, adjust the pH to 9.5 with aqueous ammonia, and add CM-cellulose (3 x 45 cm).
and elute with a linear concentration gradient of 700 ml of 0.01 M ammonium acetate buffer (PH4.5) to 700 ml of 0.3 M ammonium acetate buffer (PH4.5), and fractionate the eluate into 8.0 ml portions. The ~55th tube was collected, lyophilized, passed through a Sephadex LH-20 column (3.0 x 120 cm, 0.1N acetic acid), and the 35th to 41st tubes were collected and freeze-dried to obtain 580 mg. This was further coated with a CM-cellulose column (5x
13 cm), and elution was performed using a linear concentration gradient of 400 ml of 0.01 M ammonium acetate buffer (PH4.5) to 400 ml of 0.3 M ammonium acetate buffer (PH4.5). Fractionate the eluate into 6.0 ml portions, 120 to 131
After collecting the ingredients and freeze-drying, Sephadex LH-
20 columns (4.0 x 120 cm, 0.1N acetic acid),
Fractionate the effluent into 8.0ml portions, collect 38th to 53rd bottles,
Freeze-dry to obtain [Cys(Acm) 45 ]-peptide(46-
84) Obtained 233 mg. TLC; Rf 9 = 0.74 Amino acid analysis; Asp4.97(5), Thr1.00(1),
Ser3.67(4), Glu6.07, Pro1.01(1), Gly1.96(2),
Ala4, Val3.99(4), Cys0.43(0.5), Leu2.94(3),
Lys6.03(6), His0.91(1), Arg1.92(2), (3) [CysAcm) 45 ]-Peptide (45−84) mg
(0.02mM) dissolved in 58mg of mercuric acetate
2 ml of 50% acetic acid was added and dissolved, and after stirring at room temperature for 90 minutes, 4 ml of β-mercaptoethanol was added, and the mixture was stirred at room temperature for 24 hours. The reaction solution was centrifuged, and the supernatant was transferred to Sephadex G-25 (3.0 x 90 cm, 0.1N
acetic acid), fractionate the eluate into 10.5 ml portions, collect the 24th to 29th fractions, freeze-dry them,
64.1 mg of [Cys 45 ]-peptide (45-84) was obtained. TLC; Rf 9 = 0.73
第1〜3図は、各種h−PTH関連物質との交
叉性の測定曲線を示す。
Figures 1 to 3 show cross-reactivity measurement curves with various h-PTH-related substances.
Claims (1)
Val−Glu−Ser−His−Glu−Lys−Ser−Leu−
Gly−Glu−Ala−Asp−Lys−Ala−Asp−Val−
Asn−Val−Leu−Thr−Lys−Ala−Lys−Ser−
Gln−OH で表わされるペプチドまたはその塩。[Claims] 1 Formula H-Lys-Lys-Glu-Asp-Asn-Val-Leu-
Val−Glu−Ser−His−Glu−Lys−Ser−Leu−
Gly−Glu−Ala−Asp−Lys−Ala−Asp−Val−
Asn−Val−Leu−Thr−Lys−Ala−Lys−Ser−
Peptide represented by Gln-OH or its salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57054665A JPS58172353A (en) | 1982-04-01 | 1982-04-01 | Peptide for determination |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57054665A JPS58172353A (en) | 1982-04-01 | 1982-04-01 | Peptide for determination |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58172353A JPS58172353A (en) | 1983-10-11 |
JPH0427996B2 true JPH0427996B2 (en) | 1992-05-13 |
Family
ID=12977072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57054665A Granted JPS58172353A (en) | 1982-04-01 | 1982-04-01 | Peptide for determination |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58172353A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6345680A (en) * | 1986-08-12 | 1988-02-26 | Nasu Denki Tekko Kk | System for drawing steel tower in full size |
-
1982
- 1982-04-01 JP JP57054665A patent/JPS58172353A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6345680A (en) * | 1986-08-12 | 1988-02-26 | Nasu Denki Tekko Kk | System for drawing steel tower in full size |
Also Published As
Publication number | Publication date |
---|---|
JPS58172353A (en) | 1983-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2594259B2 (en) | Membrane anchor / active compound conjugate and method for producing the same | |
Dhaon et al. | Esterification of N-protected. alpha.-amino acids with alcohol/carbodiimide/4-(dimethylamino) pyridine. Racemization of aspartic and glutamic acid derivatives | |
US4086221A (en) | Polypeptides and process for producing the same | |
US4656250A (en) | [Nle8, Nle18, Tyr34 or Phe34 ]-h-PTH peptide derivatives | |
US4423034A (en) | Process for the preparation of antibodies | |
JPH0753752B2 (en) | Enzyme resistant immunomodulatory peptide | |
US3978035A (en) | 13-Norleucine-14-desamido motilin, a method for preparing it and an agent containing it | |
US3963691A (en) | Synthetic antigens of luteinizing hormone releasing hormone | |
US4409141A (en) | Peptides for assaying human parathyroid hormone | |
GB2062644A (en) | Glucagon fragment and utility hereof | |
SU1028662A1 (en) | Polypeptide having the effect of lowering calcium content of serum | |
EP0181121B1 (en) | Novel polypeptide and process for producing the same | |
Nussberger et al. | Selectivity of angiotensin II antisera | |
JPH0427996B2 (en) | ||
US4167508A (en) | Phlorethyl-β-alanyl-secretine | |
Chersi et al. | Isolation, chemical and immunologic characterization of κ-and λ-type light chains from IgG of normal rabbits with b9 allotype | |
US4117117A (en) | Tridecapetide having gastrin effect | |
JPS6345680B2 (en) | ||
US3790555A (en) | Octapeptide derivative of gonadotropinreleasing hormone | |
JPH0123059B2 (en) | ||
KR790001841B1 (en) | Process for producing novel polypeptides | |
JPH0122902B2 (en) | ||
KR790001842B1 (en) | Process for producing novel polypeptides | |
JPS6332145B2 (en) | ||
JPH0532697A (en) | Synthetic human osteocalcin and production thereof |